Science.gov

Sample records for high-energy neutron therapy

  1. High energy neutron radiography

    SciTech Connect

    Gavron, A.; Morley, K.; Morris, C.; Seestrom, S.; Ullmann, J.; Yates, G.; Zumbro, J.

    1996-06-01

    High-energy spallation neutron sources are now being considered in the US and elsewhere as a replacement for neutron beams produced by reactors. High-energy and high intensity neutron beams, produced by unmoderated spallation sources, open potential new vistas of neutron radiography. The authors discuss the basic advantages and disadvantages of high-energy neutron radiography, and consider some experimental results obtained at the Weapons Neutron Research (WNR) facility at Los Alamos.

  2. Neutron spectra and dose equivalents calculated in tissue for high-energy radiation therapy

    SciTech Connect

    Kry, Stephen F.; Howell, Rebecca M.; Salehpour, Mohammad; Followill, David S.

    2009-04-15

    Neutrons are by-products of high-energy radiation therapy and a source of dose to normal tissues. Thus, the presence of neutrons increases a patient's risk of radiation-induced secondary cancer. Although neutrons have been thoroughly studied in air, little research has been focused on neutrons at depths in the patient where radiosensitive structures may exist, resulting in wide variations in neutron dose equivalents between studies. In this study, we characterized properties of neutrons produced during high-energy radiation therapy as a function of their depth in tissue and for different field sizes and different source-to-surface distances (SSD). We used a previously developed Monte Carlo model of an accelerator operated at 18 MV to calculate the neutron fluences, energy spectra, quality factors, and dose equivalents in air and in tissue at depths ranging from 0.1 to 25 cm. In conjunction with the sharply decreasing dose equivalent with increased depth in tissue, the authors found that the neutron energy spectrum changed drastically as a function of depth in tissue. The neutron fluence decreased gradually as the depth increased, while the average neutron energy decreased sharply with increasing depth until a depth of approximately 7.5 cm in tissue, after which it remained nearly constant. There was minimal variation in the quality factor as a function of depth. At a given depth in tissue, the neutron dose equivalent increased slightly with increasing field size and decreasing SSD; however, the percentage depth-dose equivalent curve remained constant outside the primary photon field. Because the neutron dose equivalent, fluence, and energy spectrum changed substantially with depth in tissue, we concluded that when the neutron dose equivalent is being determined at a depth within a patient, the spectrum and quality factor used should be appropriate for depth rather than for in-air conditions. Alternately, an appropriate percent depth-dose equivalent curve should be

  3. The Clatterbridge high-energy neutron therapy facility: specification and performance.

    PubMed

    Bonnett, D E; Blake, S W; Shaw, J E; Bewley, D K

    1988-01-01

    A new high-energy neutron therapy facility has been installed at the Douglas Cyclotron Centre, Clatterbridge Hospital, Merseyside, in order to extend the clinical trials of fast neutrons initiated by the Medical Research Council. The neutron beam is produced by bombarding a beryllium target with 62 MeV protons. The target is isocentrically mounted with the potential for 360 degrees rotation and has a fully variable collimator. This gives a range of rectilinear field sizes from 5 cm x 5 cm to 30 cm x 30 cm. Basic neutron beam data including output, field flatness, penumbra and depth-dose data have been measured. For a 10 cm x 10 cm field, the 50% depth dose occurs at 16.2 cm in water and the output is 1.63 cGy microA-1 min-1 at the depth of dose maximum. The effectiveness of the target shielding and the neutron-induced radioactivity in the treatment head have also been measured. It is concluded that the equipment meets both the design specifications and also fully satisfies criticisms of earlier neutron therapy equipment. A full radiation survey of the centre was also carried out and it was found that radiation levels are low and present no significant hazard to staff. PMID:3126848

  4. Neutron beam optimization for boron neutron capture therapy using the D-D and D-T high-energy neutron sources

    SciTech Connect

    Verbeke, J.M.; Vujic, J.L.; Leung, K.N.

    2000-02-01

    A monoenergetic neutron beam simulation study is carried out to determine the most suitable neutron energy for treatment of shallow and deep-seated brain tumors in the context of boron neutron capture therapy. Two figures-of-merit--the absorbed skin dose and the absorbed tumor dose at a given depth in the brain--are used to measure the neutron beam quality. Based on the results of this study, moderators, reflectors, and delimiters are designed and optimized to moderate the high-energy neutrons from the fusion reactions {sup 2}H(d,n){sup 3}He and {sup 3}H(d,n){sup 4}He down to a suitable energy spectrum. Two different computational models (MCNP and BNCT-RTPE) have been used to study the dose distribution in the brain. With the optimal beam-shaping assembly, a 1-A mixed deuteron/triton beam of energy 150 keV accelerated onto a titanium target leads to a treatment time of 1 h. The dose near the center of the brain obtained with this configuration is > 65% higher than the dose from a typical spectrum produced by the Brookhaven Medical Research Reactor and is comparable to the dose obtained by other accelerator-produced neutron beams.

  5. High energy neutron dosimeter

    DOEpatents

    Rai, K.S.F.

    1994-01-11

    A device for measuring dose equivalents in neutron radiation fields is described. The device includes nested symmetrical hemispheres (forming spheres) of different neutron moderating materials that allow the measurement of dose equivalents from 0.025 eV to past 1 GeV. The layers of moderating material surround a spherical neutron counter. The neutron counter is connected by an electrical cable to an electrical sensing means which interprets the signal from the neutron counter in the center of the moderating spheres. The spherical shape of the device allows for accurate measurement of dose equivalents regardless of its positioning. 2 figures.

  6. High energy neutron dosimeter

    DOEpatents

    Sun, Rai Ko S.F.

    1994-01-01

    A device for measuring dose equivalents in neutron radiation fields. The device includes nested symmetrical hemispheres (forming spheres) of different neutron moderating materials that allow the measurement of dose equivalents from 0.025 eV to past 1 GeV. The layers of moderating material surround a spherical neutron counter. The neutron counter is connected by an electrical cable to an electrical sensing means which interprets the signal from the neutron counter in the center of the moderating spheres. The spherical shape of the device allows for accurate measurement of dose equivalents regardless of its positioning.

  7. High-energy neutron dosimetry

    NASA Astrophysics Data System (ADS)

    Sutton, Michele Rhea

    2001-12-01

    Fluence-to-dose conversion coefficients for the radiation protection quantity effective dose were calculated for neutrons, photons and protons with energies up to 2 GeV using the MCNPX code. The calculations were performed using the Pacific Northwest National Laboratory versions of the MIRD-V male and female anthropomorphic phantoms modified to include the skin and esophagus. The latest high-energy neutron evaluated cross-section libraries and the recommendations given in ICRP Publication 60 and ICRP Publication 74 were utilized to perform the calculations. Sets of fluence-to- effective dose conversion coefficients are given for anterior-posterior, posterior-anterior, left-lateral, right-lateral and rotational irradiation geometries. This is the first set of dose conversion coefficients over this energy range calculated for the L-LAT irradiation geometry. A unique set of high-energy neutron depth-dose benchmark experiments were performed at the Los Alamos Neutron Science Center/Weapons Neutron Research (LANSCE/WNR) complex. The experiments consisted of filtered neutron beams with energies up to 800 MeV impinging on a 30 x 30 x 30 cm3 tissue-equivalent phantom. The absorbed dose was measured in the phantom at various depths with tissue-equivalent ion chambers. The phantom and the experimental set-up were modeled using MCNPX. Comparisons of the experimental and computational depth- dose distributions indicate that the absorbed dose calculated by MCNPX is within 13% for neutrons with energies up to 750 MeV. This experiment will serve as a benchmark experiment for the testing of high-energy radiation transport codes for the international radiation protection community.

  8. Neutron therapy of cancer

    NASA Technical Reports Server (NTRS)

    Frigerio, N. A.; Nellans, H. N.; Shaw, M. J.

    1969-01-01

    Reports relate applications of neutrons to the problem of cancer therapy. The biochemical and biophysical aspects of fast-neutron therapy, neutron-capture and neutron-conversion therapy with intermediate-range neutrons are presented. Also included is a computer program for neutron-gamma radiobiology.

  9. High-energy neutron spectroscopy with thick silicon detectors

    NASA Technical Reports Server (NTRS)

    Kinnison, James D.; Maurer, Richard H.; Roth, David R.; Haight, Robert C.

    2003-01-01

    The high-energy neutron component of the space radiation environment in thick structures such as the International Space Station contributes to the total radiation dose received by an astronaut. Detector design constraints such as size and mass have limited the energy range of neutron spectrum measurements in orbit to about 12 MeV in Space Shuttle studies. We present a new method for high-energy neutron spectroscopy using small silicon detectors that can extend these measurements to more than 500 MeV. The methodology is based on measurement of the detector response function for high-energy neutrons and inversion of this response function with measured deposition data to deduce neutron energy spectra. We also present the results of an initial shielding study performed with the thick silicon detector system for high-energy neutrons incident on polyethylene.

  10. High-energy neutron spectroscopy with thick silicon detectors.

    PubMed

    Kinnison, James D; Maurer, Richard H; Roth, David R; Haight, Robert C

    2003-02-01

    The high-energy neutron component of the space radiation environment in thick structures such as the International Space Station contributes to the total radiation dose received by an astronaut. Detector design constraints such as size and mass have limited the energy range of neutron spectrum measurements in orbit to about 12 MeV in Space Shuttle studies. We present a new method for high-energy neutron spectroscopy using small silicon detectors that can extend these measurements to more than 500 MeV. The methodology is based on measurement of the detector response function for high-energy neutrons and inversion of this response function with measured deposition data to deduce neutron energy spectra. We also present the results of an initial shielding study performed with the thick silicon detector system for high-energy neutrons incident on polyethylene. PMID:12537520

  11. Practical neutron dosimetry at high energies

    SciTech Connect

    McCaslin, J.B.; Thomas, R.H.

    1980-10-01

    Dosimetry at high energy particle accelerators is discussed with emphasis on physical measurements which define the radiation environment and provide an immutable basis for the derivation of any quantities subsequently required for risk evaluation. Results of inter-laboratory dosimetric comparisons are reviewed and it is concluded that a well-supported systematic program is needed which would make possible detailed evaluations and inter-comparisons of instruments and techniques in well characterized high energy radiation fields. High-energy dosimetry is so coupled with radiation transport that it is clear their study should proceed concurrently.

  12. First observations of power MOSFET burnout with high energy neutrons

    SciTech Connect

    Oberg, D.L.; Wert, J.L.; Normand, E.; Majewski, P.P.; Wender, S.A.

    1996-12-01

    Single event burnout was seen in power MOSFETs exposed to high energy neutrons. Devices with rated voltage {ge}400 volts exhibited burnout at substantially less than the rated voltage. Tests with high energy protons gave similar results. Burnout was also seen in limited tests with lower energy protons and neutrons. Correlations with heavy-ion data are discussed. Accelerator proton data gave favorable comparisons with burnout rates measured on the APEX spacecraft. Implications for burnout at lower altitudes are also discussed.

  13. A review on photoneutrons characteristics in radiation therapy with high-energy photon beams

    PubMed Central

    Naseri, Alireza; Mesbahi, Asghar

    2010-01-01

    In radiation therapy with high-energy photon beams (E > 10 MeV) neutrons are generated mainly in linacs head thorough (γ,n) interactions of photons with nuclei of high atomic number materials that constitute the linac head and the beam collimation system. These neutrons affect the shielding requirements in radiation therapy rooms and also increase the out-of-field radiation dose of patients undergoing radiation therapy with high-energy photon beams. In the current review, the authors describe the factors influencing the neutron production for different medical linacs based on the performed measurements and Monte Carlo studies in the literature. PMID:24376940

  14. Neutrons in cancer therapy

    NASA Astrophysics Data System (ADS)

    Allen, Barry J.

    1995-03-01

    The role of neutrons in the management of cancer has a long history. However, it is only in recent years that neutrons are beginning to find an accepted place as an efficacious radiation modality. Fast neutron therapy is already well established for the treatment of certain cancers, and clinical trials are ongoing. Californium neutron sources are being used in brachytherapy. Boron neutron capture therapy has been well tested with thermal neutrons and epithermal neutron dose escalation studies are about to commence in the USA and Europe. Possibilities of neutron induced auger electron therapy are also discussed. With respect to chemotherapy, prompt neutron capture analysis is being used to study the dose optimization of chemotherapy in the management of breast cancer. The rationales behind these applications of neutrons in the management of cancer are examined.

  15. High-Energy Neutron Spectra and Flux Measurements Below Ground

    NASA Astrophysics Data System (ADS)

    Roecker, Caleb; Bernstein, Adam; Marleau, Peter; Vetter, Kai

    2016-03-01

    High-energy neutrons are a ubiquitous and often poorly measured background. Below ground, these neutrons could potentially interfere with antineutrino based reactor monitoring experiments as well as other rare-event neutral particle detectors. We have designed and constructed a transportable fast neutron detection system for measuring neutron energy spectra and flux ranging from tens to hundreds of MeV. The spectrometer uses a multiplicity technique in order to have a higher effective area than traditional transportable high-energy neutron spectrometers. Transportability ensures a common detector-related systematic bias for future measurements. The spectrometer is composed of two Gd containing plastic scintillator detectors arranged around a lead spallation target. A high-energy neutron may interact in the lead producing many secondary neutrons. The detector records the correlated secondary neutron multiplicity. Over many events, the response can be used to infer the incident neutron energy spectrum and flux. As a validation of the detector response, surface measurements have been performed; results confirm agreement with previous experiments. Below ground measurements have been performed at 3 depths (380, 600, and 1450 m.w.e.); results from these measurements will be presented.

  16. High Energy Neutron Induced Gamma Production

    SciTech Connect

    Brown, D A; Johnson, M; Navratil, P

    2007-09-28

    N Division has an interest in improving the physics and accuracy of the gamma data it provides to its customers. It was asked to look into major gamma producing reactions for 14 MeV incident neutrons for several low-Z materials and determine whether LLNL's processed data files faithfully represent the current state of experimental and theoretical knowledge for these reactions. To address this, we surveyed the evaluations of the requested materials, made recommendations for the next ENDL release and noted isotopes that will require further experimental study. This process uncovered several major problems in our translation and processing of the ENDF formatted evaluations, most of which have been resolved.

  17. High-energy neutron dosimetry with superheated drop detectors.

    PubMed

    d'Errico, F; Agosteo, S; Sannikov, A V; Silari, M

    2002-01-01

    A systematic analysis of the response of dichlorodifluoromethane superheated drop detectors was performed in the 46-133 MeV energy range. Experiments with quasi-monoenergetic neutron beams were performed at the Université Catholique de Leuvain-la-Neuve, Belgium and the Svedberg Laboratory, Sweden, while tests in a broad field were performed at CERN. To determine the response of the detectors to the high-energy beams, the spectra of incident neutrons were folded over functions modelled after the cross sections for the production of heavy ions from the detector elements. The cross sections for fluorine and chlorine were produced in this work by means of the Monte Carlo high-energy transport code HADRON based on the cascade exciton model of nuclear interactions. The new response data permit the interpretation of measurements at high-energy accelerators and on high-altitude commercial flights, where a 30-50% under-response had been consistently recorded with respect to neutron dose equivalent. The introduction of a 1 cm lead shell around the detectors effectively compensates most of the response defect. PMID:12382936

  18. Spectral correction factors for conventional neutron dosemeters used in high-energy neutron environments.

    PubMed

    Lee, K W; Sheu, R J

    2015-04-01

    High-energy neutrons (>10 MeV) contribute substantially to the dose fraction but result in only a small or negligible response in most conventional moderated-type neutron detectors. Neutron dosemeters used for radiation protection purpose are commonly calibrated with (252)Cf neutron sources and are used in various workplace. A workplace-specific correction factor is suggested. In this study, the effect of the neutron spectrum on the accuracy of dose measurements was investigated. A set of neutron spectra representing various neutron environments was selected to study the dose responses of a series of Bonner spheres, including standard and extended-range spheres. By comparing (252)Cf-calibrated dose responses with reference values based on fluence-to-dose conversion coefficients, this paper presents recommendations for neutron field characterisation and appropriate correction factors for responses of conventional neutron dosemeters used in environments with high-energy neutrons. The correction depends on the estimated percentage of high-energy neutrons in the spectrum or the ratio between the measured responses of two Bonner spheres (the 4P6_8 extended-range sphere versus the 6″ standard sphere). PMID:25280480

  19. Preliminary studies for a high energy neutron area monitor

    SciTech Connect

    Devine, R.T.; Hsu, H.H.

    1998-12-01

    Track etch detectors were exposed to neutrons produced by a spallation target struck by a beam of 800 MeV protons. The fields were filtered by 0, 10, and 40 centimeters of polyethylene. The track etch dosimeters were exposed on a polyethylene phantom. The dosimeters were exposed bare and behind lead filters of 0.25, 0.50, 0.75, 1.00, 1.25 and 1.50 cm of lead with the face of the dosimeter perpendicular to the beam and bare and behind lead filters of 0.50, 1.0, and 1.5 cm of lead with angle of incidence 45{degree} and 75{degree}. Monte Carlo calculations of these experimental configurations were done using MCNP and LAHET with input from the calculated spectra. These results are compared with the experimental results to understand the basic processes involved in the production of tracks with high energy neutrons and develop a high energy neutron area monitor.

  20. Neutron capture therapies

    SciTech Connect

    Yanch, J.C.; Shefer, R.E.; Klinkowstein, R.E.

    1999-11-02

    In one embodiment there is provided an application of the {sup 10}B(n,{alpha}){sup 7}Li nuclear reaction or other neutron capture reactions for the treatment of rheumatoid arthritis. This application, called Boron Neutron Capture Synovectomy (BNCS), requires substantially altered demands on neutron beam design than for instance treatment of deep seated tumors. Considerations for neutron beam design for the treatment of arthritic joints via BNCS are provided for, and comparisons with the design requirements for Boron Neutron Capture Therapy (BNCT) of tumors are made. In addition, exemplary moderator/reflector assemblies are provided which produce intense, high-quality neutron beams based on (p,n) accelerator-based reactions. In another embodiment there is provided the use of deuteron-based charged particle reactions to be used as sources for epithermal or thermal neutron beams for neutron capture therapies. Many d,n reactions (e.g. using deuterium, tritium or beryllium targets) are very prolific at relatively low deuteron energies.

  1. Neutron capture therapies

    SciTech Connect

    Yanch, Jacquelyn C.; Shefer, Ruth E.; Klinkowstein, Robert E.

    1999-01-01

    In one embodiment there is provided an application of the .sup.10 B(n,.alpha.).sup.7 Li nuclear reaction or other neutron capture reactions for the treatment of rheumatoid arthritis. This application, called Boron Neutron Capture Synovectomy (BNCS), requires substantially altered demands on neutron beam design than for instance treatment of deep seated tumors. Considerations for neutron beam design for the treatment of arthritic joints via BNCS are provided for, and comparisons with the design requirements for Boron Neutron Capture Therapy (BNCT) of tumors are made. In addition, exemplary moderator/reflector assemblies are provided which produce intense, high-quality neutron beams based on (p,n) accelerator-based reactions. In another embodiment there is provided the use of deuteron-based charged particle reactions to be used as sources for epithermal or thermal neutron beams for neutron capture therapies. Many d,n reactions (e.g. using deuterium, tritium or beryllium targets) are very prolific at relatively low deuteron energies.

  2. Complications of fast neutron therapy.

    PubMed

    Cohen, L

    1998-01-01

    The purpose of the study was to identify the tissues and organs at risk following high-energy neutron-beam therapy for selected radioresistant tumors, estimating the separate probabilities of both normal tissue injury and of tumor recurrence, each in relation to the absorbed dose. Published statistical and anecdotal reports on the incidence of serious complications observed following fast neutron treatment directed to the cranium, head and neck, chest, upper abdomen, pelvis, and extremities are reviewed and dose-response parameters derived using bivariate probit or logistic analyses. We then calculate the conditional probability of uncomplicated control (PUC) at various doses, assuming that tumor cure and late injury are stochastically independent events. The median effective doses and coefficients of variation, derived for neutron irradiation of human brain and spinal cord, oropharynx, lung, stomach and bowel, rectum and bladder, and extremities, are tabulated and tentative "tolerance limits" estimated. Tolerance doses are shown to depend on several factors including beam quality, chemical composition, cell cycling rate, fraction-size, and follow-up time. In patients followed over 5 years, safe tolerance doses appear to range from < 14 GY for the central nervous system up to 22 GY in the oropharynx and mandible. Given well-determined dose-response data for specific normal tissues and the associated tumors, the separate probabilities of tumor control and of normal tissue injury at a given dose can be estimated. The particular treatment scheme yielding the highest PUC can usually be identified. The maximum PUC for neutron therapy, compared with other modalities, is a measure of both efficacy and safety for the procedure under study and thus provides a useful guide for comparing various modalities and treatment plans and for designing more effective treatment strategies. PMID:9670290

  3. Neutron-induced electronic failures around a high-energy linear accelerator

    SciTech Connect

    Kry, Stephen F.; Johnson, Jennifer L.; White, R. Allen; Howell, Rebecca M.; Kudchadker, Rajat J.; Gillin, Michael T.

    2011-01-15

    Purpose: After a new in-vault CT-on-rails system repeatedly malfunctioned following use of a high-energy radiotherapy beam, we investigated the presence and impact of neutron radiation on this electronic system, as well as neutron shielding options. Methods: We first determined the CT scanner's failure rate as a function of the number of 18 MV monitor units (MUs) delivered. We then re-examined the failure rate with both 2.7-cm-thick and 7.6-cm-thick borated polyethylene (BPE) covering the linac head for neutron shielding. To further examine shielding options, as well as to explore which neutrons were relevant to the scanner failure, Monte Carlo simulations were used to calculate the neutron fluence and spectrum in the bore of the CT scanner. Simulations included BPE covering the CT scanner itself as well as covering the linac head. Results: We found that the CT scanner had a 57% chance of failure after the delivery of 200 MUs. While the addition of neutron shielding to the accelerator head reduced this risk of failure, the benefit was minimal and even 7.6 cm of BPE was still associated with a 29% chance of failure after the delivery of 200 MU. This shielding benefit was achieved regardless of whether the linac head or CT scanner was shielded. Additionally, it was determined that fast neutrons were primarily responsible for the electronic failures. Conclusions: As illustrated by the CT-on-rails system in the current study, physicists should be aware that electronic systems may be highly sensitive to neutron radiation. Medical physicists should therefore monitor electronic systems that have not been evaluated for potential neutron sensitivity. This is particularly relevant as electronics are increasingly common in the therapy vault and newer electronic systems may exhibit increased sensitivity.

  4. Iodine neutron capture therapy

    NASA Astrophysics Data System (ADS)

    Ahmed, Kazi Fariduddin

    A new technique, Iodine Neutron Capture Therapy (INCT) is proposed to treat hyperthyroidism in people. Present thyroid therapies, surgical removal and 131I treatment, result in hypothyroidism and, for 131I, involve protracted treatment times and excessive whole-body radiation doses. The new technique involves using a low energy neutron beam to convert a fraction of the natural iodine stored in the thyroid to radioactive 128I, which has a 24-minute half-life and decays by emitting 2.12-MeV beta particles. The beta particles are absorbed in and damage some thyroid tissue cells and consequently reduce the production and release of thyroid hormones to the blood stream. Treatment times and whole-body radiation doses are thus reduced substantially. This dissertation addresses the first of the several steps needed to obtain medical profession acceptance and regulatory approval to implement this therapy. As with other such programs, initial feasibility is established by performing experiments on suitable small mammals. Laboratory rats were used and their thyroids were exposed to the beta particles coming from small encapsulated amounts of 128I. Masses of 89.0 mg reagent-grade elemental iodine crystals have been activated in the ISU AGN-201 reactor to provide 0.033 mBq of 128I. This activity delivers 0.2 Gy to the thyroid gland of 300-g male rats having fresh thyroid tissue masses of ˜20 mg. Larger iodine masses are used to provide greater doses. The activated iodine is encapsulated to form a thin (0.16 cm 2/mg) patch that is then applied directly to the surgically exposed thyroid of an anesthetized rat. Direct neutron irradiation of a rat's thyroid was not possible due to its small size. Direct in-vivo exposure of the thyroid of the rat to the emitted radiation from 128I is allowed to continue for 2.5 hours (6 half-lives). Pre- and post-exposure blood samples are taken to quantify thyroid hormone levels. The serum T4 concentration is measured by radioimmunoassay at

  5. Characterization of the high-energy neutron beam of the PRISMA beamline using a diamond detector

    NASA Astrophysics Data System (ADS)

    Cazzaniga, C.; Frost, C. D.; Minniti, T.; Schooneveld, E.; Perelli Cippo, E.; Tardocchi, M.; Rebai, M.; Gorini, G.

    2016-07-01

    The high-energy neutron component (En > 10 MeV) of the neutron spectrum of PRISMA, a beam-line at the ISIS spallation source, has been characterized for the first time. Neutron measurements using a Single-crystal Diamond Detector at a short-pulse source are obtained by a combination of pulse height and time of flight analysis. An XY scan provides a 2D map of the high-energy neutron beam which has a diameter of about 40 mm. The high neutron flux, that has been found to be (3.8 ± 0.7) · 105 cm‑2s‑1 for En > 10 MeV in the centre, opens up for a possible application of the beam-line as a high-energy neutron irradiation position. Results are of interest for the development of the ChipIR beam-line, which will feature an atmospheric-like neutron spectrum for chip irradiation experiment. Furthermore, these results demonstrate that diamond detectors can be used at spallation sources to investigate the transport of high-energy neutrons down instruments which is of interest in general to designers as high-energy neutrons are a source of background in thermal beamlines.

  6. Tolerance of the human spinal cord to high energy p(66)Be(49) neutrons

    SciTech Connect

    Cohen, L.; Ten Haken, R.K.; Mansell, J.; Yalavarthi, S.D.; Hendrickson, F.R.; Awschalom, M.

    1985-04-01

    The risk of post irradiation myelopathy was evaluated in 76 patients followed for 1-5 years after neutron irradiation of the cervical and thoracic regions. No overt myelopathy was observed. Forty-six patients received doses (central cord dose) in excess of 10 Gy, 9 received doses in excess of 12 Gy, and 5 received doses between 13 and 17 Gy, all without any evidence of spinal cord injury. A review of available literature revealed a total of 14 patients with myelopathy, 13 of whom received doses in excess of 13 Gy delivered with relatively low energy neutrons generated by the deuteron + beryllium reaction. It is concluded from these studies that the tolerance limit for the human spinal cord irradiated with high energy (p(66)Be(49)) neutrons is close to 15 Gy, above which the risk of cord injury becomes significant. Central cord doses of 13 Gy or less appear to be well tolerated with little, if any, risk of myelopathy. These conclusions are valid for a treatment time of 4 weeks or more with two or more fractions per week (9 or more fractions). The RBE for the human spinal cord irradiated under the above conditions compared with conventionally fractionated photon therapy does not exceed 4.0.

  7. Measurement of high energy neutrons via Lu(n,xn) reactions

    SciTech Connect

    Henry, E.A.; Becker, J.A.; Archer, D.E.; Younes, W.; Stoyer, M.A.; Slaughter, D.

    1997-07-01

    High energy neutrons can be assayed by the use of the nuclear diagnostic material lutetium. We are measuring the (n,xn) cross sections for natural lutetium in order to develop it as a detector material. We are applying lutetium to diagnose the high energy neutrons produced in test target/blanket systems appropriate for the Accelerator Production of Tritium Project. 3 refs., 5 figs., 1 tab.

  8. High energy neutron and gamma-radiation generated during the solar flares

    NASA Technical Reports Server (NTRS)

    Kocharov, G. E.; Mandzhavidze, N. Z.

    1985-01-01

    The problem of high energy neutrons and gamma rays generation in the solar conditions is considered. It is shown that due to a peculiarity of generation and propagation of neutrons corresponding solar flares should be localized at high helio-longitudes.

  9. Neutron productions in the fragmentation of relativistic heavy nuclei and formation of a beam of high-energy neutrons

    NASA Astrophysics Data System (ADS)

    Yurevich, V. I.

    2016-03-01

    The production of quasimonoenergetic high-energy neutrons at zero angle (0°) in the spallation of relativistic heavy nuclei is discussed by considering the example of the interaction of lead nuclei with light target nuclei. It is shown that this process can be used to generate a beam of high-energy neutrons at existing heavy ion accelerators. At the same time, itmay lead to the appearance of a parasitic neutron beam because of the interaction of the heavy-ion beam used with beam line and experimental setup materials.

  10. Multigroup neutron dose calculations for proton therapy

    SciTech Connect

    Kelsey Iv, Charles T; Prinja, Anil K

    2009-01-01

    We have developed tools for the preparation of coupled multigroup proton/neutron cross section libraries. Our method is to use NJOY to process evaluated nuclear data files for incident particles below 150 MeV and MCNPX to produce data for higher energies. We modified the XSEX3 program of the MCNPX code system to produce Legendre expansions of scattering matrices generated by sampling the physics models that are comparable to the output of the GROUPR routine of NJOY. Our code combines the low and high energy scattering data with user input stopping powers and energy deposition cross sections that we also calculated using MCNPX. Our code also calculates momentum transfer coefficients for the library and optionally applies an energy straggling model to the scattering cross sections and stopping powers. The motivation was initially for deterministic solution of space radiation shielding calculations using Attila, but noting that proton therapy treatment planning may neglect secondary neutron dose assessments because of difficulty and expense, we have also investigated the feasibility of multi group methods for this application. We have shown that multigroup MCNPX solutions for secondary neutron dose compare well with continuous energy solutions and are obtainable with less than half computational cost. This efficiency comparison neglects the cost of preparing the library data, but this becomes negligible when distributed over many multi group calculations. Our deterministic calculations illustrate recognized obstacles that may have to be overcome before discrete ordinates methods can be efficient alternatives for proton therapy neutron dose calculations.

  11. Neutron dosimetry in boron neutron capture therapy

    SciTech Connect

    Fairchild, R.G.; Miola, U.J.; Ettinger, K.V.

    1981-01-01

    The recent development of various borated compounds and the utilization of one of these (Na/sub 2/B/sub 12/H/sub 11/SH) to treat brain tumors in clinical studies in Japan has renewed interest in neutron capture therapy. In these procedures thermal neutrons interact with /sup 10/B in boron containing cells through the /sup 10/B(n,..cap alpha..)/sup 7/Li reaction producing charged particles with a maximum range of approx. 10..mu..m in tissue. Borated analogs of chlorpromazine, porphyrin, thiouracil and deoxyuridine promise improved tumor uptake and blood clearance. The therapy beam from the Medical Research Reactor in Brookhaven contains neutrons from a modified and filtered fission spectrum and dosimetric consequences of the use of the above mentioned compounds in conjunction with thermal and epithermal fluxes are discussed in the paper. One of the important problems of radiation dosimetry in capture therapy is determination of the flux profile and, hence, the dose profile in the brain. This has been achieved by constructing a brain phantom made of TE plastic. The lyoluminescence technique provides a convenient way of monitoring the neutron flux distributions; the detectors for this purpose utilize /sup 6/Li and /sup 10/B compounds. Such compounds have been synthesized specially for the purpose of dosimetry of thermal and epithermal beams. In addition, standard lyoluminescent phosphors, like glutamine, could be used to determine the collisional component of the dose as well as the contribution of the /sup 14/N(n,p)/sup 14/C reaction. Measurements of thermal flux were compared with calculations and with measurements done with activation foils.

  12. Neutron beam design, development, and performance for neutron capture therapy

    SciTech Connect

    Harling, O.K.; Bernard, J.A. ); Zamenhof, R.G. )

    1990-01-01

    The report presents topics presented at a workshop on neutron beams and neutron capture therapy. Topics include: neutron beam design; reactor-based neutron beams; accelerator-based neutron beams; and dosimetry and treatment planning. Individual projects are processed separately for the databases. (CBS)

  13. Neutron capture therapy with sup 235 U seeds

    SciTech Connect

    Liu, H.B.; Brugger, R.M.; Shih, J.A. )

    1992-05-01

    A combination of brachytherapy and neutron capture therapy has been evaluated using {sup 235}U metal seeds and external neutron beam irradiation. When thermal neutrons are absorbed by {sup 235}U, high-energy neutrons and gamma rays are produced and some of these deposit energy in surrounding tissue. A Monte Carlo program, using the code MCNP, has been used to evaluate two sizes of {sup 235}U seeds in a water phantom. The results of flux suppression around the seeds and dose distributions are illustrated and discussed. The results show that high doses can be delivered in a relatively short time by using {sup 235}U seeds with neutron capture therapy. This therapy with multiple needles or seeds can be envisioned as a substitute for traditional brachytherapy to give an effective killing dose.

  14. Neutron techniques. [for study of high-energy particles produced in large solar flares

    NASA Technical Reports Server (NTRS)

    Frye, Glenn M., Jr.; Dunphy, Philip P.; Chupp, Edward L.; Evenson, Paul

    1988-01-01

    Three experimental methods are described which hold the most promise for improved energy resolution, time resolution and sensitivity in the detection of solar neutrons on satellites and/or long duration balloon flights: the neutron calorimeter, the solar neutron track chamber, and the solar neutron decay proton detector. The characteristics of the three methods as to energy range, energy resolution, time resolution, detection efficiency, and physical properties are delineated. Earlier techniques to measure the intensity of high-energy cosmic-ray neutrons at the top of the atmosphere and to search for solar neutrons are described. The past three decades of detector development has now reached the point where it is possible to make comprehensive and detailed measurements of solar neutrons on future space missions.

  15. Interaction of High-Energy Proton Beam with a Thin Target and Multiplicities of Neutron

    SciTech Connect

    Demirkol, I.; Tatar, M.; Safak, M. S.; Arasoglu, A.; Tel, E.

    2007-04-23

    An important ingredient in the performance of accelerator driven systems for energy production, waste transmutation and other applications are the number of spallation neutrons produced per incident proton. The neutron multiplicities, angular and energy distributions are usually calculated using simulation codes. We have presented multiplicities of the neutrons emitted in the interaction of a high-energy proton (1500 MeV) with a thin target Pb, Bi. In this study we have used the code ISABEL to calculate multiplicities of the neutron emitted. The results obtained have been compared with the available data.

  16. ICF ignition capsule neutron, gamma ray, and high energy x-ray images

    NASA Astrophysics Data System (ADS)

    Bradley, P. A.; Wilson, D. C.; Swenson, F. J.; Morgan, G. L.

    2003-03-01

    Post-processed total neutron, RIF neutron, gamma-ray, and x-ray images from 2D LASNEX calculations of burning ignition capsules are presented. The capsules have yields ranging from tens of kilojoules (failures) to over 16 MJ (ignition), and their implosion symmetry ranges from prolate (flattest at the hohlraum equator) to oblate (flattest towards the laser entrance hole). The simulated total neutron images emphasize regions of high DT density and temperature; the reaction-in-flight neutrons emphasize regions of high DT density; the gamma rays emphasize regions of high shell density; and the high energy x rays (>10 keV) emphasize regions of high temperature.

  17. Single event upset and charge collection measurements using high energy protons and neutrons

    SciTech Connect

    Normand, E.; Oberg, D.L.; Wert, J.L.; Ness, J.D.; Majewski, P.P. ); Wender, S.; Gavron, A. )

    1994-12-01

    RAMs, microcontrollers and surface barrier detectors were exposed to beams of high energy protons and neutrons to measure the induced number of upsets as well as energy deposition. The WNR facility at Los Alamos provided a neutron spectrum similar to that of the atmospheric neutrons. Its effect on devices was compared to that of protons with energies of 200, 400, 500, and 800 MeV. Measurements indicate that SEU cross sections for 400 MeV protons are similar to those induced by the atmospheric neutron spectrum.

  18. Improving the neutron-to-photon discrimination capability of detectors used for neutron dosimetry in high energy photon beam radiotherapy.

    PubMed

    Irazola, L; Terrón, J A; Bedogni, R; Pola, A; Lorenzoli, M; Sánchez-Nieto, B; Gómez, F; Sánchez-Doblado, F

    2016-09-01

    The increasing interest of the medical community to radioinduced second malignancies due to photoneutrons in patients undergoing high-energy radiotherapy, has stimulated in recent years the study of peripheral doses, including the development of some dedicated active detectors. Although these devices are designed to respond to neutrons only, their parasitic photon response is usually not identically zero and anisotropic. The impact of these facts on measurement accuracy can be important, especially in points close to the photon field-edge. A simple method to estimate the photon contribution to detector readings is to cover it with a thermal neutron absorber with reduced secondary photon emission, such as a borated rubber. This technique was applied to the TNRD (Thermal Neutron Rate Detector), recently validated for thermal neutron measurements in high-energy photon radiotherapy. The positive results, together with the accessibility of the method, encourage its application to other detectors and different clinical scenarios. PMID:27337649

  19. Production of charm mesons by high energy neutrons

    SciTech Connect

    Shipbaugh, C.L.

    1988-01-01

    The charmed mesons D/sup /plus minus//, D/sup 0/, and D/sub s//sup /plus minus//, have been observed in neutron-nucleus collisions at the FNAL Tevatron. A sample of 134 /plus minus/ 19 events as investigated in the decay D/sup /plus minus// /yields/ D/sup 0//pi//sup /plus minus// with the subsequent decay mode D/sup 0/ /yields/ K/sup +/K/sup /minus//. The cross section per nucleon for D/sup /plus minus//, at most probable energy /radical/s = 35 GeV, was measured to be 2.11 /plus minus/ .43 (plusreverse arrowminus/.63)/mu/b/nucleon for 0.0 < x/sub f/ < 0.14 (/bar x//sub f/ = .07). The branching ratio (BR) is defined as: BR /identicalreverse arrowto/ Br(D /yields/ D/pi/) /times/ BR(D /yields/ K/sup +/K/sup /minus//). The dependence of the cross section per nucleus on number of nucleons in target was fit to a form A /sup /alpha// and it was found that /alpha/ = .96 /plusreverse arrowminus/ .17. A sample of 64 /plusreverse arrowminus/ 16 D/sub s//sup /plus minus// events was investigates for the decay D/sub s//sup /plus minus// /yields/ /phi//pi//sup /plus minus//. The differential cross section for D/sub s//sup /plus minus// production averaged over the particle and antiparticle states is: BR.(1/2)(d/sigma/(D/sub s//sup +/)/dx/sub f/ + d/sigma/(D/sub s//sup /minus//) = 2.85 /plusreverse arrowminus/ 0.80 /plusreverse arrowminus/ .86 /mu/b/nucleon at x/sub f/ = 0.175 where the first errors is statistical and the second error is systematic. The branching fraction is defined as BR /equivalentreverse arrowto/ BR(D/sub s/ /yields/ /phi//pi/), and a linear A dependence was assumed. An estimate of relative cross section is: 0.19 /plusreverse arrowminus/ 0.09 at x/sub f/ = 0. 36 refs., 43 figs., 5 tabs.

  20. Production of charm mesons by high-energy neutrons

    SciTech Connect

    Shipbaugh, C.L.

    1988-01-01

    The charmed mesons ED{sup *{plus minus}}, D{sup 0}, and D{sub s}{sup {plus minus}} have been observed in neutron-nucleus collisions at the FNAL Tevatron. A sample of 134 {plus minus} 19 events was investigated in the decay mode D{sup *{plus minus}} {yields} D{sup 0} {pi}{sup {plus minus}} with the subsequent decay mode D{sup 0} {yields} K{sup +}K{sup {minus}}. The cross section per nucleon for D{sup *}{plus minus}, at most probable energy {radical}s = 35 GeV, was measured to be: d{sigma}(xf)/dxf {center dot} BR = 2.11 {plus minus} .43({plus minus}63){mu}b/nucleon for 0.0 < x{sub f} < 0.14 (x{sub f} = .07). The branching ratio (BR) is defined as: BR {identical to} BR(D{sup *} {yields} D{sub {pi}}) {times} BR(D {yields} K{sup +}K{sup {minus}}). The dependence of the cross section per nucleus on number of nucleons in the target was fit to a form A{sup {alpha}} and it was found that {alpha} = .96 {plus minus} .17. A sample of 64 {plus minus} 16 D{sub s}{sup {plus minus}} events was investigated for the decay D{sub s}{sup {plus minus}} {yields} {phi}{pi}{sup {plus minus}}. The differential cross section for D{sub s}{sup {plus minus}} production averaged over the particle and antiparticle states is: BR {center dot} {1/2} d{sigma}D{sub s}{sup +}/dxf + d{sigma}(D{sub s}{sup {minus}}/dxf) = 2.8 {plus minus} 0.80 {plus minus} .86 {mu}b/nucleon at x{sub f} = 0.175 where the first error is statistical and the second error is systematic. The branching fraction is defined as BR {identical to} BR(D{sub s} {yields} {phi}{pi}), and a linear A dependence was assumed.

  1. Accelerators and Neutron Capture Therapy

    NASA Astrophysics Data System (ADS)

    Burlon, A. A.; Kreiner, A. J.; Valda, A.

    2002-08-01

    Within the frame of Accelerator Based Boron Neutron Capture Therapy (AB-BNCT), the 7Li (p,n) 7Be reaction, relatively near its energy threshold is one of the most promising, due to its high yield and low neutron energy. In this work a thick LiF target irradiated with a proton beam was studied as a neutron source. The 1.88-2.0 MeV proton beam was produced by the tandem accelerator TANDAR at CNEA's facilities in Buenos Aires. A water-filled phantom, containing a boron sample was irradiated with the resulting neutron flux. The 10B(n,αγ)7Li boron neutron capture reaction produces a 0.478 MeV gamma ray in 94% of the cases. The neutron yield was measured through the detection of this gamma ray using a hyperpure germanium detector with an anti-Compton shield. In addition, the thermal neutron flux was evaluated at different depths inside the phantom using bare and Cd-covered gold foils. A maximum neutron thermal flux of 1.4×108 cm-2s-1mA-1 was obtained at 4.2 cm from the phantom surface. In order to optimize the design of the neutron production target and the beam shaping assembly extensive Monte Carlo Neutron and Photon (MCNP) simulations have been performed. Neutron fields from a thick LiF and a Li metal target (with both a D2O-graphite and a Al/AlF3-graphite moderator/reflector assembly) were evaluated along the centerline of a head and a whole body phantom. Simulations were carried out for 1.89, 2.0 and 2.3 MeV proton beams. The results show that it is more advantageous to irradiate the target with 2.3 MeV near-resonance protons, instead of very near threshold, because of the higher neutron yield at this energy. On the other hand, the Al/AlF3-graphite exhibits a more efficient performance than D2O in terms of tumor to maximum healthy tissue dose ratio. Treatment times of less than 15 min and tumor control probabilities larger than 98% are obtained for a 50 mA, 2.3 MeV proton beam. The alternative neutron-producing reaction 13C(d,n) is also briefly reviewed. A

  2. Energy and angular dependence of active-type personal dosemeter for high-energy neutron.

    PubMed

    Rito, Hirotaka; Yamauchi, Tomoya; Oda, Keiji

    2011-07-01

    In order to develop an active-type personal dosemeter having suitable sensitivity to high-energy neutrons, the characteristic response of silicon surface barrier detector has been investigated experimentally and theoretically. An agreement of the shape of pulse-height distribution, its change with radiator thickness and the relative sensitivity was confirmed between the calculated and experimental results for 14.8-MeV neutrons. The angular dependence was estimated for other neutron energies, and found that the angular dependence decreased with the incident energy. The reason was also discussed with regard to the radiator thickness relative to maximum range of recoil protons. PMID:21613268

  3. A diamond 14 MeV neutron energy spectrometer with high energy resolution.

    PubMed

    Shimaoka, Takehiro; Kaneko, Junichi H; Ochiai, Kentaro; Tsubota, Masakatsu; Shimmyo, Hiroaki; Chayahara, Akiyoshi; Umezawa, Hitoshi; Watanabe, Hideyuki; Shikata, Shin-ichi; Isobe, Mitsutaka; Osakabe, Masaki

    2016-02-01

    A self-standing single-crystal chemical vapor deposited diamond was obtained using lift-off method. It was fabricated into a radiation detector and response function measurements for 14 MeV neutrons were taken at the fusion neutronics source. 1.5% of high energy resolution was obtained by using the (12)C(n, α)(9)Be reaction at an angle of 100° with the deuteron beam line. The intrinsic energy resolution, excluding energy spreading caused by neutron scattering, slowing in the target and circuit noises was 0.79%, which was also the best resolution of the diamond detector ever reported. PMID:26931845

  4. A diamond 14 MeV neutron energy spectrometer with high energy resolution

    NASA Astrophysics Data System (ADS)

    Shimaoka, Takehiro; Kaneko, Junichi H.; Ochiai, Kentaro; Tsubota, Masakatsu; Shimmyo, Hiroaki; Chayahara, Akiyoshi; Umezawa, Hitoshi; Watanabe, Hideyuki; Shikata, Shin-ichi; Isobe, Mitsutaka; Osakabe, Masaki

    2016-02-01

    A self-standing single-crystal chemical vapor deposited diamond was obtained using lift-off method. It was fabricated into a radiation detector and response function measurements for 14 MeV neutrons were taken at the fusion neutronics source. 1.5% of high energy resolution was obtained by using the 12C(n, α)9Be reaction at an angle of 100° with the deuteron beam line. The intrinsic energy resolution, excluding energy spreading caused by neutron scattering, slowing in the target and circuit noises was 0.79%, which was also the best resolution of the diamond detector ever reported.

  5. Computational Transport Modeling of High-Energy Neutrons Found in the Space Environment

    NASA Technical Reports Server (NTRS)

    Cox, Brad; Theriot, Corey A.; Rohde, Larry H.; Wu, Honglu

    2012-01-01

    The high charge and high energy (HZE) particle radiation environment in space interacts with spacecraft materials and the human body to create a population of neutrons encompassing a broad kinetic energy spectrum. As an HZE ion penetrates matter, there is an increasing chance of fragmentation as penetration depth increases. When an ion fragments, secondary neutrons are released with velocities up to that of the primary ion, giving some neutrons very long penetration ranges. These secondary neutrons have a high relative biological effectiveness, are difficult to effectively shield, and can cause more biological damage than the primary ions in some scenarios. Ground-based irradiation experiments that simulate the space radiation environment must account for this spectrum of neutrons. Using the Particle and Heavy Ion Transport Code System (PHITS), it is possible to simulate a neutron environment that is characteristic of that found in spaceflight. Considering neutron dosimetry, the focus lies on the broad spectrum of recoil protons that are produced in biological targets. In a biological target, dose at a certain penetration depth is primarily dependent upon recoil proton tracks. The PHITS code can be used to simulate a broad-energy neutron spectrum traversing biological targets, and it account for the recoil particle population. This project focuses on modeling a neutron beamline irradiation scenario for determining dose at increasing depth in water targets. Energy-deposition events and particle fluence can be simulated by establishing cross-sectional scoring routines at different depths in a target. This type of model is useful for correlating theoretical data with actual beamline radiobiology experiments. Other work exposed human fibroblast cells to a high-energy neutron source to study micronuclei induction in cells at increasing depth behind water shielding. Those findings provide supporting data describing dose vs. depth across a water-equivalent medium. This

  6. Monte Carlo calibration of the SMM gamma ray spectrometer for high energy gamma rays and neutrons

    NASA Technical Reports Server (NTRS)

    Cooper, J. F.; Reppin, C.; Forrest, D. J.; Chupp, E. L.; Share, G. H.; Kinzer, R. L.

    1985-01-01

    The Gamma Ray Spectrometer (GRS) on the Solar Maximum Mission spacecraft was primarily designed and calibrated for nuclear gamma ray line measurements, but also has a high energy mode which allows the detection of gamma rays at energies above 10 MeV and solar neutrons above 20 MeV. The GRS response has been extrapolated until now for high energy gamma rays from an early design study employing Monte Carlo calculations. The response to 50 to 600 MeV solar neutrons was estimated from a simple model which did not consider secondary charged particles escaping into the veto shields. In view of numerous detections by the GRS of solar flares emitting high energy gamma rays, including at least two emitting directly detectable neutrons, the calibration of the high energy mode in the flight model has been recalculated by the use of more sophisticated Monte Carlo computer codes. New results presented show that the GRS response to gamma rays above 20 MeV and to neutrons above 100 MeV is significantly lower than the earlier estimates.

  7. Neutron production from flattening filter free high energy medical linac: A Monte Carlo study

    NASA Astrophysics Data System (ADS)

    Najem, M. A.; Abolaban, F. A.; Podolyák, Z.; Spyrou, N. M.

    2015-11-01

    One of the problems arising from using a conventional linac at high energy (>8 MV) is the production of neutrons. One way to reduce neutron production is to remove the flattening filter (FF). The main purpose of this work was to study the effect of FF removal on neutron fluence and neutron dose equivalent inside the treatment room at different photon beam energies. Several simulations based on Monte Carlo techniques were carried out in order to calculate the neutron fluence at different locations in the treatment room from different linac energies with and without a FF. In addition, a step-and-shoot intensity modulated radiotherapy (SnS IMRT) for prostate cancer was modelled using the 15 MV photon beam with and without a FF on a water phantom to calculate the neutron dose received in a full treatment. The results obtained show a significant drop-off in neutrons fluence and dose equivalent when the FF was removed. For example, the neutron fluence was decreased by 54%, 76% and 75% for 10, 15 and 18 MV, respectively. This can decrease the neutron dose to the patient as well as reduce the shielding cost of the treatment room. The neutron dose equivalent of the SnS IMRT for prostate cancer was reduced significantly by 71.3% when the FF was removed. It can be concluded that the flattening filter removal from the head of the linac could reduce the risk of causing secondary cancers and the shielding cost of radiotherapy treatment rooms.

  8. Development of high-energy neutron imaging for use in NDE applications

    SciTech Connect

    Dietrich, F; Hall, J; Logan, C; Schmid, G

    1999-06-01

    We are currently developing a high-energy (10 - 15 MeV) neutron imaging system for use in NDE applications. Our goal is to develop an imaging system capable of detecting cubic-mm-scale voids or other structural defects in heavily-shielded low-Z materials within thick sealed objects. The system will be relatively compact (suitable for use in a small laboratory) and capable of acquiring tomographic image data sets. The design of a prototype imaging detector and multi-axis staging system will be discussed and selected results from recent imaging experiments will be presented. The development of an intense, accelerator-driven neutron source suitable for use with the imaging system will also be discussed. Keywords: neutron imaging, neutron radiography, computed tomography, non-destructive inspection, neutron sources

  9. Liquid lithium target as a high intensity, high energy neutron source

    DOEpatents

    Parkin, Don M.; Dudey, Norman D.

    1976-01-01

    This invention provides a target jet for charged particles. In one embodiment the charged particles are high energy deuterons that bombard the target jet to produce high intensity, high energy neutrons. To this end, deuterons in a vacuum container bombard an endlessly circulating, free-falling, sheet-shaped, copiously flowing, liquid lithium jet that gushes by gravity from a rectangular cross-section vent on the inside of the container means to form a moving web in contact with the inside wall of the vacuum container. The neutrons are produced via break-up of the beam in the target by stripping, spallation and compound nuclear reactions in which the projectiles (deuterons) interact with the target (Li) to produce excited nuclei, which then "boil off" or evaporate a neutron.

  10. High-energy neutron dosimetry at the Clinton P. Anderson Meson Physics Facility

    SciTech Connect

    Mallett, M.W.; Vasilik, D.G.; Littlejohn, G.J.; Cortez, J.R.

    1990-01-01

    Neutron energy spectrum measurements performed at the Clinton P. Anderson Meson Physics Facility indicated potential areas for high energy neutron exposure to personnel. The low sensitivity of the Los Alamos thermoluminescent dosimeter (TLD) to high energy neutrons warranted issuing a NTA dosimeter in addition to the TLD badge to employees entering these areas. The dosimeter consists of a plastic holder surrounding NTA film that has been desiccated and sealed in a dry nitrogen environment. A study of the fading of latent images in NTA film demonstrated the success of this packaging method to control the phenomenon. The Los Alamos NTA dosimeter is characterized and the fading study discussed. 10 refs., 4 figs., 2 tabs.

  11. Biological Effects of High-Energy Neutrons Measured In Vivo Using a Vertebrate Model

    PubMed Central

    Kuhne, Wendy W.; Gersey, Brad B.; Wilkins, Richard; Wu, Honglu; Wender, Stephen A.; George, Varghese; Dynan, William S.

    2009-01-01

    Interaction of solar protons and galactic cosmic radiation with the atmosphere and other materials produces high-energy secondary neutrons from below 1 to 1000 MeV and higher. Although secondary neutrons may provide an appreciable component of the radiation dose equivalent received by space and high-altitude air travelers, the biological effects remain poorly defined, particularly in vivo in intact organisms. Here we describe the acute response of Japanese medaka (Oryzias latipes) embryos to a beam of high-energy spallation neutrons that mimics the energy spectrum of secondary neutrons encountered aboard spacecraft and high-altitude aircraft. To determine RBE, embryos were exposed to 0–0.5 Gy of high-energy neutron radiation or 0–15 Gy of reference γ radiation. The radiation response was measured by imaging apoptotic cells in situ in defined volumes of the embryo, an assay that provides a quantifiable, linear dose response. The slope of the dose response in the developing head, relative to reference γ radiation, indicates an RBE of 24.9 (95% CI 13.6–40.7). A higher RBE of 48.1 (95% CI 30.0–66.4) was obtained based on overall survival. A separate analysis of apoptosis in muscle showed an overall nonlinear response, with the greatest effects at doses of less than 0.3 Gy. Results of this experiment indicate that medaka are a useful model for investigating biological damage associated with high-energy neutron exposure. PMID:19772468

  12. Boron-neutron capture therapy

    NASA Astrophysics Data System (ADS)

    Haque, A. M.; Moschini, G.; Valkovic, Vlado; Zafiropoulos, D.

    1995-03-01

    The final goal of any radiotherapy project is to expose the tumor as the target to a lethal dose of ionizing radiation, sparing thereby the surrounding healthy tissues to a maximum extent. Precise treatment is nevertheless essential for cure, since the danger exists that the tumor might re-establish itself if every cancer cell is not destroyed. The conventional therapy treatments existing to date, e.g., surgery, radiation therapy, and chemotherapy, have been successful in curing some kinds of cancers, but still there are many exceptions. In the following, the progress of a promising therapy tool, called the boron neutron capture therapy (BNCT), which has made its dynamic evolution in recent years, is briefly described. The approach towards clinical trials with BNCT is described in detail.

  13. Micronuclei Induction in Human Fibroblasts Exposed In Vitro to Los Alamos High-Energy Neutrons

    NASA Technical Reports Server (NTRS)

    Gersey, Brad; Sodolak, John; Hada, Megumi; Saganti, Prem; Wilkins, Richard; Cucinotta, Francis; Wu, Honglu

    2006-01-01

    High-energy secondary neutrons, produced by the interaction of galactic cosmic rays with the atmosphere, spacecraft structure and planetary surfaces, contribute to a significant fraction to the dose equivalent in crew members and passengers during commercial aviation travel, and astronauts in space missions. The Los Alamos Nuclear Science Center (LANSCE) neutron facility#s ICE House 30L beamline is known to generate neutrons that simulate the secondary neutron spectra of earth#s atmosphere. The neutron spectrum is also similar to that measured onboard spacecraft like the MIR and International Space Station (ISS). To evaluate the biological damage, we exposed human fibroblasts in vitro to the LANSCE neutron beams without degrader at an entrance dose rate of 25 mGy/hr and analyzed the micronuclei (MN) induction. The cells were also placed behind a 9.9 cm water column to study effect of shielding in the protection of neutron induced damages. It was found that the dose response in the MN frequency was linear for the samples with and without shielding and the slope of the MN yield behind the shielding was reduced by a factor of 3.5. Compared to the MN induction in human fibroblasts exposed to a gamma source at a low dose rate, the RBE was found to be 16.7 and 10.0 for the neutrons without and with 9.9 cm water shielding, respectively.

  14. Micronuclei induction in human fibroblasts exposed in vitro to Los Alamos high-energy neutrons

    NASA Astrophysics Data System (ADS)

    Gersey, Brad; Sodolak, John; Hada, Megumi; Saganti, Prem; Wilkins, Richard; Cucinotta, Francis; Wu, Honglu

    High-energy secondary neutrons, produced by the interaction of galactic cosmic rays with the atmosphere, spacecraft structure and planetary surfaces, contribute to a significant fraction to the dose equivalent in crew members and passengers during commercial aviation travel, and astronauts in space missions. The Los Alamos Nuclear Science Center (LANSCE) neutron facility's ICE House 30L beamline is known to generate neutrons that simulate the secondary neutron spectra of earth's atmosphere. The neutron spectrum is also similar to that measured onboard spacecraft like the MIR and International Space Station (ISS). To evaluate the biological damage, we exposed human fibroblasts in vitro to the LANSCE neutron beams without degrader at an entrance dose rate of 25 mGy/h and analyzed the micronuclei (MN) induction. The cells were also placed behind a 9.9 cm water column to study the effect of shielding in the protection of neutron induced damages. It was found that the dose response in the MN frequency was linear for the samples with and without shielding and the slope of the MN yield behind the shielding was reduced by a factor of 3.5. Compared to the MN induction in human fibroblasts exposed to a γ source at a similar low dose rate, the RBE was found to be 16.7 and 10.0 for the neutrons without and with the 9.9 cm water shielding, respectively.

  15. Neutron dose per fluence and weighting factors for use at high energy accelerators

    SciTech Connect

    Cossairt, J.Donald; Vaziri, Kamran; /Fermilab

    2008-07-01

    In June 2007, the United States Department of Energy incorporated revised values of neutron weighting factors into its occupational radiation protection Regulation 10 CFR Part 835 as part of updating its radiation dosimetry system. This has led to a reassessment of neutron radiation fields at high energy proton accelerators such as those at the Fermi National Accelerator Laboratory (Fermilab). Values of dose per fluence factors appropriate for accelerator radiation fields calculated elsewhere are collated and radiation weighting factors compared. The results of this revision to the dosimetric system are applied to americium-beryllium neutron energy spectra commonly used for instrument calibrations. A set of typical accelerator neutron energy spectra previously measured at Fermilab are reassessed in light of the new dosimetry system. The implications of this revision are found to be of moderate significance.

  16. Demonstrating a directional detector based on neon for characterizing high energy neutrons

    NASA Astrophysics Data System (ADS)

    Hexley, Allie

    2016-03-01

    MITPC is a gas-based time projection chamber used for detecting fast, MeV-scale neutrons. The standard version of the detector relies on a mixture of 600 torr gas composed of 87.5% helium-4 and 12.5% tetrafluoromethane for precisely measuring the energy and direction of neutron-induced nuclear recoils. I describe studies performed with a prototype detector investigating the use of neon, as a replacement for helium-4, in the gas mixture. My discussion focuses on the advantages of neon as the fast neutron target for high energy neutron events (100 MeV) and a demonstration that the mixture will be effective for this event class. I show that the achievable gain and transverse diffusion of drifting electrons in the neon mixture are acceptable and that the detector uptime lost due to voltage breakdowns in the amplification plane is negligible, compared to 20% with the helium-4 mixture.

  17. Demonstrating a directional detector based on neon for characterizing high energy neutrons

    NASA Astrophysics Data System (ADS)

    Hexley, A.; Moulai, M. H.; Spitz, J.; Conrad, J. M.

    2015-11-01

    MITPC is a gas-based time projection chamber used for detecting fast, MeV-scale neutrons. The standard version of the detector relies on a mixture of 600 torr gas composed of 87.5% 4He and 12.5% CF4 for precisely measuring the energy and direction of neutron-induced nuclear recoils. We describe studies performed with a prototype detector investigating the use of Ne, as a replacement for 4He, in the gas mixture. Our discussion focuses on the advantages of Ne as the fast neutron target for high energy neutron events (lesssim100 MeV) and a demonstration that the mixture will be effective for this event class. We find that the achievable gain and transverse diffusion of drifting electrons in the Ne mixture are acceptable and that the detector uptime lost due to voltage breakdowns in the amplification plane is negligible, compared to ~ 20% with the 4He mixture.

  18. Induction of Micronuclei in Human Fibroblasts from the Los Alamos High Energy Neutron Beam

    NASA Technical Reports Server (NTRS)

    Cox, Bradley

    2009-01-01

    The space radiation field includes a broad spectrum of high energy neutrons. Interactions between these neutrons and a spacecraft, or other material, significantly contribute to the dose equivalent for astronauts. The 15 degree beam line in the Weapons Neutron Research beam at Los Alamos Nuclear Science Center generates a neutron spectrum relatively similar to that seen in space. Human foreskin fibroblast (AG1522) samples were irradiated behind 0 to 20 cm of water equivalent shielding. The cells were exposed to either a 0.05 or 0.2 Gy entrance dose. Following irradiation, micronuclei were counted to see how the water shield affects the beam and its damage to cell nuclei. Micronuclei induction was then compared with dose equivalent data provided from a tissue equivalent proportional counter.

  19. Superconducting gamma and fast-neutron spectrometers with high energy resolution

    DOEpatents

    Friedrich, Stephan; , Niedermayr, Thomas R.; Labov, Simon E.

    2008-11-04

    Superconducting Gamma-ray and fast-neutron spectrometers with very high energy resolution operated at very low temperatures are provided. The sensor consists of a bulk absorber and a superconducting thermometer weakly coupled to a cold reservoir, and determines the energy of the incident particle from the rise in temperature upon absorption. A superconducting film operated at the transition between its superconducting and its normal state is used as the thermometer, and sensor operation at reservoir temperatures around 0.1 K reduces thermal fluctuations and thus enables very high energy resolution. Depending on the choice of absorber material, the spectrometer can be configured either as a Gamma-spectrometer or as a fast-neutron spectrometer.

  20. Workshop on neutron capture therapy

    SciTech Connect

    Fairchild, R.G.; Bond, V.P.

    1986-01-01

    Potentially optimal conditions for Neutron Capture Therapy (NCT) may soon be in hand due to the anticipated development of band-pass filtered beams relatively free of fast neutron contaminations, and of broadly applicable biomolecules for boron transport such as porphyrins and monoclonal antibodies. Consequently, a number of groups in the US are now devoting their efforts to exploring NCT for clinical application. The purpose of this Workshop was to bring these groups together to exchange views on significant problems of mutual interest, and to assure a unified and effective approach to the solutions. Several areas of preclinical investigation were deemed to be necessary before it would be possible to initiate clinical studies. As neither the monomer nor the dimer of sulfhydryl boron hydride is unequivocally preferable at this time, studies on both compounds should be continued until one is proven superior.

  1. Radiation studies of optical interferometric modulators with fast neutrons and high energy gamma-rays

    SciTech Connect

    Tsang, T.; Radeka, V. ); Bulmer, C.H.; Burns, W.K. )

    1991-11-01

    The possibility of using Ti : LiNbO{sub 3} and single mode fibers for nuclear particle detection and transmission in large-scale machines, such as Superconducting Super Collider, calls for a detailed radiation damage study. In this report, we present radiation studies on Ti : LiNbO{sub 3} Mach-Zehnder interferometric optical modulators with fast neutrons and high energy Gamma-rays.

  2. Generation of high-energy (>15 MeV) neutrons using short pulse high intensity lasers

    SciTech Connect

    Petrov, G. M.; Davis, J.; Petrova, Tz. B.; Higginson, D. P.; McNaney, J. M.; McGuffey, C.; Qiao, B.; Beg, F. N.

    2012-09-15

    A roadmap is suggested and demonstrated experimentally for the production of high-energy (>15 MeV) neutrons using short pulse lasers. Investigation with a 3D Monte Carlo model has been employed to quantify the production of energetic neutrons. Numerical simulations have been performed for three nuclear reactions, d(d,n){sup 3}He, {sup 7}Li(d,n){sup 8}Be, and {sup 7}Li(p,n){sup 7}Be, driven by monoenergetic ion beams. Quantitative estimates for the driver ion beam energy and number have been made and the neutron spectra and yield in the ion propagation direction have been evaluated for various incident ion energies. In order to generate neutron fluence above a detection limit of 10{sup 6} neutrons/sr, either {approx}10{sup 10} protons with energy 20-30 MeV or comparable amount of deuterons with energy 5-10 MeV are required. Experimental verification of the concept with deuterons driven by the Titan laser (peak intensity 2 Multiplication-Sign 10{sup 19} W/cm{sup 2}, pulse duration of 9 ps, wavelength 1.05 {mu}m, and energy of 360 J) is provided with the generation of neutrons with energy of up to 18 MeV from {sup 7}Li(d,n){sup 8}Be reactions. Future research will focus on optimized schemes for ion acceleration for production of high-energy neutrons, which will involve efficient target design, laser parameter optimization, and converter material.

  3. High-energy in-beam neutron measurements of metal-based shielding for accelerator-driven spallation neutron sources

    NASA Astrophysics Data System (ADS)

    DiJulio, D. D.; Cooper-Jensen, C. P.; Björgvinsdóttir, H.; Kokai, Z.; Bentley, P. M.

    2016-05-01

    Metal-based shielding plays an important role in the attenuation of harmful and unwanted radiation at an accelerator-driven spallation neutron source. At the European Spallation Source, currently under construction in Lund, Sweden, metal-based materials are planned to be used extensively as neutron guide substrates in addition to other shielding structures around neutron guides. The usage of metal-based materials in the vicinity of neutron guides however requires careful consideration in order to minimize potential background effects in a neutron instrument at the facility. Therefore, we have carried out a combined study involving high-energy neutron measurements and Monte Carlo simulations of metal-based shielding, both to validate the simulation methodology and also to investigate the benefits and drawbacks of different metal-based solutions. The measurements were carried out at The Svedberg Laboratory in Uppsala, Sweden, using a 174.1 MeV neutron beam and various thicknesses of aluminum-, iron-, and copper-based shielding blocks. The results were compared to geant4 simulations and revealed excellent agreement. Our combined study highlights the particular situations where one type of metal-based solution may be preferred over another.

  4. High-energy response of the PRESCILA and WENDI-II neutron rem meters.

    PubMed

    Olsher, Richard H; McLean, Thomas D

    2008-01-01

    WENDI-II was designed at the Los Alamos National Laboratory (LANL) specifically as a wide-range rem meter, suitable for applications at particle accelerators, with response extension to 5 GeV. PRESCILA was also designed at LANL, mainly as a lightweight alternative to traditional rem meters, but has shown excellent response characteristics above 20 MeV. This Note summarises measurements performed over a span of 4 y to characterise the high-energy neutron response (>20 MeV) of these meters to several hundred million electron volts. High-energy quasi-monoenergetic beams utilised as part of this study were produced by the cyclotron facilities at the Université Catholique de Louvain (33 and 60 MeV) and the T. Svedberg Laboratory ( 46, 95, 143 and 173 MeV). In addition, measurements were also conducted at the Los Alamos Neutron Science Center, 800 MeV spallation neutron source, in broad energy fields with an average energy of 345 MeV. For the sake of completeness, data collected between 2.5 and 19 MeV in monoenergetic neutron fields at the German Physikalisch-Technische Bundesanstalt (PTB) facility are also included in this study. PMID:18381335

  5. Neutron capture therapy for melanoma

    SciTech Connect

    Coderre, J.A.; Glass, J.D.; Micca, P.; Fairchild, R.G.

    1988-01-01

    The development of boron-containing compounds which localize selectively in tumor may require a tumor-by-tumor type of approach that exploits any metabolic pathways unique to the particular type of tumor. Melanin-producing melanomas actively transport and metabolize aromatic amino acids for use as precursors in the synthesis of the pigment melanin. It has been shown that the boron-containing amino acid analog p-borono-phenylalanine (BPA) is selectively accumulated in melanoma tissue, producing boron concentrations in tumor that are within the range estimated to be necessary for successful boron neutron capture therapy (BNCT). We report here the results of therapy experiments carried out at the Brookhaven Medical Research Reactor (BMRR). 21 refs., 5 figs., 3 tabs.

  6. Monitor units are not predictive of neutron dose for high-energy IMRT

    PubMed Central

    2012-01-01

    Background Due to the substantial increase in beam-on time of high energy intensity-modulated radiotherapy (>10 MV) techniques to deliver the same target dose compared to conventional treatment techniques, an increased dose of scatter radiation, including neutrons, is delivered to the patient. As a consequence, an increase in second malignancies may be expected in the future with the application of intensity-modulated radiotherapy. It is commonly assumed that the neutron dose equivalent scales with the number of monitor units. Methods Measurements of neutron dose equivalent were performed for an open and an intensity-modulated field at four positions: inside and outside of the treatment field at 0.2 cm and 15 cm depth, respectively. Results It was shown that the neutron dose equivalent, which a patient receives during an intensity-modulated radiotherapy treatment, does not scale with the ratio of applied monitor units relative to an open field irradiation. Outside the treatment volume at larger depth 35% less neutron dose equivalent is delivered than expected. Conclusions The predicted increase of second cancer induction rates from intensity-modulated treatment techniques can be overestimated when the neutron dose is simply scaled with monitor units. PMID:22883384

  7. Gadolinium-doped water cerenkov-based neutron and high energy gamma-ray detector and radiation portal monitoring system

    SciTech Connect

    Dazeley, Steven A; Svoboda, Robert C; Bernstein, Adam; Bowden, Nathaniel

    2013-02-12

    A water Cerenkov-based neutron and high energy gamma ray detector and radiation portal monitoring system using water doped with a Gadolinium (Gd)-based compound as the Cerenkov radiator. An optically opaque enclosure is provided surrounding a detection chamber filled with the Cerenkov radiator, and photomultipliers are optically connected to the detect Cerenkov radiation generated by the Cerenkov radiator from incident high energy gamma rays or gamma rays induced by neutron capture on the Gd of incident neutrons from a fission source. The PMT signals are then used to determine time correlations indicative of neutron multiplicity events characteristic of a fission source.

  8. COMPTEL measurements of the omnidirectional high-energy neutron flux in near-earth orbit.

    PubMed

    Morris, D J; Aarts, H; Bennett, K; Lockwood, J A; McConnell, M L; Ryan, J M; Schonfelder, V; Steinle, H; Weidenspointner, G

    1998-01-01

    On four occasions, twice in 1991 (near solar maximum) and twice in 1994 (near solar minimum), one COMPTEL D1 detector module was used as an omnidirectional detector to measure the high-energy (> 12.8 MeV) neutron flux near an altitude of 450 km. The D1 modules are cylindrical, with radius 13.8 cm and depth 8 cm, and are filled with liquid scintillator (NE213A). The combined flux measurements can be fit reasonably well by a product of the Mt. Washington neutron monitor rate, a linear function in the spacecraft geocenter zenith angle, and an exponential function of the vertical geomagnetic cutoff rigidity in which the coefficient of the rigidity is a linear function of the neutron monitor rate. When pointed at the nadir, the flux is consistent with that expected from the atmospheric neutron albedo alone. When pointed at the zenith the flux is reduced by a factor of about 0.54. Thus the production of secondary neutrons in the massive (16000 kg) Compton Gamma-Ray Observatory spacecraft is negligible. Rather, the mass of the spacecraft provides shielding from the earth albedo. PMID:11542901

  9. Apparatus, Method and Program Storage Device for Determining High-Energy Neutron/Ion Transport to a Target of Interest

    NASA Technical Reports Server (NTRS)

    Wilson, John W. (Inventor); Tripathi, Ram K. (Inventor); Badavi, Francis F. (Inventor); Cucinotta, Francis A. (Inventor)

    2012-01-01

    An apparatus, method and program storage device for determining high-energy neutron/ion transport to a target of interest. Boundaries are defined for calculation of a high-energy neutron/ion transport to a target of interest; the high-energy neutron/ion transport to the target of interest is calculated using numerical procedures selected to reduce local truncation error by including higher order terms and to allow absolute control of propagated error by ensuring truncation error is third order in step size, and using scaling procedures for flux coupling terms modified to improve computed results by adding a scaling factor to terms describing production of j-particles from collisions of k-particles; and the calculated high-energy neutron/ion transport is provided to modeling modules to control an effective radiation dose at the target of interest.

  10. The Impact of Neutrons in Clinical Proton Therapy

    PubMed Central

    Schneider, Uwe; Hälg, Roger

    2015-01-01

    In proton therapy, high-energy proton beams cause the production of secondary neutrons. This leads to an unwanted dose contribution, which can be considerable for tissues outside of the target volume regarding the long-term health of cancer patients. Due to the high biological effectiveness of neutrons with regard to cancer induction, small neutron doses can be important. Published comparisons of neutron dose measurements and the corresponding estimates of cancer risk between different treatment modalities differ over orders of magnitude. In this report, the controversy about the impact of the neutron dose in proton therapy is critically discussed and viewed in the light of new epidemiological studies. In summary, the impact of neutron dose on cancer risk can be determined correctly only if the dose distributions are carefully measured or computed. It is important to include not only the neutron component into comparisons but also the complete deposition of energy as precisely as possible. Cancer risk comparisons between different radiation qualities, treatment machines, and techniques have to be performed under similar conditions. It seems that in the past, the uncertainty in the models which lead from dose to risk were overestimated when compared with erroneous dose comparisons. Current risk models used with carefully obtained dose distributions predict a second cancer risk reduction for active protons vs. photons and a more or less constant risk of passive protons vs. photons. Those findings are in general agreement with newly obtained epidemiologically results. PMID:26557501

  11. Disk-accreting magnetic neutron stars as high-energy particle accelerators

    NASA Technical Reports Server (NTRS)

    Hamilton, Russell J.; Lamb, Frederick K.; Miller, M. Coleman

    1994-01-01

    Interaction of an accretion disk with the magnetic field of a neutron star produces large electromotive forces, which drive large conduction currents in the disk-magnetosphere-star circuit. Here we argue that such large conduction currents will cause microscopic and macroscopic instabilities in the magnetosphere. If the minimum plasma density in the magnetosphere is relatively low is less than or aproximately 10(exp 9)/cu cm, current-driven micro-instabilities may cause relativistic double layers to form, producing voltage differences in excess of 10(exp 12) V and accelerating charged particles to very high energies. If instead the plasma density is higher (is greater than or approximately = 10(exp 9)/cu cm, twisting of the stellar magnetic field is likely to cause magnetic field reconnection. This reconnection will be relativistic, accelerating plasma in the magnetosphere to relativistic speeds and a small fraction of particles to very high energies. Interaction of these high-energy particles with X-rays, gamma-rays, and accreting plasma may produce detectable high-energy radiation.

  12. The Fascinating High-Energy World of Neutron Stars and Supernova Remnants

    NASA Astrophysics Data System (ADS)

    Safi-Harb, Samar

    2006-06-01

    The past few years have witnessed a fast growth in the high-energy astrophysics community in Canada, thanks to new opportunities including the University Faculty Award (UFA) program introduced by the Natural Sciences and Engineering Research Council of Canada (NSERC) to appoint promising female researchers to faculty positions in science and engineering. As a UFA fellow at the University of Manitoba, I have had the unique opportunity to contribute to the launch of a new astronomy program in the department of Physics (renamed to Physics and Astronomy). My research focuses on observational studies of neutron stars, pulsar wind nebulae, and supernova remnants. The study of these exotic objects helps address the physics of the extreme and probe some of the most energetic events in the Universe. I will highlight exciting discoveries in this field and some of the questions to be addressed with current and future high-energy missions.

  13. High energy excitations measured by neutron spectroscopy in FePS3

    NASA Astrophysics Data System (ADS)

    Rule, K C; Wildes, A R; Bewley, R I; Visser, D; Hicks, T J

    2009-03-01

    The quasi-two-dimensional antiferromagnet FePS3 has been investigated using inelastic neutron spectroscopy with the time-of-flight spectrometer HET at the ISIS spallation neutron source. In the paramagnetic regime, two clearly resolved, high energy excitations were observed in the low scattering angle detector banks at 195(5) meV and 430(10) meV. The absence of these transitions from the high angle detector banks indicates that they are likely to be due to the crystal fields and magnetic in origin. The two transitions most probably represent electronic transitions in the Fe2+ ion among the low lying crystal field and spin-orbit split levels raised from the ground state. It has not yet been determined why the energies are greater than those observed in a comparable Raman experiment.

  14. High energy excitations measured by neutron spectroscopy in FePS(3).

    PubMed

    Rule, K C; Wildes, A R; Bewley, R I; Visser, D; Hicks, T J

    2009-03-25

    The quasi-two-dimensional antiferromagnet FePS(3) has been investigated using inelastic neutron spectroscopy with the time-of-flight spectrometer HET at the ISIS spallation neutron source. In the paramagnetic regime, two clearly resolved, high energy excitations were observed in the low scattering angle detector banks at 195(5) meV and 430(10) meV. The absence of these transitions from the high angle detector banks indicates that they are likely to be due to the crystal fields and magnetic in origin. The two transitions most probably represent electronic transitions in the Fe(2+) ion among the low lying crystal field and spin-orbit split levels raised from the ground state. It has not yet been determined why the energies are greater than those observed in a comparable Raman experiment. PMID:21817456

  15. Hexagonal boron nitride thin film thermal neutron detectors with high energy resolution of the reaction products

    NASA Astrophysics Data System (ADS)

    Doan, T. C.; Majety, S.; Grenadier, S.; Li, J.; Lin, J. Y.; Jiang, H. X.

    2015-05-01

    Hexagonal boron nitride (h-BN) is highly promising for solid-state thermal neutron detector applications due to its many outstanding physical properties, especially its very large thermal neutron capture cross-section (~3840 barns for 10B), which is several orders of magnitude larger than those of most other isotopes. The focus of the present work is to carry out studies on h-BN thin film and detector properties to lay the foundation for the development of a direct-conversion solid-state thermal neutron detector with high sensitivity. The measured carrier mobility-lifetime (μτ) product of h-BN thin films grown on sapphire substrates is 2.83×10-7 cm2/V for electrons and holes, which is comparable to the value of about 10-7 cm2/V for GaN thin films grown on sapphire. Detectors based on h-BN thin films were fabricated and the nuclear reaction product pulse height spectra were measured. Under a bias of 20 V, very narrow individual peaks corresponding to the reaction product energies of α and Li particles as well as the sum peaks have been clearly resolved in the pulse height spectrum for the first time by a B-based direct-conversion semiconductor neutron detector. Our results indicate that h-BN thin film detectors possess unique advantages including small size, low weight, portability, low voltage operation and high energy resolution of specific reaction products.

  16. Proton linacs for boron neutron capture therapy

    SciTech Connect

    Lennox, A.J. |

    1993-08-01

    Recent advances in the ability to deliver boron-containing drugs to brain tumors have generated interest in {approximately}4 MeV linacs as sources of epithermal neutrons for radiation therapy. In addition, fast neutron therapy facilities have been studying methods to moderate their beams to take advantage of the high cross section for epithermal neutrons on boron-10. This paper describes the technical issues involved in each approach and presents the motivation for undertaking such studies using the Fermilab linac. the problems which must be solved before therapy can begin are outlined. Status of preparatory work and results of preliminary measurements are presented.

  17. High-energy and thermal-neutron imaging and modeling with an amorphous silicon flat-panel detector.

    PubMed

    Claytor, Thomas N; Taddeucci, Terry N; Hills, Charles R; Summa, Deborah A; Davis, Anthony W; McDonald, Thomas E; Schwab, Mark J

    2004-10-01

    The Los Alamos Neutron Science Center (LANSCE) operates two spallation neutron sources dedicated to research in materials science, condensed-matter physics, and fundamental and applied nuclear physics. Prior to 1995, all thermal neutron radiography at Los Alamos was done on a beam port attached to the Omega West reactor, a small 8MW research reactor used primarily for radioisotope production and prompt and delayed neutron activation analysis. After the closure of this facility, two largely independent radiography development efforts were begun at LANSCE using moderated cold and thermal neutrons from the Target-1 source and high-energy neutrons from the Target-4 source. Investigations with cold and thermal neutrons employed a neutron converter and film, a scintillation screen and CCD camera system, and a new high-resolution amorphous silicon (a-Si) flat-panel detector system. Recent work with high-energy neutrons (En > 1 MeV) has involved storage-phosphor image plates. Some comparison high-energy images were obtained with both image plates and the a-Si panel and showed equivalent image quality for approximately equal exposure times. PMID:15246402

  18. Gadolinium in human glioblastoma cells for gadolinium neutron capture therapy.

    PubMed

    De Stasio, G; Casalbore, P; Pallini, R; Gilbert, B; Sanità, F; Ciotti, M T; Rosi, G; Festinesi, A; Larocca, L M; Rinelli, A; Perret, D; Mogk, D W; Perfetti, P; Mehta, M P; Mercanti, D

    2001-05-15

    157Gd is a potential agent for neutron capture cancer therapy (GdNCT). We directly observed the microdistribution of Gd in cultured human glioblastoma cells exposed to Gd-diethylenetriaminepentaacetic acid (Gd-DTPA). We demonstrated, with three independent techniques, that Gd-DTPA penetrates the plasma membrane, and we observed no deleterious effect on cell survival. A systematic microchemical analysis revealed a higher Gd accumulation in cell nuclei compared with cytoplasm. This is significant for prospective GdNCT because the proximity of Gd to DNA increases the cell-killing potential of the short-range, high-energy electrons emitted during the neutron capture reaction. We also exposed Gd-containing cells to thermal neutrons and demonstrated the GdNC reaction effectiveness in inducing cell death. These results in vitro stimulated in vivo Gd-DTPA uptake studies, currently underway, in human glioblastoma patients. PMID:11358855

  19. Calibration of a Bonner sphere extension (BSE) for high-energy neutron spectrometry

    PubMed Central

    Howell, R.M.; Burgett, E.A.; Wiegel, B.; Hertel, N.E.

    2011-01-01

    In a recent work, we constructed modular multisphere system which expands upon the design of an existing, commercially available Bonner sphere system by adding concentric shells of copper, tungsten, or lead. Our modular multisphere system is referred to as the Bonner Sphere Extension (BSE). The BSE was tested in a high energy neutron beam (thermal to 800 MeV) at Los Alamos Neutron Science Center and provided improvement in the measurement of the neutron spectrum in the energy regions above 20 MeV when compared to the standard BSS (Burgett, 2008 and Howell et al., 2009). However, when the initial test of the system was carried-out at LANSCE, the BSE had not yet been calibrated. Therefore the objective of the present study was to perform calibration measurements. These calibration measurements were carried out using monoenergetic neutron ISO 8529-1 reference beams at the Physikalisch-Technische Bundesanstalt (PTB), Braunschweig, Germany. The following monoenergetic reference beams were used for these experiments: 14.8 MeV, 1.2 MeV, 565 keV, and 144 keV. Response functions for the BSE were calculated using the Monte Carlo N-Particle Code, eXtended (MCNPX). The percent difference between the measured and calculated responses was calculated for each sphere and energy. The difference between measured and calculated responses for individual spheres ranged between 7.9 % and 16.7 % and the arithmetic mean for all spheres was (10.9 ± 1.8) %. These sphere specific correction factors will be applied for all future measurements carried-out with the BSE. PMID:22888283

  20. Production of the D/sub s//sup +- / by high-energy neutrons

    SciTech Connect

    Shipbaugh, C.; Wiss, J.; Binkley, M.; Butler, J.; Cumalat, J.P.; Coteus, P.; DiCorato, M.; Diesburg, M.; Enagonio, J.; Filaseta, J.; and others

    1988-05-23

    We have observed the production of the D/sub s//sup +- / by a high-energy neutron beam on nuclear targets. The D/sub s//sup +- / was observed in the decay mode D/sub s//sup +- /..-->..phi..pi../sup +- /, phi..-->..K/sup +/K/sup -/. The average of the inclusive cross sections for D/sub s//sup +/ and D/sub s//sup -/ hadroproduction is measured to be B dsigmadchi/sub F/ = 2.85 +- 0.80 +- 0.86 ..mu..bnucleon at chi/sub F/ = 0.175 on the assumption of a linear A dependence, where BequivalentGAMMA(D/sub s//sup +- /..-->..phi..pi../sup +- /)GAMMA(D/sub s//sup +- /..-->..all). GAMMA(D/sub s//sup +- /..-->..all)

  1. Accelerator based epithermal neutron source for neutron capture therapy

    SciTech Connect

    Brugger, R.; Kunze, J.

    1991-05-01

    Several investigators have suggested that a charged particle accelerator with light element reactions might be able to produce enough epithermal neutrons to be useful in Neutron Capture Therapy. The reaction choice so far has been the Li(p,n) reaction with protons up to 2.5 MeV. A moderator around the target would reduce the faster neutrons down to the epithermal energy region. The goals of the present research are: identify better reactions; improve the moderators; and find better combinations of 1 and 2. The target is to achieve, at the patient location, an epithermal neutron current of greater than 10{sup 9}n/cm{sup 2}sec, with a dose to tissue from the neutrons alone of less than 10{sup {minus}10} rads/n and a dose from the gamma rays in the beam of less than 10{sup {minus}10} rads/n.

  2. Monte Carlo characterizations mapping of the (γ,n) and (n,γ) photonuclear reactions in the high energy X-ray radiation therapy

    PubMed Central

    Ghiasi, Hosein

    2013-01-01

    Aim The aim of this work was to map the characteristics of (n,γ) and (γ,n) reactions in a high energy photon radiation therapy. Background Photoneutrons produced in the high energy X-Ray radiation therapy may damage patients and staff. It is due to high RBE of the produced neutrons according to their energy and isotropic emission. Characterization of the photoneutrons can help us in appropriate shielding. Materials and methods This study focused on the photoneutron and capture gamma ray phenomena. Characteristics such as dose value, fluence and spectra of both the neutrons and the by produced prompt gamma ray were described. Results and discussion Neutron and prompt gamma spectra in different points showed the neutrons to be thermalized when increasing the distance from the linac. Energy of the neutrons changed from about 0.6 MeV at the isocentre to around 10−08 MeV at the outer door position. Although the neutrons were found as fast neutrons, their spectra showed they were thermal neutrons at the outer door position. Additionally, it was seen that the energy of the gamma rays is higher than the scattered X-ray energy. The energy of gamma rays was seen to be up to 10 MeV while the linac photons had energy lower than 1 MeV. Neutron source strength obtained in this work was in good agreement with the published data, which may be a confirmation of our simulation accuracy. Conclusion The study showed that the Monte Carlo simulation can be applied in the radiotherapy and industrial radiation works as a useful and precise estimator. We also concluded that the dose from the prompt gamma ray at the outer door location is higher than the scattered radiation from the linac and should be considered in the shielding. PMID:24936317

  3. Approach to magnetic neutron capture therapy

    SciTech Connect

    Kuznetsov, Anatoly A. . E-mail: spod@sky.chph.ras.ru; Podoynitsyn, Sergey N.; Filippov, Victor I.; Komissarova, Lubov Kh.; Kuznetsov, Oleg A.

    2005-11-01

    Purpose: The method of magnetic neutron capture therapy can be described as a combination of two methods: magnetic localization of drugs using magnetically targeted carriers and neutron capture therapy itself. Methods and Materials: In this work, we produced and tested two types of particles for such therapy. Composite ultradispersed ferro-carbon (Fe-C) and iron-boron (Fe-B) particles were formed from vapors of respective materials. Results: Two-component ultradispersed particles, containing Fe and C, were tested as magnetic adsorbent of L-boronophenylalanine and borax and were shown that borax sorption could be effective for creation of high concentration of boron atoms in the area of tumor. Kinetics of boron release into the physiologic solution demonstrate that ultradispersed Fe-B (10%) could be applied for an effective magnetic neutron capture therapy. Conclusion: Both types of the particles have high magnetization and magnetic homogeneity, allow to form stable magnetic suspensions, and have low toxicity.

  4. Gadolinium as a Neutron Capture Therapy Agent

    NASA Astrophysics Data System (ADS)

    Shih, Jing-Luen Allen

    The clinical results of treating brain tumors with boron neutron capture therapy are very encouraging and researchers around the world are once again making efforts to develop this therapeutic modality. Boron-10 is the agent receiving the most attention for neutron capture therapy but ^{157}Gd is a nuclide that also holds interesting properties of being a neutron capture therapy agent. The objective of this study is to evaluate ^{157}Gd as a neutron capture therapy agent. In this study it is determined that tumor concentrations of about 300 mug ^{157}Gd/g tumor can be achieved in brain tumors with some FDA approved MRI contrast agents such as Gd-DTPA and Gd-DOTA, and up to 628 mug ^{157 }Gd/g tumor can be established in bone tumors with Gd-EDTMP. Monte Carlo calculations show that with only 250 ppm of ^{157}Gd in tumor, neutron capture therapy can deliver 2,000 cGy to a tumor of 2 cm diameter or larger with 5 times 10^{12} n/cm ^2 fluence at the tumor. Dose measurements which were made with films and TLD's in phantoms verified these calculations. More extended Monte Carlo calculations demonstrate that neutron capture therapy with Gd possesses comparable dose distribution to B neutron capture therapy. With 5 times 10^{12 } n/cm^2 thermal neutrons at the tumor, Auger electrons from the Gd produced an optical density enhancement on the films that is similar to the effect caused by about 300 cGy of Gd prompt gamma dose which will further enhance the therapeutic effects. A technique that combines brachytherapy with Gd neutron capture therapy has been evaluated. Monte Carlo calculations show that 5,000 cGy of prompt gamma dose can be delivered to a treatment volume of 40 cm^3 with a 3-plane implant of a total of 9 Gd needles. The tumor to normal tissue advantage of this method is as good as ^{60} Co brachytherapy. Measurements of prompt gamma dose with films and TLD-700's in a lucite phantom verify the Monte Carlo evaluation. A technique which displays the Gd

  5. A study on the optimum fast neutron flux for boron neutron capture therapy of deep-seated tumors.

    PubMed

    Rasouli, Fatemeh S; Masoudi, S Farhad

    2015-02-01

    High-energy neutrons, named fast neutrons which have a number of undesirable biological effects on tissue, are a challenging problem in beam designing for Boron Neutron Capture Therapy, BNCT. In spite of this fact, there is not a widely accepted criterion to guide the beam designer to determine the appropriate contribution of fast neutrons in the spectrum. Although a number of researchers have proposed a target value for the ratio of fast neutron flux to epithermal neutron flux, it can be shown that this criterion may not provide the optimum treatment condition. This simulation study deals with the determination of the optimum contribution of fast neutron flux in the beam for BNCT of deep-seated tumors. Since the dose due to these high-energy neutrons damages shallow tissues, delivered dose to skin is considered as a measure for determining the acceptability of the designed beam. To serve this purpose, various beam shaping assemblies that result in different contribution of fast neutron flux are designed. The performances of the neutron beams corresponding to such configurations are assessed in a simulated head phantom. It is shown that the previously used criterion, which suggests a limit value for the contribution of fast neutrons in beam, does not necessarily provide the optimum condition. Accordingly, it is important to specify other complementary limits considering the energy of fast neutrons. By analyzing various neutron spectra, two limits on fast neutron flux are proposed and their validity is investigated. The results show that considering these limits together with the widely accepted IAEA criteria makes it possible to have a more realistic assessment of sufficiency of the designed beam. Satisfying these criteria not only leads to reduction of delivered dose to skin, but also increases the advantage depth in tissue and delivered dose to tumor during the treatment time. The Monte Carlo Code, MCNP-X, is used to perform these simulations. PMID:25479433

  6. Neutron tube design study for boron neutron capture therapy application

    SciTech Connect

    Verbeke, J.M.; Lee, Y.; Leung, K.N.; Vujic, J.; Williams, M.D.; Wu, L.K.; Zahir, N.

    1999-05-06

    Radio-frequency (RF) driven ion sources are being developed in Lawrence Berkeley National Laboratory (LBNL) for sealed-accelerator-tube neutron generator application. By using a 5-cm-diameter RF-driven multicusp source H{sup +} yields over 95% have been achieved. These experimental findings will enable one to develop compact neutron generators based on the D-D or D-T fusion reactions. In this new neutron generator, the ion source, the accelerator and the target are all housed in a sealed metal container without external pumping. Recent moderator design simulation studies have shown that 14 MeV neutrons could be moderated to therapeutically useful energy ranges for boron neutron capture therapy (BNCT). The dose near the center of the brain with optimized moderators is about 65% higher than the dose obtained from a typical neutron spectrum produced by the Brookhaven Medical Research Reactor (BMRR), and is comparable to the dose obtained by other accelerator-based neutron sources. With a 120 keV and 1 A deuteron beam, a treatment time of {approx}35 minutes is estimated for BNCT.

  7. Pulse Radiolysis Using Very-high-energy Ions for Optimizing Cancer Therapy.

    PubMed

    Getoff, Nikola

    2016-01-01

    Cancer therapy by means of high-energy ions is very efficient. As a consequence of the linear-energy-transfer effect only a negligible part of the produced free radicals can escape combination processes to form molecular products and to cause undesired side processes. Positrons (e⁺) and γ-rays, generated by the nuclear interaction of high-energy ions in the medium, serve in monitoring the radiation dose absorbed by the tumor. However, due to the dipole nature of water molecules a small proportion of thermalized positrons (e⁺th) can become solvated (e⁺aq). Hence, they are stabilized, live longer and can initiate side reactions. In addition, positronium (Ps), besides solvated electrons (e⁺aq), can be generated and involved in the reaction mechanisms. For a better understanding of the reaction mechanisms involved and to improve cancer therapy, a time-resolved pulse radiolysis instrument using high-energy particles is discussed here. The proposed method is examined and recommended by CERN experts. It is planned to be realized at the MedAustron Radiation Therapy and Research Centre in Wiener Neustadt, Austria. PMID:26912822

  8. Radiolysis in aqueous solution of dinucleoside monophosphates by high-energy electrons and fission neutrons.

    PubMed

    Vaishnav, Y N; Swenberg, C E

    1993-01-01

    The radiation chemistry in aqueous solution of the dinucleoside monophosphate d-[CpT] and its sequence isomer d-[TpC] in air or nitrogen was examined using different qualities and quantities of radiations. High-performance liquid chromatography and gas chromatography-mass spectrometry were used to analyze the high-energy electron (13.2 MeV) exposure products or fission-neutron exposure products of d-[CpT] and d-[TpC]. A comparison of product profiles obtained from irradiated d-[CpT] and d-[TpC] suggests that, at relatively low radiation doses (50-250 Gy), products are formed by N-glycosidic or phosphodiester bond-cleavage, while at higher doses (500-1000 Gy) additional products were detected as a consequence of ring-modification mechanisms. The plots of radiation dose-yield and corresponding calculated G values of the released undamaged bases and nucleosides from d-[CpT] and d-[TpC] suggest a base-sequence dependence and a quality- and quantity-dependent response to ionizing radiation. Although the product quantities formed from sequence isomers were slightly different, we found no qualitative differences in the product formed at the lowest doses examined. PMID:8434108

  9. Microdosimetry for Boron Neutron Capture Therapy

    SciTech Connect

    Maughan, R.L.; Kota, C.

    2000-09-05

    The specific aims of the research proposal were as follows: (1) To design and construct small volume tissue equivalent proportional counters for the dosimetry and microdosimetry of high intensity thermal and epithermal neutron beams used in BNCT, and of modified fast neutron beams designed for boron neutron capture enhanced fast neutron therapy (BNCEFNT). (2) To develop analytical methods for estimating the biological effectiveness of the absorbed dose in BNCT and BNCEFNT based on the measured microdosimetric spectra. (3) To develop an analytical framework for comparing the biological effectiveness of different epithermal neutron beams used in BNCT and BNCEFNT, based on correlated sets of measured microdosimetric spectra and radiobiological data. Specific aims (1) and (2) were achieved in their entirety and are comprehensively documented in Jay Burmeister's Ph.D. dissertation entitled ''Specification of physical and biologically effective absorbed dose in radiation therapies utilizing the boron neutron capture reaction'' (Wayne State University, 1999). Specific aim (3) proved difficult to accomplish because of a lack of sufficient radiobiological data.

  10. Porphyrins for boron neutron capture therapy

    DOEpatents

    Miura, Michiko; Gabel, Detlef

    1990-01-01

    Novel compounds for treatment of brain tumors in Boron Neutron Capture Therapy are disclosed. A method for preparing the compounds as well as pharmaceutical compositions containing said compounds are also disclosed. The compounds are water soluble, non-toxic and non-labile boronated porphyrins which show significant uptake and retention in tumors.

  11. 21 CFR 892.5300 - Medical neutron radiation therapy system.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Medical neutron radiation therapy system. 892.5300... (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5300 Medical neutron radiation therapy system. (a) Identification. A medical neutron radiation therapy system is a device intended...

  12. Testing The High-Energy Prompt Neutron Signature At Low Beam Energies

    SciTech Connect

    Thompson, Scott J.; Kinlaw, Mathew T.; Hunt, Alan W.

    2011-06-01

    Prompt fission neutrons continue to be examined as a signature for detecting the presence of fissionable material. This technique exploits the neutron energy limitations inherent with photonuclear emissions from non-fissionable material, allowing prompt fission neutrons to be identified and engaged for detecting nuclear material. Prompt neutron signal measurements were acquired with bremsstrahlung endpoint energies of 6 MeV for 18 targets comprised of both fissionable and non-fissionable material; delayed neutron measurements were also collected as a reference. The {sup 238}U target was also shielded with increasing thicknesses of lead or borated polyethylene to compare the resulting detection rates of the prompt and delayed fission neutron signals.

  13. Characteristics of high-energy neutrons estimated using the radioactive spallation products of Au at the 500-MeV neutron irradiation facility of KENS.

    PubMed

    Matsumura, Hiroshi; Masumoto, Kazuyoshi; Nakao, Noriaki; Wang, Qingbin; Toyoda, Akihiro; Kawai, Masayoshi; Aze, Takahiro; Fujimura, Masatsugu

    2005-01-01

    We carried out a shielding experiment of high-energy neutrons, generated from a tungsten target bombarded with primary 500-MeV protons at KENS, which penetrated through a concrete shield in the zero-degree direction. We propose a new method to evaluate the spectra of high-energy neutrons ranging from 8 to 500 MeV. Au foils were set in a concrete shield, and the reaction rates for 13 radionuclides produced by the spallation reactions on the Au targets were measured by radiochemical techniques. The experimental results were compared with those obtained by the MARS14 Monte-Carlo code. A good agreement (between them) was found for energies beyond 100 MeV. The profile of the neutron spectrum, ranging from 8 to 500 MeV, does not depend on the thickness of the concrete shield. PMID:16604584

  14. Recent advances in neutron capture therapy (NCT)

    SciTech Connect

    Fairchild, R.G.

    1985-01-01

    The application of the /sup 10/B(n,..cap alpha..)/sup 7/Li reaction to cancer radiotherapy (Neutron Capture therapy, or NCT) has intrigued investigators since the discovery of the neutron. This paper briefly summarizes data describing recently developed boronated compounds with evident tumor specificity and extended biological half-lives. The implication of these compounds to NCT is evaluated in terms of Therapeutic Gain (TG). The optimization of NCT using band-pass filtered beams is described, again in terms of TG, and irradiation times with these less intense beams are estimated. 24 refs., 3 figs., 3 tabs.

  15. New measurement system for on line in core high-energy neutron flux monitoring in materials testing reactor conditions

    SciTech Connect

    Geslot, B.; Filliatre, P.; Barbot, L.; Jammes, C.; Breaud, S.; Oriol, L.; Villard, J.-F.; Lopez, A. Legrand

    2011-03-15

    Flux monitoring is of great interest for experimental studies in material testing reactors. Nowadays, only the thermal neutron flux can be monitored on line, e.g., using fission chambers or self-powered neutron detectors. In the framework of the Joint Instrumentation Laboratory between SCK-CEN and CEA, we have developed a fast neutron detector system (FNDS) capable of measuring on line the local high-energy neutron flux in fission reactor core and reflector locations. FNDS is based on fission chambers measurements in Campbelling mode. The system consists of two detectors, one detector being mainly sensitive to fast neutrons and the other one to thermal neutrons. On line data processing uses the CEA depletion code DARWIN in order to disentangle fast and thermal neutrons components, taking into account the isotopic evolution of the fissile deposit. The first results of FNDS experimental test in the BR2 reactor are presented in this paper. Several fission chambers have been irradiated up to a fluence of about 7 x 10{sup 20} n/cm{sup 2}. A good agreement (less than 10% discrepancy) was observed between FNDS fast flux estimation and reference flux measurement.

  16. A theoretical model for the production of Ac-225 for cancer therapy by neutron capture transmutation of Ra-226.

    PubMed

    Melville, G; Melville, P

    2013-02-01

    Radium needles that were once implanted into tumours as a cancer treatment are now obsolete and constitute a radioactive waste problem, as their half-life is 1600 years. We are investigating the reduction of radium by transmutation by bombarding Ra-226 with high-energy neutrons from a neutron source to produce Ra-225 and hence Ac-225, which can be used as a generator to produce Bi-213 for use in 'Targeted Alpha Therapy' for cancer. This paper examines the possibility of producing Ac-225 by neutron capture using a theoretical model in which neutron energy is convoluted with the corresponding neutron cross sections of Ra-226. The total integrated yield can then be obtained. This study shows that an intense beam of high-energy neutrons could initiate neutron capture on Ra-226 to produce Ra-225 and hence practical amounts of Ac-225 and a useful reduction of Ra-226. PMID:23220026

  17. Gamma-ray, neutron, and hard X-ray studies and requirements for a high-energy solar physics facility

    NASA Technical Reports Server (NTRS)

    Ramaty, R.; Dennis, B. R.; Emslie, A. G.

    1988-01-01

    The requirements for future high-resolution spatial, spectral, and temporal observation of hard X-rays, gamma rays and neutrons from solar flares are discussed in the context of current high-energy flare observations. There is much promise from these observations for achieving a deep understanding of processes of energy release, particle acceleration and particle transport in a complicated environment such as the turbulent and highly magnetized atmosphere of the active sun.

  18. Accelerator-driven boron neutron capture therapy

    NASA Astrophysics Data System (ADS)

    Edgecock, Rob

    2014-05-01

    Boron Neutron Capture Therapy is a binary treatment for certain types of cancer. It works by loading the cancerous cells with a boron-10 carrying compound. This isotope has a large cross-section for thermal neutrons, the reaction producing a lithium nucleus and alpha particle that kill the cell in which they are produced. Recent studies of the boron carrier compound indicate that the uptake process works best in particularly aggressive cancers. Most studied is glioblastoma multiforme and a trial using a combination of BNCT and X-ray radiotherapy has shown an increase of nearly a factor of two in mean survival over the state of the art. However, the main technical problem with BNCT remains producing a sufficient flux of neutrons for a reasonable treatment duration in a hospital environment. This paper discusses this issue.

  19. A parametric model to describe neutron spectra around high-energy electron accelerators and its application in neutron spectrometry with Bonner Spheres

    NASA Astrophysics Data System (ADS)

    Bedogni, Roberto; Pelliccioni, Maurizio; Esposito, Adolfo

    2010-03-01

    Due to the increased interest of the scientific community in the applications of synchrotron light, there is an increasing demand of high-energy electron facilities, testified by the construction of several new facilities worldwide. The radiation protection around such facilities requires accurate experimental methods to determine the dose due to prompt radiation fields. Neutron fields, in particular, are the most complex to measure, because they extend in energy from thermal (10 -8 MeV) up to hundreds MeV and because the responses of dosemeters and survey meters usually have large energy dependence. The Bonner Spheres Spectrometer (BSS) is in practice the only instrument able to respond over the whole energy range of interest, and for this reason it is frequently used to derive neutron spectra and dosimetric quantities in accelerator workplaces. Nevertheless, complex unfolding algorithms are needed to derive the neutron spectra from the experimental BSS data. This paper presents a parametric model specially developed for the unfolding of the experimental data measured with BSS around high-energy electron accelerators. The work consists of the following stages: (1) Generation with the FLUKA code, of a set of neutron spectra representing the radiation environment around accelerators with different electron energies; (2) formulation of a parametric model able to describe these spectra, with particular attention to the high-energy component (>10 MeV), which may be responsible for a large part of the dose in workplaces; and (3) implementation of this model in an existing unfolding code.

  20. Optimization of intensity-modulated very high energy (50-250 MeV) electron therapy

    NASA Astrophysics Data System (ADS)

    Yeboah, C.; Sandison, G. A.; Moskvin, V.

    2002-04-01

    This work evaluates the potential of very high energy (50-250 MeV) electron beams for dose conformation and identifies those variables that influence optimized dose distributions for this modality. Intensity-modulated plans for a prostate cancer model were optimized as a function of the importance factors, beam energy and number of energy bins, number of beams, and the beam orientations. A trial-and-error-derived constellation of importance factors for target and sensitive structures to achieve good conformal dose distributions was 500, 50, 10 and 1 for the target, rectum, bladder and normal tissues respectively. Electron energies greater than 100 MeV were found to be desirable for intensity-modulated very high energy electron therapy (VHEET) of prostate cancer. Plans generated for lower energy beams had relatively poor conformal dose distributions about the target region and delivered high doses to sensitive structures. Fixed angle beam treatments utilizing a large number of fields in the range 9-21 provided acceptable plans. Using more than 21 beams at fixed gantry angles had an insignificant effect on target coverage, but resulted in an increased dose to sensitive structures and an increased normal tissue integral dose. Minor improvements in VHEET plans utilizing a `small' number (=<9) of beams may be achieved if, in addition to intensity modulation, energy modulation is implemented using a small number (=<3) of beam energies separated by 50 to 100 MeV. Rotation therapy provided better target dose homogeneity but unfortunately resulted in increased rectal dose, bladder dose and normal tissue integral dose relative to the 21-field fixed angle treatment plan. Modulation of the beam energy for rotation therapy had no beneficial consequences on the optimized dose distributions. Lastly, selection of beam orientations influenced the optimized treatment plan even when a large number of beams (approximately 15) were employed.

  1. Canted-Cosine-Theta Superconducting Accelerator Magnets for High Energy Physics and Ion Beam Cancer Therapy

    NASA Astrophysics Data System (ADS)

    Brouwer, Lucas Nathan

    Advances in superconducting magnet technology have historically enabled the construction of new, higher energy hadron colliders. Looking forward to the needs of a potential future collider, a significant increase in magnet field and performance is required. Such a task requires an open mind to the investigation of new design concepts for high field magnets. Part I of this thesis will present an investigation of the Canted-Cosine-Theta (CCT) design for high field Nb3Sn magnets. New analytic and finite element methods for analysis of CCT magnets will be given, along with a discussion on optimization of the design for high field. The design, fabrication, and successful test of the 2.5 T NbTi dipole CCT1 will be presented as a proof-of-principle step towards a high field Nb3Sn magnet. Finally, the design and initial steps in the fabrication of the 16 T Nb3Sn dipole CCT2 will be described. Part II of this thesis will investigate the CCT concept extended to a curved magnet for use in an ion beam therapy gantry. The introduction of superconducting technology in this field shows promise to reduce the weight and cost of gantries, as well as open the door to new beam optics solutions with high energy acceptance. An analytic approach developed for modeling curved CCT magnets will be presented, followed by a design study of a superconducting magnet for a proton therapy gantry. Finally, a new magnet concept called the "Alternating Gradient CCT" (AG-CCT) will be introduced. This concept will be shown to be a practical magnet solution for achieving the alternating quadrupole fields desired for an achromatic gantry, allowing for the consideration of treatment with minimal field changes in the superconducting magnets. The primary motivation of this thesis is to share new developments for Canted-Cosine-Theta superconducting magnets, with the hope this design will improve technology for high energy physics and ion beam cancer therapy.

  2. Boron neutron capture therapy: Moving toward targeted cancer therapy.

    PubMed

    Mirzaei, Hamid Reza; Sahebkar, Amirhossein; Salehi, Rasoul; Nahand, Javid Sadri; Karimi, Ehsan; Jaafari, Mahmoud Reza; Mirzaei, Hamed

    2016-01-01

    Boron neutron capture therapy (BNCT) occurs when a stable isotope, boton-10, is irradiated with low-energy thermal neutrons to yield stripped down helium-4 nuclei and lithium-7 nuclei. It is a binary therapy in the treatment of cancer in which a cytotoxic event is triggered when an atom placed in a cancer cell. Here, we provide an overview on the application of BNCT in cancer therapy as well as current preclinical and clinical evidence on the efficacy of BNCT in the treatment of melanoma, brain tumors, head and neck cancer, and thyroid cancer. Several studies have shown that BNCT is effective in patients who had been treated with a full dose of conventional radiotherapy, because of its selectivity. In addition, BNCT is dependent on the normal/tumor tissue ratio of boron distribution. Increasing evidence has shown that BNCT can be combined with different drug delivery systems to enhance the delivery of boron to cancer cells. The flexibility of BNCT to be used in combination with different tumor-targeting approaches has made this strategy a promising option for cancer therapy. This review aims to provide a state-of-the-art overview of the recent advances in the use of BNCT for targeted therapy of cancer. PMID:27461603

  3. Simulation experiments for gamma-ray mapping of planetary surfaces: Scattering of high-energy neutrons

    NASA Technical Reports Server (NTRS)

    Brueckner, J.; Englert, P.; Reedy, R. C.; Waenke, H.

    1986-01-01

    The concentration and distribution of certain elements in surface layers of planetary objects specify constraints on models of their origin and evolution. This information can be obtained by means of remote sensing gamma-ray spectroscopy, as planned for a number of future space missions, i.e., Mars, Moon, asteroids, and comets. To investigate the gamma-rays made by interactions of neutrons with matter, thin targets of different composition were placed between a neutron-source and a high-resolution germanium spectrometer. Gamma-rays in the range of 0.1 to 8 MeV were accumulated. In one set of experiments a 14-MeV neutron generator using the T(d,n) reaction as neutron-source was placed in a small room. Scattering in surrounding walls produced a spectrum of neutron energies from 14 MeV down to thermal. This complex neutron-source induced mainly neutron-capture lines and only a few scattering lines. As a result of the set-up, there was a considerable background of discrete lines from surrounding materials. A similar situation exists under planetary exploration conditions: gamma-rays are induced in the planetary surface as well as in the spacecraft. To investigate the contribution of neutrons with higher energies, an experiment for the measurement of prompt gamma radiation was set up at the end of a beam-line of an isochronous cyclotron.

  4. Design and characterization of an SRAM-based neutron detector for particle therapy

    NASA Astrophysics Data System (ADS)

    Ytre-Hauge, Kristian S.; Velure, Arild; Larsen, Eivind F.; Stokkevåg, Camilla H.; Röhrich, Dieter; Brekke, Njål; Odland, Odd Harald

    2015-12-01

    A neutron detector based on registration of radiation effects in Static Random Access Memories (SRAMs) has been developed at the University of Bergen for applications in particle therapy. Nine different SRAMs were tested and a 16 Mibit SRAM from Cypress was chosen for the final detector. The SRAMs were irradiated in beam lines at PTB Braunschweig, the Oslo Cyclotron Laboratory, The Svedberg Laboratory, The Institute for Energy Technology (IFE, Kjeller) and the CERN-EU high-energy reference field. The results from the measurements demonstrate the feasibility of using the selected SRAMs for neutron detection. The results indicate low or no sensitivity to thermal neutrons while the cross section for fast neutrons increases with neutron energy before reaching a more stable level at energies of several tenths of MeV.

  5. First experiments on neutron detection on the accelerator-based source for boron neutron capture therapy

    NASA Astrophysics Data System (ADS)

    Kuznetsov, A. S.; Malyshkin, G. N.; Makarov, A. N.; Sorokin, I. N.; Sulyaev, Yu. S.; Taskaev, S. Yu.

    2009-04-01

    A pilot accelerator-based source of epithermal neutrons, which is intended for wide application in clinics for boron neutron capture therapy, has been constructed at the Budker Institute of Nuclear Physics (Novosibirsk). A stationary proton beam has been obtained and near-threshold neutron generation regime has been realized. Results of the first experiments on neutron generation using the proposed source are described.

  6. Chromosome Aberrations in Human Epithelial Cells Exposed Los Alamos High-Energy Secondary Neutrons: M-BAND Analysis

    NASA Technical Reports Server (NTRS)

    Hada, M.; Saganti, P. B.; Gersey, B.; Wilkins, R.; Cucinotta, F. A.; Wu, H.

    2007-01-01

    High-energy secondary neutrons, produced by the interaction of galactic cosmic rays (GCR) with the atmosphere, spacecraft structure and planetary surfaces, contribute a significant fraction to the dose equivalent radiation measurement in crew members and passengers of commercial aviation travel as well as astronauts in space missions. The Los Alamos Nuclear Science Center (LANSCE) neutron facility's 30L beam line (4FP30L-A/ICE House) is known to generate neutrons that simulate the secondary neutron spectrum of the Earth's atmosphere at high altitude. The neutron spectrum is also similar to that measured onboard spacecrafts like the MIR and the International Space Station (ISS). To evaluate the biological damage, we exposed human epithelial cells in vitro to the LANSCE neutron beams with an entrance dose rate of 2.5 cGy/hr, and studied the induction of chromosome aberrations that were identified with multicolor-banding in situ hybridization (mBAND) technique. With this technique, individually painted chromosomal bands on one chromosome allowed the identification of inter-chromosomal aberrations (translocation to unpainted chromosomes) and intra-chromosomal aberrations (inversions and deletions within a single painted chromosome). Compared to our previous results with gamma-rays and 600 MeV/nucleon Fe ions of high dose rate at NSRL (NASA Space Radiation Laboratory at Brookhaven National Laboratory), the neutron data from the LANSCE experiments showed significantly higher frequency of chromosome aberrations. However, detailed analysis of the inversion type revealed that all of the three radiation types in the study induced a low incidence of simple inversions. Most of the inversions in gamma-ray irradiated samples were accompanied by other types of intrachromosomal aberrations but few inversions were accompanied by interchromosomal aberrations. In contrast, neutrons and Fe ions induced a significant fraction of inversions that involved complex rearrangements of both

  7. Progress in neutron capture therapy for cancer

    SciTech Connect

    Allen, B.J.; Harrington, B.V.; Moore, D.E.

    1992-09-01

    Prognosis for some cancers is good, but for others, few patients will survive 12 months. This latter group of cancers is characterised by a proclivity to disseminate malignant cells in the host organ. In some cases systemic metastases occur, but in other cases, failure to achieve local control results in death. First among these cancers are the high grade brain tumours, astrocytoma 3,4 and glioblastoma multiforme. Local control of these tumors should lead to cure. Other cancers melanoma metastatic to the brain, for which a useful palliative therapy is not yet available, and pancreatic cancer for which localised control at an early stage could bring about improved prognosis. Patients with these cancers have little grounds for hope. Our primary objective is to reverse this situation with Neutron Capture Therapy (NCT). The purpose of this fourth symposium is to hasten the day whereby patients with these cancers can reasonably hope for substantial remissions.

  8. Progress in neutron capture therapy for cancer

    SciTech Connect

    Allen, B.J.; Harrington, B.V. ); Moore, D.E. )

    1992-01-01

    Prognosis for some cancers is good, but for others, few patients will survive 12 months. This latter group of cancers is characterised by a proclivity to disseminate malignant cells in the host organ. In some cases systemic metastases occur, but in other cases, failure to achieve local control results in death. First among these cancers are the high grade brain tumours, astrocytoma 3,4 and glioblastoma multiforme. Local control of these tumors should lead to cure. Other cancers melanoma metastatic to the brain, for which a useful palliative therapy is not yet available, and pancreatic cancer for which localised control at an early stage could bring about improved prognosis. Patients with these cancers have little grounds for hope. Our primary objective is to reverse this situation with Neutron Capture Therapy (NCT). The purpose of this fourth symposium is to hasten the day whereby patients with these cancers can reasonably hope for substantial remissions.

  9. Simulation of neutron displacement damage in bipolar junction transistors using high-energy heavy ion beams.

    SciTech Connect

    Doyle, Barney Lee; Buller, Daniel L.; Hjalmarson, Harold Paul; Fleming, Robert M; Bielejec, Edward Salvador; Vizkelethy, Gyorgy

    2006-12-01

    Electronic components such as bipolar junction transistors (BJTs) are damaged when they are exposed to radiation and, as a result, their performance can significantly degrade. In certain environments the radiation consists of short, high flux pulses of neutrons. Electronics components have traditionally been tested against short neutron pulses in pulsed nuclear reactors. These reactors are becoming less and less available; many of them were shut down permanently in the past few years. Therefore, new methods using radiation sources other than pulsed nuclear reactors needed to be developed. Neutrons affect semiconductors such as Si by causing atomic displacements of Si atoms. The recoiled Si atom creates a collision cascade which leads to displacements in Si. Since heavy ions create similar cascades in Si we can use them to create similar damage to what neutrons create. This LDRD successfully developed a new technique using easily available particle accelerators to provide an alternative to pulsed nuclear reactors to study the displacement damage and subsequent transient annealing that occurs in various transistor devices and potentially qualify them against radiation effects caused by pulsed neutrons.

  10. A New Facility for High-Energy Neutron-Induced Fission Studies

    SciTech Connect

    Prokofiev, A.; Carlsson, M.; Einarsson, L.; Haag, N.; Pomp, S.; Bergenwall, B.; Blomgren, J.; Hildebrand, A.; Johansson, C.; Mermod, P.; Oesterlund, M.; Tippawan, U.; Dangtip, S.

    2005-05-24

    A new facility is constructed for measurements of neutron-induced fission cross sections in the 20-180 MeV energy region versus the np scattering cross section, which is adopted as the primary neutron standard. The advantage of the experiment compared to earlier studies is that the fission-fragment detection and the neutron-flux measurement via np scattering are performed simultaneously and at the same position in the beam, and, therefore, many sources of systematic errors cancel out. Further reduction of systematic errors is achieved due to 'embedded' determination of effective solid angle of particle detectors using {alpha}-particles from the radioactive decay of the target nuclei. The performance of the facility is illustrated by first data obtained for angular distributions of fission fragments in the 238U(n,f) reaction.

  11. Research needs for neutron capture therapy

    SciTech Connect

    1995-12-01

    Key issues and questions addressed by the workshop related to optimization of Boron Neutron Capture Therapy (BNCT), in general, and to the possibility of success of the present BNCT trials at Brookhaven National Laboratory (BNL) and Massachusetts Institute of Technology (MIT), in particular. Both trials use nuclear fission reactors as neutron sources for BNCT of glioblastoma multiforme (BNL) and of deep seated melanoma (MIT). Presentations and discussions focussed on optimal boron-labeled compounds, mainly for brain tumors such as glioblastoma multiforme, and the best mode of compound delivery to the tumor. Also, optimizing neutron irradiation with dose delivery to the tumor cells and the issues of dosimetry of BNCT especially in the brain were discussed. Planning of treatment and of follow-up of patients, coordination of BNCT at various treatment sites, and the potential of delivering BNCT to various types of cancer with an appropriately tailored protocol were additional issues. The need for multicentric interdisciplinary cooperation among the different medical specialties was highlighted.

  12. The neutron component of two high-energy photon reference fields.

    PubMed

    Röttger, S; Schäler, K; Behrens, R; Nolte, R; Wissmann, F

    2007-01-01

    The 4.4 MeV photon reference field described in ISO 4037 is produced by the (12)C(p,p')(12)C (E(x) = 4.4389 MeV) reaction using a thick elemental carbon target and a proton beam with an energy of 5.7 MeV. The relative abundance of the isotope (13)C in elemental carbon is 1.10%. Therefore, the 4.4 MeV photon field is contaminated by neutrons produced by the (13)C(p,n) (13)N reaction (Q = -3.003 MeV). The ambient dose equivalent H*(10) produced by these neutrons is of the same order of magnitude as the ambient dose equivalent produced by the 4.4 MeV photons. For the calibration of dosemeters, especially those also sensitive to neutrons, the spectral fluence distribution of these neutrons has to be known in detail. On the other hand, a mixed photon/neutron field is very useful for the calibration of tissue-equivalent proportional counters (TEPC), if this field combines a high-linear energy transfer (LET) component produced by low-energy neutrons and a low-LET component resulting from photons with about the same ambient dose equivalent and energies up to 7 MeV. Such a mixed field was produced at the PTB accelerator facility using a thin CaF(2) + (nat)C target and a 5.7 MeV proton beam. PMID:17675300

  13. (A neutron scattering experiment to study the high-energy spin dynamics of the itinerant antiferromagnet Mn sub 90 Cu sub 10 )

    SciTech Connect

    Fernandez-Baca, J.A.

    1990-10-26

    The traveler performed a neutron scattering experiment to study the high-energy spin dynamics of the itinerant antiferromagnet. This experiment was conducted at a unique instrument located at the hot-neutron source at the ILL. The traveler also held various scientific discussions with ILL research staff members and visiting scientists.

  14. Measurement of high-energy neutrons at ISS by SEDA-AP

    NASA Astrophysics Data System (ADS)

    Koga, K.; Goka, T.; Matsumoto, H.; Obara, T.; Muraki, Y.; Yamamoto, T.

    2011-09-01

    A new type of solar neutron detector (NEM) was launched by the space shuttle Endeavour on 16 July 2009 and it began collecting data on 25 August 2009 at the International Space Station (ISS). In this paper we introduce preliminary results obtained by the NEM.

  15. Characterisation of three high-energy photon and fast neutron reference radiation fields.

    PubMed

    Behrens, R; Röttger, S

    2008-01-01

    Three reference radiation fields for the purpose of radiation protection were characterised: (1) radiation field R-F, consisting of photons in the energy range of about 6 and 7 MeV and a small neutron contamination; (2) radiation field R-C, consisting of photons with energies of about 4.4 MeV and neutrons with energies up to 2.65 MeV; (3) radiation field R-CF, consisting of photons in the energy range of about 1 and 7 MeV and neutrons with energies about 1.5 MeV. The radiation fields R-F and R-C have previously been defined in the ISO standard 4037. Their neutron components, however, have never been described accurately in the past. The new radiation field R-CF is proposed for the first time. This radiation field can, e.g., be used to calibrate tissue-equivalent proportional counters instruments for measurements at flight altitudes. PMID:19131379

  16. High-energy astrophysics: A theoretical analysis of thermal radiation from neutron stars

    NASA Technical Reports Server (NTRS)

    Applegate, James H.

    1994-01-01

    The unambiguous detection of thermal radiation from the surface of a cooling neutron star was one of the most anxiously awaited results in neutron star physics. This particular Holy Grail was found by Halpern and Holt, who used ROSAT to detect pulsed X-rays from the gamma-ray source Geminga and demonstrate that it was a neutron star, probably a radio pulsar beamed away from us. At an age of approximately 3.4 x 10(exp 5) years, Geminga is in the photon cooling era. Its surface temperature of 5.2 x 10(exp 5) K can be explained within the contexts of both the slow and fast cooling scenarios. In the slow cooling scenario, the surface temperature is too high unless the specific heat of the interior is reduced by extensive baryon pairing. In the fast cooling scenario, the surface temperature will be much too low unless the fast neutrino cooling is shut off by baryon pairing. Two other pulsars, PSR 0656+14 and PSR 1055-52, have also been detected in thermal X-rays by ROSAT. They are also in the photon cooling era. All of this research's neutron star cooling models to date have used the unmagnetized effective temperature-interior temperature relation for the outer boundary condition. Models are being improved by using published magnetic envelope calculations and assumed geometried for the surface magnetic field to determine local interior temperature-emitted flux relations for the surface of the star.

  17. Backward emitted high-energy neutrons in hard reactions of p and π+ on carbon

    NASA Astrophysics Data System (ADS)

    Malki, A.; Alster, J.; Asryan, G.; Averichev, Y.; Barton, D.; Baturin, V.; Bukhtoyarova, N.; Carroll, A.; Heppelmann, S.; Kawabata, T.; Leksanov, A.; Makdisi, Y.; Minina, E.; Navon, I.; Nicholson, H.; Ogawa, A.; Panebratsev, Yu.; Piasetzky, E.; Schetkovsky, A.; Shimanskiy, S.; Tang, A.; Watson, J. W.; Yoshida, H.; Zhalov, D.

    2002-01-01

    Beams of protons and pions of 5.9 GeV/c were incident on a C target. Neutrons emitted into the backward hemisphere, in the laboratory system, were detected in (triple) coincidence with two emerging particles of tranverse momenta pt>0.6 GeV/c. We determined that for (46.5+/-3.7)% of the proton-induced events and for (40.8+/-4.5)% of the pion-induced events with the two high-pt particles, there is also at least one backward emitted neutron with momentum greater than 0.32 GeV/c. This observation is in sharp contrast to a well- established universal pattern from a large variety of earlier inclusive measurements with hadrons, electrons, photons, neutrinos, and antineutrinos where the probability for backward nucleon emission was in the 5 to 10 % range. We present also a measurement of the momentum spectra for the backward going neutrons. The spectra have the same universal shape observed in the inclusive reactions. We speculate that the enhanced backward neutron emission in this semi-inclusive region could be an indication for a strong dependence of the cross section on the squared total center-of-mass energy (s) and for the importance of short-range nucleon-nucleon correlations.

  18. Time gating for energy selection and scatter rejection: High-energy pulsed neutron imaging at LANSCE

    NASA Astrophysics Data System (ADS)

    Swift, Alicia; Schirato, Richard; McKigney, Edward; Hunter, James; Temple, Brian

    2015-09-01

    The Los Alamos Neutron Science Center (LANSCE) is a linear accelerator in Los Alamos, New Mexico that accelerates a proton beam to 800 MeV, which then produces spallation neutron beams. Flight path FP15R uses a tungsten target to generate neutrons of energy ranging from several hundred keV to ~600 MeV. The beam structure has micropulses of sub-ns width and period of 1.784 ns, and macropulses of 625 μs width and frequency of either 50 Hz or 100 Hz. This corresponds to 347 micropulses per macropulse, or 1.74 x 104 micropulses per second when operating at 50 Hz. Using a very fast, cooled ICCD camera (Princeton Instruments PI-Max 4), gated images of various objects were obtained on FP15R in January 2015. Objects imaged included blocks of lead and borated polyethylene; a tungsten sphere; and a tungsten, polyethylene, and steel cylinder. Images were obtained in 36 min or less, with some in as little as 6 min. This is novel because the gate widths (some as narrow as 10 ns) were selected to reject scatter and other signal not of interest (e.g. the gamma flash that precedes the neutron pulse), which has not been demonstrated at energies above 14 MeV. This proof-of-principle experiment shows that time gating is possible above 14MeV and is useful for selecting neutron energy and reducing scatter, thus forming clearer images. Future work (simulation and experimental) is being undertaken to improve camera shielding and system design and to precisely determine optical properties of the imaging system.

  19. Neutron capture therapy: Years of experimentation---Years of reflection

    SciTech Connect

    Farr, L.E.

    1991-12-16

    This report describes early research on neutron capture therapy over a number of years, beginning in 1950, speaking briefly of patient treatments but dwelling mostly on interpretations of our animal experiments. This work carried out over eighteen years, beginning over forty years ago. Yet, it is only fitting to start by relating how neutron capture therapy became part of Brookhaven's Medical Research Center program.

  20. A comprehensive spectrometry study of a stray neutron radiation field in scanning proton therapy.

    PubMed

    Mares, Vladimir; Romero-Expósito, Maite; Farah, Jad; Trinkl, Sebastian; Domingo, Carles; Dommert, Martin; Stolarczyk, Liliana; Van Ryckeghem, Laurent; Wielunski, Marek; Olko, Pawel; Harrison, Roger M

    2016-06-01

    The purpose of this study is to characterize the stray neutron radiation field in scanning proton therapy considering a pediatric anthropomorphic phantom and a clinically-relevant beam condition. Using two extended-range Bonner sphere spectrometry systems (ERBSS), Working Group 9 of the European Radiation Dosimetry Group measured neutron spectra at ten different positions around a pediatric anthropomorphic phantom irradiated for a brain tumor with a scanning proton beam. This study compares the different systems and unfolding codes as well as neutron spectra measured in similar conditions around a water tank phantom. The ten spectra measured with two ERBSS systems show a generally similar thermal component regardless of the position around the phantom while high energy neutrons (above 20 MeV) were only registered at positions near the beam axis (at 0°, 329° and 355°). Neutron spectra, fluence and ambient dose equivalent, H (*)(10), values of both systems were in good agreement (<15%) while the unfolding code proved to have a limited effect. The highest H (*)(10) value of 2.7 μSv Gy(-1) was measured at 329° to the beam axis and 1.63 m from the isocenter where high-energy neutrons (E  ⩾  20 MeV) contribute with about 53%. The neutron mapping within the gantry room showed that H (*)(10) values significantly decreased with distance and angular position with respect to the beam axis dropping to 0.52 μSv Gy(-1) at 90° and 3.35 m. Spectra at angles of 45° and 135° with respect to the beam axis measured here with an anthropomorphic phantom showed a similar peak structure at the thermal, fast and high energy range as in the previous water-tank experiments. Meanwhile, at 90°, small differences at the high-energy range were observed. Using ERBSS systems, neutron spectra mapping was performed to characterize the exposure of scanning proton therapy patients. The ten measured spectra provide precise information about the exposure of healthy organs to

  1. A comprehensive spectrometry study of a stray neutron radiation field in scanning proton therapy

    NASA Astrophysics Data System (ADS)

    Mares, Vladimir; Romero-Expósito, Maite; Farah, Jad; Trinkl, Sebastian; Domingo, Carles; Dommert, Martin; Stolarczyk, Liliana; Van Ryckeghem, Laurent; Wielunski, Marek; Olko, Pawel; Harrison, Roger M.

    2016-06-01

    The purpose of this study is to characterize the stray neutron radiation field in scanning proton therapy considering a pediatric anthropomorphic phantom and a clinically-relevant beam condition. Using two extended-range Bonner sphere spectrometry systems (ERBSS), Working Group 9 of the European Radiation Dosimetry Group measured neutron spectra at ten different positions around a pediatric anthropomorphic phantom irradiated for a brain tumor with a scanning proton beam. This study compares the different systems and unfolding codes as well as neutron spectra measured in similar conditions around a water tank phantom. The ten spectra measured with two ERBSS systems show a generally similar thermal component regardless of the position around the phantom while high energy neutrons (above 20 MeV) were only registered at positions near the beam axis (at 0°, 329° and 355°). Neutron spectra, fluence and ambient dose equivalent, H *(10), values of both systems were in good agreement (<15%) while the unfolding code proved to have a limited effect. The highest H *(10) value of 2.7 μSv Gy‑1 was measured at 329° to the beam axis and 1.63 m from the isocenter where high-energy neutrons (E  ⩾  20 MeV) contribute with about 53%. The neutron mapping within the gantry room showed that H *(10) values significantly decreased with distance and angular position with respect to the beam axis dropping to 0.52 μSv Gy‑1 at 90° and 3.35 m. Spectra at angles of 45° and 135° with respect to the beam axis measured here with an anthropomorphic phantom showed a similar peak structure at the thermal, fast and high energy range as in the previous water-tank experiments. Meanwhile, at 90°, small differences at the high-energy range were observed. Using ERBSS systems, neutron spectra mapping was performed to characterize the exposure of scanning proton therapy patients. The ten measured spectra provide precise information about the exposure of healthy organs to thermal

  2. Neutron dosimetry at a high-energy electron-positron collider

    NASA Astrophysics Data System (ADS)

    Bedogni, Roberto

    Electron-positron colliders with energy of hundreds of MeV per beam have been employed for studies in the domain of nuclear and sub-nuclear physics. The typical structure of such a collider includes an LINAC, able to produce both types of particles, an accumulator ring and a main ring, whose diameter ranges from several tens to hundred meters and allows circulating particle currents of several amperes per beam. As a consequence of the interaction of the primary particles with targets, shutters, structures and barriers, a complex radiation environment is produced. This paper addresses the neutron dosimetry issues associated with the operation of such accelerators, referring in particular to the DAΦ NE complex, operative since 1997 at INFN-Frascati National Laboratory (Italy). Special attention is given to the active and passive techniques used for the spectrometric and dosimetric characterization of the workplace neutron fields, for radiation protection dosimetry purposes.

  3. An ionization chamber with Frisch grids for studies of high-energy neutron-induced fission

    NASA Astrophysics Data System (ADS)

    Tutin, G. A.; Ryzhov, I. V.; Eismont, V. P.; Kireev, A. V.; Condé, H.; Elmgren, K.; Olsson, N.; Renberg, P.-U.

    2001-01-01

    A gridded ionization chamber for fission fragment detection is described. The chamber has been specially designed for use at the quasi-monoenergetic 7Li(p, n) neutron source at the The Svedberg Laboratory, Uppsala, Sweden. The detector permits measurements of fission fragment energy and emission angle for two targets with diameter of up to 10 cm. The time response of the chamber (⩽5 ns FWHM) is adequate to apply time-of-flight discrimination against background events induced by non-peak neutrons. Results of angular anisotropy measurements for the 232Th (n, f) and 238U(n, f) reactions in the 20-160 MeV energy range are given.

  4. High-energy transients. [from weakly and strongly magnetic neutron stars

    NASA Technical Reports Server (NTRS)

    Lamb, D. Q.

    1991-01-01

    The observational characteristics of X-ray bursts are reviewed and the thermonuclear-flash model is examined to assess the suitability of the model and the sources of X- and gamma-ray bursts. The profiles of X-ray bursts from five different sources are delineated, and the global analysis of nuclear burning is discussed to review th range possible X-ray burst behavior. The analysis by Fushiki and Lamb (1987) is noted for the description of regions which lie away from the steady-state cut. The discussion of cyclotron lines in gamma-ray bursts emphasizes the source GB880205, and it is shown that Raman and cyclotron resonant scattering can explain the observed positions, strengths, and widths of the dips in the spectrum. X-ray bursts are theorized to emanate from weakly magnetic neutron stars, and gamma-ray bursts are shown to be the products of strongly magnetic neutron stars.

  5. Backward emitted high-energy neutrons in hard reactions of p and π+ on carbon

    NASA Astrophysics Data System (ADS)

    Malki, A.; Piasetzky, E.; Alster, J.; Asryan, G.; Averichev, Y.; Barton, D.; Baturin, V.; Bukhtoyarova, N.; Carroll, A.; Heppelmann, S.; Kawabata, T.; Leksanov, A.; Makdisi, Y.; Minina, E.; Navon, I.; Nicholson, H.; Ogawa, A.; Panebratsev, Yu.; Schetkovsky, A.; Shimanskiy, S.; Tang, A.; Watson, J. W.; Yoshida, H.; Zhalov, D.

    2000-12-01

    Beams of protons and pions of 5.9 GeV/c were incident on a C target. Neutrons emitted into the back hemisphere, in the laboratory system, were detected in (triple) coincidence with two emerging pt>0.6 GeV/c particles. We present the momentum spectra of the backward going neutrons. We also integrated the spectra and determined the fraction of the hard scattering events which are in coincidence with at least one neutron emitted into the back hemisphere, with momenta above 0.32 GeV/c. Contrary to the earlier measurements which found that only a small fraction (of the order of 10%) of the total inelastic cross section for light nuclei was associated with backward going nucleons, we find that about half of the events are of this nature. We speculate that the reason for the large difference is due to the strong dependence of the hard-scattering reaction upon the total center of mass energy(s) and short range nucleon correlations in nuclei.

  6. Slightly focused high-energy shockwave therapy: a potential adjuvant treatment for osteoporotic fracture

    PubMed Central

    Chen, Xiao-Feng; Huang, Hai-Ming; Li, Xiao-Lin; Liu, Ge-Jun; Zhang, Hui

    2015-01-01

    Slightly focused high-energy shockwave (HESW) therapy is characterized by a wide focal area, a large therapy zone, easy positioning and less pain during treatment. The objective of this study was to perform for the first time an in vivo test of the slightly focused HESWs for osteoporotic fractures. Bilateral proximal tibial osteotomies were made in 30 ovariectomized (OVX) Sprague-Dawley rats and secured with internal fixation. The osteotomy site in the left tibia was subsequently treated with slightly focused HESWs with the energy flux density of 0.26 mj/mm2, shock repetition frequency of 1 Hz and 2000 shocks (OVX + HESW group). The contralateral right tibia was not treated and served as the control (OVX group). Roentgenographic examination 2, 4, 6, and 8 weeks after osteotomy showed that HESW treatment accelerated tibia fracture healing in osteoporotic rats. Histological examination 2, 4, and 8 weeks after HESW treatment showed a greater inflammatory reaction in the OVX + HESW group, with more mature collagen and trabeculae than in the OVX group. Micro computer tomography (Micro-CT) scanning after 4 and 8 weeks showed that bone volume (BV), bone volume/tissue volume (BV/TV), mean trabecular thickness (Tb.Th), and mean trabecular number (Tb.N) were about 45.0% and 33.1%, 18.4% and 20.1%, 38.2% and 20.9%, 26.7% and 28.4%, respectively, higher in the treatment group than in the control group (P < 0.05); and the mean trabecular separation (Tb.Sp) was about 16.7% and 27.3% lower in the treatment group (P < 0.05). Four and eight weeks after HESW treatment, the maximum compressive callus endurance was about 72.3% and 25.5%, respectively, higher in the treatment group than in the control group (P < 0.05). These results show that slightly focused HESW therapy has a beneficial effect on osteoporotic tibial fracture healing. Slightly focused HESWs could increase callus endurance, induce bone formation, and improve trabecular bone microarchitecture and biomechanical

  7. Characterization of extended range Bonner Sphere Spectrometers in the CERF high-energy broad neutron field at CERN

    NASA Astrophysics Data System (ADS)

    Agosteo, S.; Bedogni, R.; Caresana, M.; Charitonidis, N.; Chiti, M.; Esposito, A.; Ferrarini, M.; Severino, C.; Silari, M.

    2012-12-01

    The accurate determination of the ambient dose equivalent in the mixed neutron-photon fields encountered around high-energy particle accelerators still represents a challenging task. The main complexity arises from the extreme variability of the neutron energy, which spans over 10 orders of magnitude or more. Operational survey instruments, which response function attempts to mimic the fluence-to-ambient dose equivalent conversion coefficient up to GeV neutrons, are available on the market, but their response is not fully reliable over the entire energy range. Extended range rem counters (ERRC) do not require the exact knowledge of the energy distribution of the neutron field and the calibration can be done with a source spectrum. If the actual neutron field has an energy distribution different from the calibration spectrum, the measurement is affected by an added uncertainty related to the partial overlap of the fluence-to-ambient dose equivalent conversion curve and the response function. For this reason their operational use should always be preceded by an "in-field" calibration, i.e. a calibration made against a reference instrument exposed in the same field where the survey-meter will be employed. In practice the extended-range Bonner Sphere Spectrometer (ERBSS) is the only device which can serve as reference instrument in these fields, because of its wide energy range and the possibility to assess the neutron fluence and the ambient dose equivalent (H*(10)) values with the appropriate accuracy. Nevertheless, the experience gained by a number of experimental groups suggests that mandatory conditions for obtaining accurate results in workplaces are: (1) the use of a well-established response matrix, thus implying validation campaigns in reference monochromatic neutrons fields, (2) the expert and critical use of suitable unfolding codes, and (3) the performance test of the whole system (experimental set-up, elaboration and unfolding procedures) in a well

  8. Transport analysis of measured neutron leakage spectra from spheres as tests of evaluated high energy cross sections

    NASA Technical Reports Server (NTRS)

    Bogart, D. D.; Shook, D. F.; Fieno, D.

    1973-01-01

    Integral tests of evaluated ENDF/B high-energy cross sections have been made by comparing measured and calculated neutron leakage flux spectra from spheres of various materials. An Am-Be (alpha,n) source was used to provide fast neutrons at the center of the test spheres of Be, CH2, Pb, Nb, Mo, Ta, and W. The absolute leakage flux spectra were measured in the energy range 0.5 to 12 MeV using a calibrated NE213 liquid scintillator neutron spectrometer. Absolute calculations of the spectra were made using version 3 ENDF/B cross sections and an S sub n discrete ordinates multigroup transport code. Generally excellent agreement was obtained for Be, CH2, Pb, and Mo, and good agreement was observed for Nb although discrepancies were observed for some energy ranges. Poor comparative results, obtained for Ta and W, are attributed to unsatisfactory nonelastic cross sections. The experimental sphere leakage flux spectra are tabulated and serve as possible benchmarks for these elements against which reevaluated cross sections may be tested.

  9. Evaluation of Neutron Component in Patients under High Energy Radiotherapy By Means of an On Line and In Vivo procedure

    SciTech Connect

    Exposito, M. R.; Palma, B. A.; Terron, J. A.; Gomez, F.; Domingo, C.; Barquero, R.; Sanchez-Doblado, F.

    2010-12-07

    The use of improved radiotherapy methods has raised the concern about second cancer induction. Epidemiological studies have shown a major incidence of secondary cancer in radiotherapy patients compared to patients subjected to another type of treatment. In this regard, it is important to determine the peripheral dose received by the patient during the treatment. While photon doses have been deeply contemplated, neutron contamination in high energy photon beams is still a subject of research and discussion. In the present work, we introduce a new procedure based on a digital device that allows real time neutron contamination evaluation. Several irradiations of an anthropomorphic phantom have been carried out in a variety of facilities and treatments. The purpose was to correlate the measurements from the digital detector with the neutron doses obtained in the phantom by Monte Carlo simulations and experimental measurements. A model has been designed to calculate the organ equivalent dose and risk estimates during any therapeutic session. The procedure has been used to monitor more than 1000 patients showing its applicability in clinical routine. It can be used both for inductive and retrospective studies with a reasonable uncertainty. Thus, this could provide the necessary information to complement the dosimetry of patient and estimate the treatment risk.

  10. Evaluation of Neutron Component in Patients under High Energy Radiotherapy By Means of an On Line and In Vivo procedure

    NASA Astrophysics Data System (ADS)

    Expósito, M. R.; Terrón, J. A.; Palma, B. A.; Gómez, F.; Domingo, C.; Barquero, R.; Sánchez-Doblado, F.

    2010-12-01

    The use of improved radiotherapy methods has raised the concern about second cancer induction. Epidemiological studies have shown a major incidence of secondary cancer in radiotherapy patients compared to patients subjected to another type of treatment. In this regard, it is important to determine the peripheral dose received by the patient during the treatment. While photon doses have been deeply contemplated, neutron contamination in high energy photon beams is still a subject of research and discussion. In the present work, we introduce a new procedure based on a digital device that allows real time neutron contamination evaluation. Several irradiations of an anthropomorphic phantom have been carried out in a variety of facilities and treatments. The purpose was to correlate the measurements from the digital detector with the neutron doses obtained in the phantom by Monte Carlo simulations and experimental measurements. A model has been designed to calculate the organ equivalent dose and risk estimates during any therapeutic session. The procedure has been used to monitor more than 1000 patients showing its applicability in clinical routine. It can be used both for inductive and retrospective studies with a reasonable uncertainty. Thus, this could provide the necessary information to complement the dosimetry of patient and estimate the treatment risk.

  11. Boron thermal/epithermal neutron capture therapy

    SciTech Connect

    Fairchild, R.G.

    1982-01-01

    The development of various particle beams for radiotherapy represents an attempt to improve dose distribution, and to provide high LET radiations which are less sensitive to ambient physical and radiobiological factors such as oxygen tension, cell cycle, and dose rate. In general, a compromise is necessary as effective RBE is reduced in order to spread the dose distribution over the anticipated tumor volume. The approach of delivering stable non-toxic isotopes to tumor, and then activating these atoms subsequently via an external radiation beam has mator advantages; problems associated with high uptake of these isotopes in competing cell pools are obviated, and the general tumor volume can be included in the treatment field of the activating beam. As long as the normal tissues supporting tumor show a low uptake of the isotope to be activated, and as long as the range of the reaction products is short, dose will be restricted to tumor, with a consequent high therapeutic ratio. Neutron Capture Therapy (NCT) is generally carried out by activating boron-10 with low energy neutrons. The range of the high LET, low OER particles from the /sup 10/B(n, ..cap alpha..)/sup 7/Li reaction is approx. 10..mu.., or one cell diameter, a situation that is optimal for cell killing. Significant advantages may be gained by using the NCT procedure in conjunction with improved tissue penetration provided with epithermal or filtered beams, and new compounds showing physiological binding to tumor.

  12. NIFTI and DISCOS: New concepts for a compact accelerator neutron source for boron neutron capture therapy applications

    SciTech Connect

    Powell, J.; Ludewig, H.; Todosow, M.; Reich, M.

    1995-06-01

    Two new concepts, NIFTI and DISCOS, are described. These concepts enable the efficient production of epithermal neutrons for BNCT (Boron Neutron Capture Therapy) medical treatment, utilizing a low current, low energy proton beam impacting on a lithium target. The NIFTI concept uses fluoride compounds, such as lead or beryllium fluoride, to efficiently degrade high energy neutrons from the lithium target to the lower energies required for BNCT. The fluoride compounds are in turn encased in an iron layer that strongly impedes the transmission of neutrons with energies above 24 KeV. Lower energy neutrons readily pass through this iron filter, which has a deep window in its scattering cross section at 24 KeV. The DISCOS concept uses a rapidly rotating, high g disc to create a series of thin ({approximately} 1 micron thickness) liquid lithium targets in the form of continuous films or sheets of discrete droplets--through which the proton beam passes. The average energy lost by a proton as it passes through a single target is small, approximately 10 KeV. Between the targets, the proton beam is re-accelerated by an applied DC electric field. The DISCOS approach enables the accelerator--target facility to operate with a beam energy only slightly above the threshold value for neutron production--resulting in an output beam of low-energy epithermal neutrons--while achieving a high yield of neutrons per milliamp of proton beam current. Parametric trade studies of the NIFTI and DISCOS concepts are described. These include analyses of a broad range of NIFTI designs using the Monte carlo MCNP neutronics code, as well as mechanical and thermal-hydraulic analyses of various DISCOS designs.

  13. Evaluation of neutron radiation field in carbon ion therapy

    NASA Astrophysics Data System (ADS)

    Xu, Jun-Kui; Su, You-Wu; Li, Wu-Yuan; Yan, Wei-Wei; Chen, Xi-Meng; Mao, Wang; Pang, Cheng-Guo

    2016-01-01

    Carbon ions have significant advantages in tumor therapy because of their physical and biological properties. In view of the radiation protection, the safety of patients is the most important issue in therapy processes. Therefore, the effects of the secondary particles produced by the carbon ions in the tumor therapy should be carefully considered, especially for the neutrons. In the present work, the neutron radiation field induced by carbon ions was evaluated by using the FLUKA code. The simulated results of neutron energy spectra and neutron dose was found to be in good agreement with the experiment data. In addition, energy deposition of carbon ions and neutrons in tissue-like media was studied, it is found that the secondary neutron energy deposition is not expected to exceed 1% of the carbon ion energy deposition in a typical treatment.

  14. Measurements of the neutron dose equivalent for various radiation qualities, treatment machines and delivery techniques in radiation therapy

    NASA Astrophysics Data System (ADS)

    Hälg, R. A.; Besserer, J.; Boschung, M.; Mayer, S.; Lomax, A. J.; Schneider, U.

    2014-05-01

    In radiation therapy, high energy photon and proton beams cause the production of secondary neutrons. This leads to an unwanted dose contribution, which can be considerable for tissues outside of the target volume regarding the long term health of cancer patients. Due to the high biological effectiveness of neutrons in regards to cancer induction, small neutron doses can be important. This study quantified the neutron doses for different radiation therapy modalities. Most of the reports in the literature used neutron dose measurements free in air or on the surface of phantoms to estimate the amount of neutron dose to the patient. In this study, dose measurements were performed in terms of neutron dose equivalent inside an anthropomorphic phantom. The neutron dose equivalent was determined using track etch detectors as a function of the distance to the isocenter, as well as for radiation sensitive organs. The dose distributions were compared with respect to treatment techniques (3D-conformal, volumetric modulated arc therapy and intensity-modulated radiation therapy for photons; spot scanning and passive scattering for protons), therapy machines (Varian, Elekta and Siemens linear accelerators) and radiation quality (photons and protons). The neutron dose equivalent varied between 0.002 and 3 mSv per treatment gray over all measurements. Only small differences were found when comparing treatment techniques, but substantial differences were observed between the linear accelerator models. The neutron dose equivalent for proton therapy was higher than for photons in general and in particular for double-scattered protons. The overall neutron dose equivalent measured in this study was an order of magnitude lower than the stray dose of a treatment using 6 MV photons, suggesting that the contribution of the secondary neutron dose equivalent to the integral dose of a radiotherapy patient is small.

  15. Measurements of the neutron dose equivalent for various radiation qualities, treatment machines and delivery techniques in radiation therapy.

    PubMed

    Hälg, R A; Besserer, J; Boschung, M; Mayer, S; Lomax, A J; Schneider, U

    2014-05-21

    In radiation therapy, high energy photon and proton beams cause the production of secondary neutrons. This leads to an unwanted dose contribution, which can be considerable for tissues outside of the target volume regarding the long term health of cancer patients. Due to the high biological effectiveness of neutrons in regards to cancer induction, small neutron doses can be important. This study quantified the neutron doses for different radiation therapy modalities. Most of the reports in the literature used neutron dose measurements free in air or on the surface of phantoms to estimate the amount of neutron dose to the patient. In this study, dose measurements were performed in terms of neutron dose equivalent inside an anthropomorphic phantom. The neutron dose equivalent was determined using track etch detectors as a function of the distance to the isocenter, as well as for radiation sensitive organs. The dose distributions were compared with respect to treatment techniques (3D-conformal, volumetric modulated arc therapy and intensity-modulated radiation therapy for photons; spot scanning and passive scattering for protons), therapy machines (Varian, Elekta and Siemens linear accelerators) and radiation quality (photons and protons). The neutron dose equivalent varied between 0.002 and 3 mSv per treatment gray over all measurements. Only small differences were found when comparing treatment techniques, but substantial differences were observed between the linear accelerator models. The neutron dose equivalent for proton therapy was higher than for photons in general and in particular for double-scattered protons. The overall neutron dose equivalent measured in this study was an order of magnitude lower than the stray dose of a treatment using 6 MV photons, suggesting that the contribution of the secondary neutron dose equivalent to the integral dose of a radiotherapy patient is small. PMID:24778349

  16. High-energy quasi-monoenergetic neutron fields: existing facilities and future needs.

    PubMed

    Pomp, S; Bartlett, D T; Mayer, S; Reitz, G; Röttger, S; Silari, M; Smit, F D; Vincke, H; Yasuda, H

    2014-10-01

    The argument that well-characterised quasi-monoenergetic neutron (QMN) sources reaching into the energy domain >20 MeV are needed is presented. A brief overview of the existing facilities is given, and a list of key factors that an ideal QMN source for dosimetry and spectrometry should offer is presented. The authors conclude that all of the six QMN facilities currently in existence worldwide operate in sub-optimal conditions for dosimetry. The only currently available QMN facility in Europe capable of operating at energies >40 MeV, TSL in Uppsala, Sweden, is threatened with shutdown in the immediate future. One facility, NFS at GANIL, France, is currently under construction. NFS could deliver QMN beams up to about 30 MeV. It is, however, so far not clear if and when NFS will be able to offer QMN beams or operate with only so-called white neutron beams. It is likely that by 2016, QMN beams with energies >40 MeV will be available only in South Africa and Japan, with none in Europe. PMID:24153422

  17. SU-E-T-543: Measurement of Neutron Activation From Different High Energy Varian Linear Accelerators

    SciTech Connect

    Thatcher, T; Madsen, S; Sudowe, R; Meigooni, A Soleimani

    2015-06-15

    Purpose: Linear accelerators producing photons above 10 MeV may induce photonuclear reactions in high Z components of the accelerator. These liberated neutrons can then activate the structural components of the accelerator and other materials in the beam path through neutron capture reactions. The induced activity within the accelerator may contribute to additional dose to both patients and personnel. This project seeks to determine the total activity and activity per activated isotope following irradiation in different Varian accelerators at energies above 10 MeV. Methods: A Varian 21IX accelerator was used to irradiate a 30 cm × 30 cm × 20 cm solid water phantom with 15 MV x-rays. The phantom was placed at an SSD of 100 cm and at the center of a 20 cm × 20 cm field. Activation induced gamma spectra were acquired over a 5 minute interval after 1 and 15 minutes from completion of the irradiation. All measurements were made using a CANBERRA Falcon 5000 Portable HPGe detector. The majority of measurements were made in scattering geometry with the detector situated at 90° to the incident beam, 30 cm from the side of the phantom and approximately 10 cm from the top. A 5 minute background count was acquired and automatically subtracted from all subsequent measurements. Photon spectra were acquired for both open and MLC fields. Results: Based on spectral signatures, nuclides have been identified and their activities calculated for both open and MLC fields. Preliminary analyses suggest that activities from the activation products in the microcurie range. Conclusion: Activation isotopes have been identified and their relative activities determined. These activities are only gross estimates since efficiencies have not been determined for this source-detector geometry. Current efforts are focused on accurate determination of detector efficiencies using Monte Carlo calculations.

  18. Neutron therapy for salivary and thyroid gland cancer

    NASA Astrophysics Data System (ADS)

    Gribova, O. V.; Musabaeva, L. I.; Choynzonov, E. L.; Lisin, V. A.; Novikov, V. A.

    2016-08-01

    The purpose of this study was to analyze the results of the combined modality treatment and radiation therapy using 6.3 MeV fast neutrons for salivary gland cancer and prognostically unfavorable thyroid gland cancer. The study group comprised 127 patients with salivary gland cancer and 46 patients with thyroid gland cancer, who received neutron therapy alone and in combination with surgery. The results obtained demonstrated that the combined modality treatment including fast neutron therapy led to encouraging local control in patients with salivary and thyroid gland cancers.

  19. Accelerator-based neutron source for the neutron-capture and fast neutron therapy at hospital

    NASA Astrophysics Data System (ADS)

    Bayanov, B. F.; Belov, V. P.; Bender, E. D.; Bokhovko, M. V.; Dimov, G. I.; Kononov, V. N.; Kononov, O. E.; Kuksanov, N. K.; Palchikov, V. E.; Pivovarov, V. A.; Salimov, R. A.; Silvestrov, G. I.; Skrinsky, A. N.; Soloviov, N. A.; Taskaev, S. Yu.

    The proton accelerator complex for neutron production in lithium target discussed, which can operate in two modes. The first provides a neutron beam kinematically collimated with good forward direction in 25° and average energy of 30 keV, directly applicable for neutron-capture therapy with high efficiency of proton beam use. The proton energy in this mode is 1.883-1.890 MeV that is near the threshold of the 7Li( p, n) 7Be reaction. In the second mode, at proton energy of 2.5 MeV, the complex-produced neutron beam with maximum energy board of 790 keV which can be used directly for fast neutron therapy and for neutron-capture therapy after moderation. The project of such a neutron source is based on the 2.5 MeV original electrostatic accelerator tandem with vacuum insulation developed at BINP which is supplied with a high-voltage rectifier. The rectifier is produced in BINP as a part of ELV-type industrial accelerator. Design features of the tandem determining its high reliability in operation with a high-current (up to 40 mA) H - ion beam are discussed. They are: the absence of ceramic accelerator columns around the beam passage region, good conditions for pumping out of charge-exchange gaseous target region, strong focusing optics and high acceleration rate minimizing the space charge effects. The possibility of stabilization of protons energy with an accuracy level of 0.1% necessary for operation in the near threshold region is considered. The design description of H - continuous ion source with a current of 40 mA is also performed. To operate with a 100 kW proton beam it is proposed to use liquid-lithium targets. A thin lithium layer on the surface of a tungsten disk cooled intensively by a liquid metal heat carrier is proposed for use in case of the vertical beam, and a flat liquid lithium jet flowing through the narrow nozzle - for the horizontal beam.

  20. Characterization of neutron-irradiated HT-UPS steel by high-energy X-ray diffraction microscopy

    NASA Astrophysics Data System (ADS)

    Zhang, Xuan; Park, Jun-Sang; Almer, Jonathan; Li, Meimei

    2016-04-01

    This paper presents the first measurement of neutron-irradiated microstructure using far-field high-energy X-ray diffraction microscopy (FF-HEDM) in a high-temperature ultrafine-precipitate-strengthened (HT-UPS) austenitic stainless steel. Grain center of mass, grain size distribution, crystallographic orientation (texture), diffraction spot broadening and lattice constant distributions of individual grains were obtained for samples in three different conditions: non-irradiated, neutron-irradiated (3dpa/500 °C), and irradiated + annealed (3dpa/500 °C + 600 °C/1 h). It was found that irradiation caused significant increase in grain-level diffraction spot broadening, modified the texture, reduced the grain-averaged lattice constant, but had nearly no effect on the average grain size and grain size distribution, as well as the grain size-dependent lattice constant variations. Post-irradiation annealing largely reversed the irradiation effects on texture and average lattice constant, but inadequately restored the microstrain.

  1. Possible high-energy neutrino and photon signals from gravitational wave bursts due to double neutron star mergers

    NASA Astrophysics Data System (ADS)

    Gao, He; Zhang, Bing; Wu, Xue-Feng; Dai, Zi-Gao

    2013-08-01

    As the technology of gravitational-wave and neutrino detectors becomes increasingly mature, a multimessenger era of astronomy is ushered in. Advanced gravitational-wave detectors are close to making a ground-breaking discovery of gravitational-wave bursts (GWBs) associated with mergers of double neutron stars (NS-NS). It is essential to study the possible electromagnetic and neutrino emission counterparts of these GWBs. Recent observations and numerical simulations suggest that at least a fraction of NS-NS mergers may leave behind a massive millisecond magnetar as the merger product. Here we show that protons accelerated in the forward shock powered by a magnetar wind pushing the ejecta launched during the merger process would interact with photons generated in the dissipating magnetar wind and emit high-energy neutrinos and photons. We estimate the typical energy and fluence of the neutrinos from such a scenario. We find that ˜PeV neutrinos could be emitted from the shock front as long as the ejecta could be accelerated to a relativistic speed. The diffuse neutrino flux from these events, even under the most optimistic scenarios, is too low to account for the two events announced by the IceCube Collaboration, but it is only slightly lower than the diffuse flux of GRBs, making it an important candidate for the diffuse background of ˜PeV neutrinos. The neutron-pion decay of these events make them a moderate contributor to the sub-TeV gamma-ray diffuse background.

  2. Laser-driven high-energy-density deuterium and tritium ions for neutron production in a double-cone configuration

    NASA Astrophysics Data System (ADS)

    Hu, Li-Xiang; Yu, Tong-Pu; Shao, Fu-Qiu; Zhu, Qing-Jun; Yin, Yan; Ma, Yan-Yun

    2015-12-01

    By using two-dimensional particle-in-cell simulations, we investigate laser-driven ion acceleration and compression from a thin DT foil in a double-cone configuration. By using two counterpropagating laser pulses, it is shown that a double-cone structure can effectively guide, focus, and strengthen the incident laser pulses, resulting in the enhanced acceleration and compression of D+ and T+. Due to the ion Coulomb repulsion and the effective screening from the external laser electric fields, the transverse diffusion of ions is significantly suppressed. Finally, the peak energy density of the compressed ions exceeds 2.73 × 1016 J/m3, which is about five orders of magnitude higher than the threshold for high energy density physics, 1011 J/m3. Under this condition, DT fusion reactions are initiated and the neutron production rate per volume is estimated to be as high as 7.473 × 1035/m3 s according to Monte Carlo simulations. It is much higher than that of the traditional large neutron sources, which may facilitate many potential applications.

  3. Laser-driven high-energy-density deuterium and tritium ions for neutron production in a double-cone configuration

    SciTech Connect

    Hu, Li-Xiang; Yu, Tong-Pu Shao, Fu-Qiu; Yin, Yan; Ma, Yan-Yun; Zhu, Qing-Jun

    2015-12-15

    By using two-dimensional particle-in-cell simulations, we investigate laser-driven ion acceleration and compression from a thin DT foil in a double-cone configuration. By using two counterpropagating laser pulses, it is shown that a double-cone structure can effectively guide, focus, and strengthen the incident laser pulses, resulting in the enhanced acceleration and compression of D{sup +} and T{sup +}. Due to the ion Coulomb repulsion and the effective screening from the external laser electric fields, the transverse diffusion of ions is significantly suppressed. Finally, the peak energy density of the compressed ions exceeds 2.73 × 10{sup 16 }J/m{sup 3}, which is about five orders of magnitude higher than the threshold for high energy density physics, 10{sup 11 }J/m{sup 3}. Under this condition, DT fusion reactions are initiated and the neutron production rate per volume is estimated to be as high as 7.473 × 10{sup 35}/m{sup 3} s according to Monte Carlo simulations. It is much higher than that of the traditional large neutron sources, which may facilitate many potential applications.

  4. Production of the SIGMA(0)(C) and SIGMA(++)(C) by High Energy Neutrons.

    NASA Astrophysics Data System (ADS)

    Ladbury, Raymond Llewellyn, Jr.

    We present the first observation of hadroproduction of the Sigma_sp{c}{++ } and Sigma_sp{c }{0}, decaying into Lambda _{c}pi. The daughter Lambda_{c} is observed in the decay modes pKpi and pK _{s}pipi. The Experiment was conducted at a broadband neutron beam in the Proton East area of the Fermi National Accelerator Laboratory. A two-magnet multiparticle spectrometer equipped with proportional wire chambers and a high resolution MWPC vertex detector was used to momentum analyze charged particles produced in the interactions of neutrons on targets of beryllium, silicon and tungsten. Particles were identified using three Cerenkov counters. The beam energy for each event was reconstructed using hadronic and electromagnetic calorimetry. The mass differences delta m_ {Sigma_sp{c}{++}- Lambda_{c}}, delta m_{Sigma_sp{c }{0}-Lambda_{c}} and delta m_{Sigma _sp{c}{++}-Sigma_sp {c}{0}} are measured and found to be 166.4 +/-.3 +/- 2.0 MeV/c^2, 178.5 +/-.3 +/- 2.5MeV/c ^2 and -12.1 +/- .4 +/- 2.8MeV/c^2 . This last value is larger in magnitude than the predictions of most theoretical calculations. We also report measurements of particle to antiparticle ratios, x_{f} dependence, A dependence, and p_{t} dependence of the production cross sections. The total production cross sections of the Sigma_sp{c} {0} and Sigma_sp {c}{++} are calculated, assuming {dsigmaover dx_{f }} ~ (1 -x)^4, linear atomic weight dependence, B(Lambda_{c} to pKpi) =.022, and symmetric production of particle and antiparticle. From this, and the value of sigma cdot B( Lambda_{c} to pK_sp{s}{0} pipi), calculated under the same assumptions, we calculate the ratio of branching fractions {B(Lambda_{c} to p| K^{0}pipi)}over {B(Lambda_{c}to pKpi) }. We conclude that the level of charm production indicated by our measurements is substantially higher than that predicted by first order gluon-gluon fusion.

  5. Impact of nuclear data on fast neutron therapy

    SciTech Connect

    Hartmann Siantar, C.L.; Chandler, W.P.; Rathkopf, J.A.; Resler, D.A.; Cox, L.J.; Chadwick, M.B.; White, R.M.

    1994-05-12

    By combining a new, all-particle Monte Carlo radiation transport code, PEREGRINE, with the Lawrence Livermore National Laboratory (LLNL) nuclear data base, we have studied the importance of various neutron reactions on dose distributions in biological materials. Monte Carlo calculations have been performed for 5--20 MeV neutron pencil beams incident on biologically relevant materials arranged in several simple geometries. Results highlight the importance of nuclear data used for calculating dose distributions resulting from fast neutron therapy.

  6. Neutron sources for a neutron capture therapy facility

    SciTech Connect

    Lennox, A.J.

    1993-04-01

    Recent advances in the development of boron pharmaceuticals have reopened the possibility of using epithermal neutrons to treat brain tumors containing boron-10. This paper summarizes the approaches being used to generate the neutron sources and identifies specific areas where more research and development are needed.

  7. Applicability of self-activation of an NaI scintillator for measurement of photo-neutrons around a high-energy X-ray radiotherapy machine.

    PubMed

    Wakabayashi, Genichiro; Nohtomi, Akihiro; Yahiro, Eriko; Fujibuchi, Toshioh; Fukunaga, Junichi; Umezu, Yoshiyuki; Nakamura, Yasuhiko; Nakamura, Katsumasa; Hosono, Makoto; Itoh, Tetsuo

    2015-01-01

    The applicability of the activation of an NaI scintillator for neutron monitoring at a clinical linac was investigated experimentally. Thermal neutron fluence rates are derived by measurement of the I-128 activity generated in an NaI scintillator irradiated by neutrons; β-rays from I-128 are detected efficiently by the NaI scintillator. In order to verify the validity of this method for neutron measurement, we irradiated an NaI scintillator at a research reactor, and the neutron fluence rate was estimated. The method was then applied to neutron measurement at a 10-MV linac (Varian Clinac 21EX), and the neutron fluence rate was estimated at the isocenter and at 30 cm from the isocenter. When the scintillator was irradiated directly by high-energy X-rays, the production of I-126 was observed due to photo-nuclear reactions, in addition to the generation of I-128 and Na-24. From the results obtained by these measurements, it was found that the neutron measurement by activation of an NaI scintillator has a great advantage in estimates of a low neutron fluence rate by use of a quick measurement following a short-time irradiation. Also, the future application of this method to quasi real-time monitoring of neutrons during patient treatments at a radiotherapy facility is discussed, as well as the method of evaluation of the neutron dose. PMID:25404493

  8. 21 CFR 892.5300 - Medical neutron radiation therapy system.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Medical neutron radiation therapy system. 892.5300 Section 892.5300 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5300 Medical neutron...

  9. 21 CFR 892.5300 - Medical neutron radiation therapy system.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 8 2012-04-01 2012-04-01 false Medical neutron radiation therapy system. 892.5300 Section 892.5300 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5300 Medical neutron...

  10. 21 CFR 892.5300 - Medical neutron radiation therapy system.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 8 2013-04-01 2013-04-01 false Medical neutron radiation therapy system. 892.5300 Section 892.5300 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5300 Medical neutron...

  11. 21 CFR 892.5300 - Medical neutron radiation therapy system.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 8 2014-04-01 2014-04-01 false Medical neutron radiation therapy system. 892.5300 Section 892.5300 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES RADIOLOGY DEVICES Therapeutic Devices § 892.5300 Medical neutron...

  12. Neutron capture therapy: Years of experimentation---Years of reflection

    SciTech Connect

    Farr, L.E.

    1991-12-16

    This report describes early research on neutron capture therapy over a number of years, beginning in 1950, speaking briefly of patient treatments but dwelling mostly on interpretations of our animal experiments. This work carried out over eighteen years, beginning over forty years ago. Yet, it is only fitting to start by relating how neutron capture therapy became part of Brookhaven`s Medical Research Center program.

  13. Role of gel dosimeters in boron neutron capture therapy.

    PubMed

    Khajeali, Azim; Farajollahi, Ali Reza; Khodadadi, Roghayeh; Kasesaz, Yaser; Khalili, Assef

    2015-09-01

    Gel dosimeters have acquired a unique status in radiotherapy, especially with the advent of the new techniques in which there is a need for three-dimensional dose measurement with high spatial resolution. One of the techniques in which the use of gel dosimeters has drawn the attention of the researchers is the boron neutron capture therapy. Exploring the history of gel dosimeters, this paper sets out to study their role in the boron neutron capture therapy dosimetric process. PMID:26070173

  14. Halogenated sulfidohydroboranes for nuclear medicine and boron neutron capture therapy

    DOEpatents

    Miura, M.; Slatkin, D.N.

    1995-10-03

    A method for performing boron neutron capture therapy for the treatment of tumors is disclosed. The method includes administering to a patient an iodinated sulfidohydroborane, a boron-10-containing compound. The site of the tumor is localized by visualizing the increased concentration of the iodine labelled compound at the tumor. The targeted tumor is then irradiated with a beam of neutrons having an energy distribution effective for neutron capture. Destruction of the tumor occurs due to high LET particle irradiation of the tissue secondary to the incident neutrons being captured by the boron-10 nuclei. Iodinated sulfidohydroboranes are disclosed which are especially suitable for the method of the invention. In a preferred embodiment, a compound having the formula Na{sub 4}B{sub 12}I{sub 11}SSB{sub 12}I{sub 11}, or another pharmaceutically acceptable salt of the compound, may be administered to a cancer patient for boron neutron capture therapy. 1 fig.

  15. Halogenated sulfidohydroboranes for nuclear medicine and boron neutron capture therapy

    DOEpatents

    Miura, M.; Slatkin, D.N.

    1997-08-05

    A method for performing boron neutron capture therapy for the treatment of tumors is disclosed. The method includes administering to a patient an iodinated sulfidohydroborane, a boron-10-containing compound. The site of the tumor is localized by visualizing the increased concentration of the iodine labelled compound at the tumor. The targeted tumor is then irradiated with a beam of neutrons having an energy distribution effective for neutron capture. Destruction of the tumor occurs due to high LET particle irradiation of the tissue secondary to the incident neutrons being captured by the boron-10 nuclei. Iodinated sulfidohydroboranes are disclosed which are especially suitable for the method of the invention. In a preferred embodiment, a compound having the formula Na{sub 4}B{sub 12}I{sub 11}SSB{sub 12}I{sub 11}, or another pharmaceutically acceptable salt of the compound, may be administered to a cancer patient for boron neutron capture therapy. 1 fig.

  16. Halogenated sulfidohydroboranes for nuclear medicine and boron neutron capture therapy

    DOEpatents

    Miura, M.; Slatkin, D.N.

    1997-03-18

    A method for performing boron neutron capture therapy for the treatment of tumors is disclosed. The method includes administering to a patient an iodinated sulfidohydroborane, a boron-10-containing compound. The site of the tumor is localized by visualizing the increased concentration of the iodine labelled compound at the tumor. The targeted tumor is then irradiated with a beam of neutrons having an energy distribution effective for neutron capture. Destruction of the tumor occurs due to high LET particle irradiation of the tissue secondary to the incident neutrons being captured by the boron-10 nuclei. Iodinated sulfidohydroboranes are disclosed which are especially suitable for the method of the invention. In a preferred embodiment, a compound having the formula Na{sub 4}B{sub 12}I{sub 11}SSB{sub 12}I{sub 11}, or another pharmaceutically acceptable salt of the compound, may be administered to a cancer patient for boron neutron capture therapy. 1 fig.

  17. Halogenated sulfidohydroboranes for nuclear medicine and boron neutron capture therapy

    DOEpatents

    Miura, Michiko; Slatkin, Daniel N.

    1995-10-03

    A method for performing boron neutron capture therapy for the treatment of tumors is disclosed. The method includes administering to a patient an iodinated sulfidohydroborane, a boron-10-containing compound. The site of the tumor is localized by visualizing the increased concentration of the iodine labelled compound at the tumor. The targeted tumor is then irradiated with a beam of neutrons having an energy distribution effective for neutron capture. Destruction of the tumor occurs due to high LET particle irradiation of the tissue secondary to the incident neutrons being captured by the boron-10 nuclei. Iodinated sulfidohydroboranes are disclosed which are especially suitable for the method of the invention. In a preferred embodiment, a compound having the formula Na.sub.4 B.sub.12 I.sub.11 SSB.sub.12 I.sub.11, or another pharmaceutically acceptable salt of the compound, may be administered to a cancer patient for boron neutron capture therapy.

  18. Halogenated sulfidohydroboranes for nuclear medicine and boron neutron capture therapy

    DOEpatents

    Miura, Michiko; Slatkin, Daniel N.

    1997-03-18

    A method for performing boron neutron capture therapy for the treatment of tumors is disclosed. The method includes administering to a patient an iodinated sulfidohydroborane, a boron-10-containing compound. The site of the tumor is localized by visualizing the increased concentration of the iodine labelled compound at the tumor. The targeted tumor is then irradiated with a beam of neutrons having an energy distribution effective for neutron capture. Destruction of the tumor occurs due to high LET particle irradiation of the tissue secondary to the incident neutrons being captured by the boron-10 nuclei. Iodinated sulfidohydroboranes are disclosed which are especially suitable for the method of the invention. In a preferred embodiment, a compound having the formula Na.sub.4 B.sub.12 I.sub.11 SSB.sub.12 I.sub.11, or another pharmaceutically acceptable salt of the compound, may be administered to a cancer patient for boron neutron capture therapy.

  19. Halogenated sulfidohydroboranes for nuclear medicine and boron neutron capture therapy

    DOEpatents

    Miura, Michiko; Slatkin, Daniel N.

    1997-08-05

    A method for performing boron neutron capture therapy for the treatment of tumors is disclosed. The method includes administering to a patient an iodinated sulfidohydroborane, a boron-10-containing compound. The site of the tumor is localized. by visualizing the increased concentration of the iodine labelled compound at the tumor. The targeted tumor is then irradiated with a beam of neutrons having an energy distribution effective for neutron capture. Destruction of the tumor occurs due to high LET particle irradiation of the tissue secondary to the incident neutrons being captured by the boron-10 nuclei. Iodinated sulfidohydroboranes are disclosed which are especially suitable for the method of the invention. In a preferred embodiment, a compound having the formula Na.sub.4 B.sub.12 I.sub.11 SSB.sub.12 I.sub.11, or another pharmaceutically acceptable salt of the compound, may be administered to a cancer patient for boron neutron capture therapy.

  20. Neutron and proton therapy in the treatment of cancer

    SciTech Connect

    Lennox, A.J. |

    1996-08-01

    Several decades of clinical research have established that neutron and proton therapy constitute useful and practical additions to the radiation oncologist`s treatment modalities. This paper discusses the rationale for using these therapies and describes practical solutions to their implementation.

  1. Monte Carlo simulation of the neutron spectral fluence and dose equivalent for use in shielding a proton therapy vault

    PubMed Central

    Zheng, Yuanshui; Newhauser, Wayne; Klein, Eric; Low, Daniel

    2014-01-01

    Neutron production is of principal concern when designing proton therapy vault shielding. Conventionally, neutron calculations are based on analytical methods, which do not accurately consider beam shaping components and nozzle shielding. The goal of this study was to calculate, using Monte Carlo modeling, the neutron spectral fluence and neutron dose equivalent generated by a realistic proton therapy nozzle and evaluate how these data could be used in shielding calculations. We modeled a contemporary passive scattering proton therapy nozzle in detail with the MCNPX simulation code. The neutron spectral fluence and dose equivalent at various locations in the treatment room were calculated and compared to those obtained from a thick iron target bombarded by parallel proton beams, the simplified geometry on which analytical methods are based. The neutron spectral fluence distributions were similar for both methods, with deeply penetrating high-energy neutrons (E > 10 MeV) being most prevalent along the beam central axis, and low-energy neutrons predominating the neutron spectral fluence in the lateral region. However, unlike the inverse square falloff used in conventional analytical methods, this study shows that the neutron dose equivalent per therapeutic dose in the treatment room decreased with distance approximately following a power law, with an exponent of about −1.63 in the lateral region and −1.73 in the downstream region. Based on the simulated data according to the detailed nozzle modeling, we developed an empirical equation to estimate the neutron dose equivalent at any location and distance in the treatment vault, e.g. for cases in which detailed Monte Carlo modeling is not feasible. We applied the simulated neutron spectral fluence and dose equivalent to a shielding calculation as an example. PMID:19887713

  2. Potential to raise the efficiency of neutron and neutron-photon therapy using metal nonradioactive nanoparticles

    NASA Astrophysics Data System (ADS)

    Shmatov, M. L.

    2016-07-01

    The use of metal nonradioactive nanoparticles (specifically, gold ones) in neutron and neutron-photon cancer therapy is proposed. The minimum therapeutically effective average density of gold within a tumor subjected to neutron irradiation is estimated as a value on the order of 10-5-10-4 g/cm3. Potential benefits of the use of data obtained when using Peteosthor (a drug containing 224Ra and colloidal platinum) and Thorotrast (a radiopaque contrast agent containing thorium oxide nanoparticles) and its analogues in the analysis of safety and efficiency of application of nonradioactive nanoparticles in radiation therapy and diagnostics are discussed.

  3. Improved performance in synthetic diamond neutron detectors: Application to boron neutron capture therapy

    NASA Astrophysics Data System (ADS)

    Almaviva, S.; Marinelli, Marco; Milani, E.; Prestopino, G.; Tucciarone, A.; Verona, C.; Verona-Rinati, G.; Angelone, M.; Pillon, M.

    2010-01-01

    An improved thermal and fast neutrons detector is obtained, modifying a recently proposed multilayered homoepitaxial Chemical Vapor Deposition (CVD) diamond detector (M. Marinelli, et al., Appl. Phys. Lett. 89 (2006) 143509), where a 6LiF layer deposited on the sensing layer was used to convert thermal neutrons into charged particles. By sandwiching this layer between two CVD diamond detectors connected in parallel, a better signal-to-background separation is achieved. This allows to use 10B as converting element, so to realize a detector suitable for Boron Neutron Capture Therapy dosimetry. Also, the doubled detector volume enhances the sensitivity to fast neutrons.

  4. Theoretical and experimental physical methods of neutron-capture therapy

    NASA Astrophysics Data System (ADS)

    Borisov, G. I.

    2011-09-01

    This review is based to a substantial degree on our priority developments and research at the IR-8 reactor of the Russian Research Centre Kurchatov Institute. New theoretical and experimental methods of neutron-capture therapy are developed and applied in practice; these are: A general analytical and semi-empiric theory of neutron-capture therapy (NCT) based on classical neutron physics and its main sections (elementary theories of moderation, diffuse, reflection, and absorption of neutrons) rather than on methods of mathematical simulation. The theory is, first of all, intended for practical application by physicists, engineers, biologists, and physicians. This theory can be mastered by anyone with a higher education of almost any kind and minimal experience in operating a personal computer.

  5. Simplified method for deducing high-energy neutron spectra between 1 and 100 MeV using Foil-Activation Method

    SciTech Connect

    Kasugai, Y.; Matsuda, N.; Sakamoto, Y.; Nakashima, H.; Yashima, H.; Matsumura, H.; Iwase, H.; Hirayama, H.; Mokhov, N.; Leveling, A.; Boehnlein, D.; Vaziri, K.; Lauten, G.; Oishi, K.; Nakamura, T.

    2011-07-01

    The Japanese and American Study of Muon Interaction and Neutron detection (JASMIN) collaboration, has been conducting shielding experiments using the Fermilab anti-proton target station (Pbar) shielding assembly. A multi-foil technique was used to measure the high energy neutron spectra, in the range of 1 to 100 MeV, for the target station shielding configuration. The neutron spectra were de-convoluted using a new fitting method. This method is based on the assumption that a neutron spectrum can be expressed as a simple sum of two exponentials. The validity of the fitting method was confirmed by comparison with the results obtained using SAND-II computer code and theoretical calculations. Finally, it was found that there are simple correlations between reaction rates and the adjustable parameters in the fitting function. (authors)

  6. Boron neutron capture therapy: from physics to treatment

    NASA Astrophysics Data System (ADS)

    Gabel, Detlef

    1997-02-01

    For successful application of boron neutron capture therapy for treatment of cancer, it is required that the tumor receives a higher radiation dose than the surrounding healthy tissue. This is achieved by the use of appropriate boron compounds with selective accumulation or retention, and the subsequent irradiation with neutrons of suitable characteristics. The basics of these two requirement are given, and the implementation in clinical trials is discussed.

  7. Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy.

    PubMed

    Luderer, Micah John; de la Puente, Pilar; Azab, Abdel Kareem

    2015-09-01

    Boron neutron capture therapy (BNCT) is a promising cancer therapy modality that utilizes the nuclear capture reaction of epithermal neutrons by boron-10 resulting in a localized nuclear fission reaction and subsequent cell death. Since cellular destruction is limited to approximately the diameter of a single cell, primarily only cells in the neutron field with significant boron accumulation will be damaged. However, the emergence of BNCT as a prominent therapy has in large part been hindered by a paucity of tumor selective boron containing agents. While L-boronophenylalanine and sodium borocaptate are the most commonly investigated clinical agents, new agents are desperately needed due to their suboptimal tumor selectivity. This review will highlight the various strategies to improve tumor boron delivery including: nucleoside and carbohydrate analogs, unnatural amino acids, porphyrins, antibody-dendrimer conjugates, cationic polymers, cell-membrane penetrating peptides, liposomes and nanoparticles. PMID:26033767

  8. Accelerator Based Neutron Beams for Neutron Capture Therapy

    SciTech Connect

    Yanch, Jacquelyn C.

    2003-04-11

    The DOE-funded accelerator BNCT program at the Massachusetts Institute of Technology has resulted in the only operating accelerator-based epithermal neutron beam facility capable of generating significant dose rates in the world. With five separate beamlines and two different epithermal neutron beam assemblies installed, we are currently capable of treating patients with rheumatoid arthritis in less than 15 minutes (knee joints) or 4 minutes (finger joints) or irradiating patients with shallow brain tumors to a healthy tissue dose of 12.6 Gy in 3.6 hours. The accelerator, designed by Newton scientific Incorporated, is located in dedicated laboratory space that MIT renovated specifically for this project. The Laboratory for Accelerator Beam Applications consists of an accelerator room, a control room, a shielded radiation vault, and additional laboratory space nearby. In addition to the design, construction and characterization of the tandem electrostatic accelerator, this program also resulted in other significant accomplishments. Assemblies for generating epithermal neutron beams were designed, constructed and experimentally evaluated using mixed-field dosimetry techniques. Strategies for target construction and target cooling were implemented and tested. We demonstrated that the method of submerged jet impingement using water as the coolant is capable of handling power densities of up to 6 x 10(sup 7) W/m(sup 2) with heat transfer coefficients of 10(sup 6)W/m(sup 2)-K. Experiments with the liquid metal gallium demonstrated its superiority compared with water with little effect on the neutronic properties of the epithermal beam. Monoenergetic proton beams generated using the accelerator were used to evaluate proton RBE as a function of LET and demonstrated a maximum RBE at approximately 30-40 keV/um, a finding consistent with results published by other researchers. We also developed an experimental approach to biological intercomparison of epithermal beams and

  9. Research in Boron Neutron Capture Therapy at MIT LABA

    SciTech Connect

    Yanch, J.C.; Shefer, R.E.; Klinkowstein, R.E.; Howard, W.B.; Song, H.; Blackburn, B.; Binello, E.

    1997-02-01

    A 4.1 MeV tandem electrostatic accelerator designed for research into Boron Neutron Capture Therapy (BNCT) has recently been installed in the MIT Laboratory for Accelerator Beam Applications (LABA). This accelerator uses a very high current switch mode high voltage power supply in conjunction with a multi-cusp negative ion source to supply the multimilliampere current required for clinical BNCT applications. A number of individual research projects aimed at evaluating the potential of this accelerator design as a hospital-based neutron source for radiation therapy of both tumors and rheumatoid arthritis are described here. {copyright} {ital 1997 American Institute of Physics.}

  10. Hospital based superconducting cyclotron for neutron therapy: Medical physics perspective

    NASA Astrophysics Data System (ADS)

    Yudelev, M.; Burmeister, J.; Blosser, E.; Maughan, R. L.; Kota, C.

    2001-12-01

    The neutron therapy facility at the Gershenson Radiation Oncology Center, Harper University Hospital in Detroit has been operational since September 1991. The d(48.5)+Be beam is produced in a gantry mounted superconducting cyclotron designed and built at the National Superconducting Cyclotron Laboratory (NSCL). Measurements were performed in order to obtain the physical characteristics of the neutron beam and to collect the data necessary for treatment planning. This included profiles of the dose distribution in a water phantom, relative output factors and the design of various beam modifiers, i.e., wedges and tissue compensators. The beam was calibrated in accordance with international protocol for fast neutron dosimetry. Dosimetry and radiobiology intercomparions with three neutron therapy facilities were performed prior to clinical use. The radiation safety program was established in order to monitor and reduce the exposure levels of the personnel. The activation products were identified and the exposure in the treatment room was mapped. A comprehensive quality assurance (QA) program was developed to sustain safe and reliable operation of the unit at treatment standards comparable to those for conventional photon radiation. The program can be divided into three major parts: maintenance of the cyclotron and related hardware; QA of the neutron beam dosimetry and treatment delivery; safety and radiation protection. In addition the neutron beam is used in various non-clinical applications. Among these are the microdosimetric characterization of the beam, the effects of tissue heterogeneity on dose distribution, the development of boron neutron capture enhanced fast neutron therapy and variety of radiobiology experiments.

  11. System and method for delivery of neutron beams for medical therapy

    DOEpatents

    Nigg, D.W.; Wemple, C.A.

    1999-07-06

    A neutron delivery system that provides improved capability for tumor control during medical therapy is disclosed. The system creates a unique neutron beam that has a bimodal or multi-modal energy spectrum. This unique neutron beam can be used for fast-neutron therapy, boron neutron capture therapy (BNCT), or both. The invention includes both an apparatus and a method for accomplishing the purposes of the invention. 5 figs.

  12. System and method for delivery of neutron beams for medical therapy

    DOEpatents

    Nigg, David W.; Wemple, Charles A.

    1999-01-01

    A neutron delivery system that provides improved capability for tumor control during medical therapy. The system creates a unique neutron beam that has a bimodal or multi-modal energy spectrum. This unique neutron beam can be used for fast-neutron therapy, boron neutron capture therapy (BNCT), or both. The invention includes both an apparatus and a method for accomplishing the purposes of the invention.

  13. Analytic estimates of secondary neutron dose in proton therapy

    NASA Astrophysics Data System (ADS)

    Anferov, V.

    2010-12-01

    Proton beam losses in various components of a treatment nozzle generate secondary neutrons, which bring unwanted out of field dose during treatments. The purpose of this study was to develop an analytic method for estimating neutron dose to a distant organ at risk during proton therapy. Based on radiation shielding calculation methods proposed by Sullivan, we developed an analytical model for converting the proton beam losses in the nozzle components and in the treatment volume into the secondary neutron dose at a point of interest. Using the MCNPx Monte Carlo code, we benchmarked the neutron dose rates generated by the proton beam stopped at various media. The Monte Carlo calculations confirmed the validity of the analytical model for simple beam stop geometry. The analytical model was then applied to neutron dose equivalent measurements performed on double scattering and uniform scanning nozzles at the Midwest Proton Radiotherapy Institute (MPRI). Good agreement was obtained between the model predictions and the data measured at MPRI. This work provides a method for estimating analytically the neutron dose equivalent to a distant organ at risk. This method can be used as a tool for optimizing dose delivery techniques in proton therapy.

  14. Design criteria for a high energy Compton Camera and possible application to targeted cancer therapy

    NASA Astrophysics Data System (ADS)

    Conka Nurdan, T.; Nurdan, K.; Brill, A. B.; Walenta, A. H.

    2015-07-01

    The proposed research focuses on the design criteria for a Compton Camera with high spatial resolution and sensitivity, operating at high gamma energies and its possible application for molecular imaging. This application is mainly on the detection and visualization of the pharmacokinetics of tumor targeting substances specific for particular cancer sites. Expected high resolution (< 0.5 mm) permits monitoring the pharmacokinetics of labeled gene constructs in vivo in small animals with a human tumor xenograft which is one of the first steps in evaluating the potential utility of a candidate gene. The additional benefit of high sensitivity detection will be improved cancer treatment strategies in patients based on the use of specific molecules binding to cancer sites for early detection of tumors and identifying metastasis, monitoring drug delivery and radionuclide therapy for optimum cell killing at the tumor site. This new technology can provide high resolution, high sensitivity imaging of a wide range of gamma energies and will significantly extend the range of radiotracers that can be investigated and used clinically. The small and compact construction of the proposed camera system allows flexible application which will be particularly useful for monitoring residual tumor around the resection site during surgery. It is also envisaged as able to test the performance of new drug/gene-based therapies in vitro and in vivo for tumor targeting efficacy using automatic large scale screening methods.

  15. Accelerator based epithermal neutron source for neutron capture therapy. Annual report, [October 1990--April 1991

    SciTech Connect

    Brugger, R.; Kunze, J.

    1991-05-01

    Several investigators have suggested that a charged particle accelerator with light element reactions might be able to produce enough epithermal neutrons to be useful in Neutron Capture Therapy. The reaction choice so far has been the Li(p,n) reaction with protons up to 2.5 MeV. A moderator around the target would reduce the faster neutrons down to the epithermal energy region. The goals of the present research are: identify better reactions; improve the moderators; and find better combinations of 1 and 2. The target is to achieve, at the patient location, an epithermal neutron current of greater than 10{sup 9}n/cm{sup 2}sec, with a dose to tissue from the neutrons alone of less than 10{sup {minus}10} rads/n and a dose from the gamma rays in the beam of less than 10{sup {minus}10} rads/n.

  16. Out-of-field neutron and leakage photon exposures and the associated risk of second cancers in high-energy photon radiotherapy: current status.

    PubMed

    Takam, R; Bezak, E; Marcu, L G; Yeoh, E

    2011-10-01

    Determination and understanding of out-of-field neutron and photon doses in accelerator-based radiotherapy is an important issue since linear accelerators operating at high energies (>10 MV) produce secondary radiations that irradiate parts of the patient's anatomy distal to the target region, potentially resulting in detrimental health effects. This paper provides a compilation of data (technical and clinical) reported in the literature on the measurement and Monte Carlo simulations of peripheral neutron and photon doses produced from high-energy medical linear accelerators and the reported risk and/or incidence of second primary cancer of tissues distal to the target volume. Information in the tables facilitates easier identification of (1) the various methods and measurement techniques used to determine the out-of-field neutron and photon radiations, (2) reported linac-dependent out-of-field doses, and (3) the risk/incidence of second cancers after radiotherapy due to classic and modern treatment methods. Regardless of the measurement technique and type of accelerator, the neutron dose equivalent per unit photon dose ranges from as low as 0.1 mSv/Gy to as high as 20.4 mSv/Gy. This radiation dose potentially contributes to the induction of second primary cancer in normal tissues outside the treated area. PMID:21756083

  17. Proceedings of the first international symposium on neutron capture therapy

    SciTech Connect

    Fairchild, R.G.; Brownell, G.L.

    1982-01-01

    This meeting was arranged jointly by MIT and BNL in order to illuminate progress in the synthesis and targeting of boron compounds and to evaluate and document progress in radiobiological and dosimetric aspects of neutron capture therapy. It is hoped that this meeting will facilitate transfer of information between groups working in these fields, and encourage synergistic collaboration.

  18. Microdosimetric investigations at the fast neutron therapy facility at Fermilab

    SciTech Connect

    Langen, K.M.

    1997-12-01

    Microdosimetry was used to investigate three issues at the neutron therapy facility (NTF) at Fermilab. Firstly, the conversion factor from absorbed dose in A-150 tissue equivalent plastic to absorbed dose in ICRU tissue was determined. For this, the effective neutron kerma factor ratios, i.e., oxygen tissue equivalent plastic and carbon to A-150 tissue equivalent plastic, were measured in the neutron beam. An A-150 tissue equivalent plastic to ICRU tissue absorbed dose conversion factor of 0.92 {+-} 0.04 was determined. Secondly, variations in the radiobiological effectiveness (RBE) in the beam were mapped by determining variations in two related quantities, e{sup *} and R, with field size and depth in tissue. Maximal variation in e{sup *} and R of 9% and 15% respectively were determined. Lastly, the feasibility of utilizing the boron neutron capture reaction on boron-10 to selectively enhance the tumor dose in the NTF beam was investigated.

  19. Target studies for accelerator-based boron neutron capture therapy

    SciTech Connect

    Powell, J.R.; Ludewig, H.; Todosow, M.; Reich, M.

    1996-03-01

    Two new concepts, NIFTI and DISCOS, are described. These concepts enable the efficient production of epithermal neutrons for BNCT (Boron Neutron Capture Therapy) medical treatment, utilizing a low current, low energy proton beam impacting on a lithium target. The NIFTI concept uses an iron layer that strongly impedes the transmission of neutrons with energies above 24 KeV. Lower energy neutrons readily pass through this iron ``filter``, which has a deep ``window`` in its scattering cross section at 24 KeV. The DISCOS concept uses a rapidly rotating, high g disc to create a series of thin ({approximately} 1 micron thickness) liquid lithium targets in the form of continuous films through which the proton beam passes. The average energy lost by a proton as it passes through a single target is small, approximately 10 KeV. Between the targets, the proton beam is reaccelerated by an applied DC electric field. The DISCOS approach enables the accelerator -- target facility to operate with a beam energy only slightly above the threshold value for neutron production -- resulting in an output beam of low-energy epithermal neutrons -- while achieving a high yield of neutrons per milliamp of proton beam current.

  20. Design of a boron neutron capture enhanced fast neutron therapy assembly

    NASA Astrophysics Data System (ADS)

    Wang, Zhonglu

    The use of boron neutron capture to boost tumor dose in fast neutron therapy has been investigated at several fast neutron therapy centers worldwide. This treatment is termed boron neutron capture enhanced fast neutron therapy (BNCEFNT). It is a combination of boron neutron capture therapy (BNCT) and fast neutron therapy (FNT). It is believed that BNCEFNT may be useful in the treatment of some radioresistant brain tumors, such as glioblastoma multiforme (GBM). A boron neutron capture enhanced fast neutron therapy assembly has been designed for the Fermilab Neutron Therapy Facility (NTF). This assembly uses a tungsten filter and collimator near the patient's head, with a graphite reflector surrounding the head to significantly increase the dose due to boron neutron capture reactions. The assembly was designed using Monte Carlo radiation transport code MCNP version 5 for a standard 20x20 cm2 treatment beam. The calculated boron dose enhancement at 5.7-cm depth in a water-filled head phantom in the assembly with a 5x5 cm2 collimation was 21.9% per 100-ppm 10B for a 5.0-cm tungsten filter and 29.8% for a 8.5-cm tungsten filter. The corresponding dose rate for the 5.0-cm and 8.5-cm thick filters were 0.221 and 0.127 Gy/min, respectively; about 48.5% and 27.9% of the dose rate of the standard 10x10 cm2 fast neutron treatment beam. To validate the design calculations, a simplified BNCEFNT assembly was built using four lead bricks to form a 5x5 cm2 collimator. Five 1.0-cm thick 20x20 cm2 tungsten plates were used to obtain different filter thicknesses and graphite bricks/blocks were used to form a reflector. Measurements of the dose enhancement of the simplified assembly in a water-filled head phantom were performed using a pair of tissue-equivalent ion chambers. One of the ion chambers is loaded with 1000-ppm natural boron (184-ppm 10B) to measure dose due to boron neutron capture. The measured dose enhancement at 5.0-cm depth in the head phantom for the 5.0-cm thick

  1. Design of a boron neutron capture enhanced fast neutron therapy assembly

    SciTech Connect

    Wang, Zhonglu

    2006-08-01

    The use of boron neutron capture to boost tumor dose in fast neutron therapy has been investigated at several fast neutron therapy centers worldwide. This treatment is termed boron neutron capture enhanced fast neutron therapy (BNCEFNT). It is a combination of boron neutron capture therapy (BNCT) and fast neutron therapy (FNT). It is believed that BNCEFNT may be useful in the treatment of some radioresistant brain tumors, such as glioblastoma multiform (GBM). A boron neutron capture enhanced fast neutron therapy assembly has been designed for the Fermilab Neutron Therapy Facility (NTF). This assembly uses a tungsten filter and collimator near the patient's head, with a graphite reflector surrounding the head to significantly increase the dose due to boron neutron capture reactions. The assembly was designed using Monte Carlo radiation transport code MCNP version 5 for a standard 20x20 cm{sup 2} treatment beam. The calculated boron dose enhancement at 5.7-cm depth in a water-filled head phantom in the assembly with a 5x5 cm{sup 2} collimation was 21.9% per 100-ppm {sup 10}B for a 5.0-cm tungsten filter and 29.8% for a 8.5-cm tungsten filter. The corresponding dose rate for the 5.0-cm and 8.5-cm thick filters were 0.221 and 0.127 Gy/min, respectively; about 48.5% and 27.9% of the dose rate of the standard 10x10 cm{sup 2} fast neutron treatment beam. To validate the design calculations, a simplified BNCEFNT assembly was built using four lead bricks to form a 5x5 cm{sup 2} collimator. Five 1.0-cm thick 20x20 cm{sup 2} tungsten plates were used to obtain different filter thicknesses and graphite bricks/blocks were used to form a reflector. Measurements of the dose enhancement of the simplified assembly in a water-filled head phantom were performed using a pair of tissue-equivalent ion chambers. One of the ion chambers is loaded with 1000-ppm natural boron (184-ppm {sup 10}B) to measure dose due to boron neutron capture. The measured dose enhancement at 5.0-cm depth in

  2. Accelerator-based neutron source for boron neutron capture therapy (BNCT) and method

    DOEpatents

    Yoon, Woo Y.; Jones, James L.; Nigg, David W.; Harker, Yale D.

    1999-01-01

    A source for boron neutron capture therapy (BNCT) comprises a body of photoneutron emitter that includes heavy water and is closely surrounded in heat-imparting relationship by target material; one or more electron linear accelerators for supplying electron radiation having energy of substantially 2 to 10 MeV and for impinging such radiation on the target material, whereby photoneutrons are produced and heat is absorbed from the target material by the body of photoneutron emitter. The heavy water is circulated through a cooling arrangement to remove heat. A tank, desirably cylindrical or spherical, contains the heavy water, and a desired number of the electron accelerators circumferentially surround the tank and the target material as preferably made up of thin plates of metallic tungsten. Neutrons generated within the tank are passed through a surrounding region containing neutron filtering and moderating materials and through neutron delimiting structure to produce a beam or beams of epithermal neutrons normally having a minimum flux intensity level of 1.0.times.10.sup.9 neutrons per square centimeter per second. Such beam or beams of epithermal neutrons are passed through gamma ray attenuating material to provide the required epithermal neutrons for BNCT use.

  3. Accelerator-based neutron source for boron neutron capture therapy (BNCT) and method

    DOEpatents

    Yoon, W.Y.; Jones, J.L.; Nigg, D.W.; Harker, Y.D.

    1999-05-11

    A source for boron neutron capture therapy (BNCT) comprises a body of photoneutron emitter that includes heavy water and is closely surrounded in heat-imparting relationship by target material; one or more electron linear accelerators for supplying electron radiation having energy of substantially 2 to 10 MeV and for impinging such radiation on the target material, whereby photoneutrons are produced and heat is absorbed from the target material by the body of photoneutron emitter. The heavy water is circulated through a cooling arrangement to remove heat. A tank, desirably cylindrical or spherical, contains the heavy water, and a desired number of the electron accelerators circumferentially surround the tank and the target material as preferably made up of thin plates of metallic tungsten. Neutrons generated within the tank are passed through a surrounding region containing neutron filtering and moderating materials and through neutron delimiting structure to produce a beam or beams of epithermal neutrons normally having a minimum flux intensity level of 1.0{times}10{sup 9} neutrons per square centimeter per second. Such beam or beams of epithermal neutrons are passed through gamma ray attenuating material to provide the required epithermal neutrons for BNCT use. 3 figs.

  4. Boron neutron capture therapy (BNCT): A radiation oncology perspective

    SciTech Connect

    Dorn, R.V. III Idaho National Engineering Lab., Idaho Falls, ID )

    1994-03-30

    Boron neutron capture therapy (BNCT) offers considerable promise in the search for the ideal cancer therapy, a therapy which selectively and maximally damages malignant cells while sparing normal tissue. This bimodal treatment modality selectivity concentrates a boron compound in malignant cells, and then [open quotes]activates[close quotes] this compound with slow neutrons resulting in a highly lethal event within the cancer cell. This article reviews this treatment modality from a radiation oncology, biology, and physics perspective. The remainder of the articles in this special issue provide a survey of the current [open quotes]state-of-the-art[close quotes] in this rapidly expanding field, including information with regard to boron compounds and their localization. 118 refs., 3 figs.

  5. [Principles of therapy with fission neutrons and boron neutron capture therapy for radioresistant head-neck malignancies].

    PubMed

    Clasen, B

    1990-08-01

    Neutron therapy has proven to be clinically useful in cases of advanced, slow-growing radioresistant head and neck carcinoma. Therapeutic effects might be based on direct DNA damaging and thus immediate cell-killing, on the generation of free oxygen radicals and, among others, on the fact that heavy particle radiation is said to be less dependent on the presence of oxygen than gamma rays, i.e. on a lower oxygen enhancement ratio (OER). The smaller difference in reaction between oxygenated and nonoxygenated cells could entail advantages as well as disadvantages, depending on the characteristics of the tumor cell population and of the normal tissue. It is therefore essential to select patients and tumours with an expectedly high therapeutic gain factor. Fission neutrons for tumour therapy: As evaluated by several in vitro and in vivo studies (11/13) the biological efficiency (RBE) of the RENT (Reactor Neutron Therapy) beam in Munich seems to be among the highest of all clinically used neutron beams. For a single dose range between 2 and 8 Gy the RBE for chronic radiation damage is relatively small (2). Consequently, patients with recurrent or metastatic carcinomas of the head and neck are treated with a single dose of 200-250 cGy after previous surgery and/or combined radiochemotherapy. The main limitation of fission neutrons is the small penetration depth. Possibilities of clinical implementation of boron neutron capture therapy (BNCT) in otorhinolaryngology: In near surface tumours it is possible to administer high doses of 10boron not selectively, i.e. no selective tumour-seeking compound is needed. Animal experiments with intratumoural injection of 10boron glycine have shown a strong effect on tumour growth delay (18).(ABSTRACT TRUNCATED AT 250 WORDS) PMID:2222692

  6. Determination of Endpoint Energy and Bremsstrahlung Spectra for High-Energy Radiation-Therapy Beams

    NASA Astrophysics Data System (ADS)

    Landry, Danny Joe

    Few attempts have been made to experimentally determine thick-target bremsstrahlung spectra of megavoltage therapy beams. For spectral studies using the Compton scattering technique, sodium iodine (NaI) detectors with relatively poor energy resolution have been used. Other experimental techniques for determining spectra are generally not suited for a clinical environment with the inherent time and space constraints. To gather more spectral information than previously obtained in the region near the endpoint energy, the use of a high-resolution intrinsic-germanium (Ge) detector was proposed. A response function matrix was determined from experimentally obtained pulse height distributions on the multichannel analyzer. The distributions were for nine various monoenergetic sources between 280 adn 1525 keV. The response function was used to convert the measured pulse height distributions to photon flux spectra using an iterative approximation technique with a computer. Photon flux spectra from the Sagittaire Linear Accelerator were obtained at average-electron endpoint energies of 15, 20, and 25 MeV. Two spectra were measured at the 25 MeV setting; one spectrum was measured along the central axis and one spectrum at 4(DEGREES) off axis. Photon spectra were also obtained for a Van de Graaff generator at the nominal endpoint energies of 2.2, 2.35, and 2.5 MeV. The results for both the linac and the Van de Graaff generator were compared with theoretical spectra and previously measured spectra where available. Also, photon spectra from a Theratron-80 (('60)Co) unit were determined for three field sizes and for a 10 x 10 cm. field with a lucite tray or a 45(DEGREES) wedge in the beam. The resulting spectra were compared to previously measured ('60)Co spectra.

  7. Secondary neutron spectrum from 250-MeV passively scattered proton therapy: Measurement with an extended-range Bonner sphere system

    SciTech Connect

    Howell, Rebecca M.; Burgett, E. A.

    2014-09-15

    Purpose: Secondary neutrons are an unavoidable consequence of proton therapy. While the neutron dose is low compared to the primary proton dose, its presence and contribution to the patient dose is nonetheless important. The most detailed information on neutrons includes an evaluation of the neutron spectrum. However, the vast majority of the literature that has reported secondary neutron spectra in proton therapy is based on computational methods rather than measurements. This is largely due to the inherent limitations in the majority of neutron detectors, which are either not suitable for spectral measurements or have limited response at energies greater than 20 MeV. Therefore, the primary objective of the present study was to measure a secondary neutron spectrum from a proton therapy beam using a spectrometer that is sensitive to neutron energies over the entire neutron energy spectrum. Methods: The authors measured the secondary neutron spectrum from a 250-MeV passively scattered proton beam in air at a distance of 100 cm laterally from isocenter using an extended-range Bonner sphere (ERBS) measurement system. Ambient dose equivalent H*(10) was calculated using measured fluence and fluence-to-ambient dose equivalent conversion coefficients. Results: The neutron fluence spectrum had a high-energy direct neutron peak, an evaporation peak, a thermal peak, and an intermediate energy continuum between the thermal and evaporation peaks. The H*(10) was dominated by the neutrons in the evaporation peak because of both their high abundance and the large quality conversion coefficients in that energy interval. The H*(10) 100 cm laterally from isocenter was 1.6 mSv per proton Gy (to isocenter). Approximately 35% of the dose equivalent was from neutrons with energies ≥20 MeV. Conclusions: The authors measured a neutron spectrum for external neutrons generated by a 250-MeV proton beam using an ERBS measurement system that was sensitive to neutrons over the entire

  8. In vivo neutron activation analysis of sodium and chlorine in tumor tissue after fast neutron therapy.

    PubMed

    Auberger, T; Koester, L; Knopf, K; Weissfloch, L

    1996-01-01

    In 12 patients with recurrences and metastases of different primaries (head and neck cancer, breast cancer, malignant melanoma, and osteosarcoma) who were treated with reactor fission neutrons the photon emission of irradiated tissue was measured after each radiotherapy fraction. Spectral analyses of the decay rates resulted in data for the exchange of sodium (Na) and chlorine (Cl) between the irradiated tissue and the body. About 60% of Na and Cl exchanged rapidly with a turnover half-life of 13 +/- 2 min. New defined mass exchange rates for Na and Cl amount to an average of 0.8 mval/min/kg of soft tissue. At the beginning of radiotherapy the turnover of the electrolytes in tissues with large tumor volumes was about twice that in tissues with small tumor volumes. Depending on the dose, neutron therapy led in all cases to variation in the metabolism. A maximum of Cl exchange and a minimum of Na exchange occurred after 10 Gy of neutrons (group of six previously untreated patients) or after 85 Gy (photon equivalent dose) of combined photon-neutron therapy. A significant increase in non-exchangeable fraction of Na from about 40 to 80% was observed in three tumors after a neutron dose of 10 Gy administered in five fractions correlated with a rapid reduction of tissue within 4 weeks after end of therapy. These results demonstrate for the first time the local response of the electrolyte metabolism to radiotherapy. PMID:8949749

  9. Amsterdam fast neutron therapy project: a final report

    SciTech Connect

    Battermann, J.J.; Mijnheer, B.J.

    1986-12-01

    In the period from February 1975 through September 1981 a total of 435 patients received radiotherapy with the 14 MeV d + T neutron generator, hospital based in the Netherlands Cancer Institute. Preliminary data on clinical results were published during the past few years. In this paper a final report is given of the program. The results can be summarized as follows: The neutron generator fulfilled the criteria for clinical use, that is it was reliable and had the required minimal output of 10(12) neutrons s-1. However, the dose distribution was more comparable with a 250 kV X-ray machine than with a modern accelerator. A number of physical parameters of importance for clinical neutron dosimetry have been determined for our therapy unit. These data, as well as the results of dosimetry intercomparisons in which our institute participated, contributed in the drafting of a European protocol for clinical neutron dosimetry. Pilot studies were carried out on different tumor sites, including head and neck, brain, pelvis, soft tissue and pulmonary metastases. In many patients local tumor control was seen, however, often concomitant with severe complications, especially in deep seated tumors. Randomized clinical trials were carried out for head and neck tumors (in collaboration with some other European centers) and for inoperable bladder and rectal tumors. No significant difference was observed in local tumor control or late morbidity between photon and neutron irradiation for the head and neck tumors. Also the results for pelvic tumors failed to demonstrate an advantage for neutron therapy.

  10. Scaling and asymptotic properties of evaporated neutron inclusive cross sections in high energy hadron-nucleus and nucleus-nucleus interactions

    NASA Astrophysics Data System (ADS)

    Galoyan, A. S.; Ribon, A.; Uzhinsky, V. V.

    2015-09-01

    New properties of the evaporated neutron ( E < 30 MeV) energy spectra in hadron-nucleus interactions have been found. Particularly, the spectra approach the asymptotic regime, namely, they weakly depend on the collision energy at momenta of projectile protons larger than 5-6 GeV/ c; the spectra for various nuclei are similar, and can be approximately described by the function A n f( E). Experimental data on neutron spectra in the case of projectile π-mesons show analogous behavior, but the statistics of the data do not allow one to draw clear conclusions. In our analysis we used ITEP experimental data on inclusive cross sections of neutrons produced in interactions of π-mesons and protons with various nuclei in the energy range from 747 MeV up to 8.1 GeV. The observed properties allow one to predict neutron yields in the nucleus-nucleus interactions at high and super high energies. Predictions for the NICA/MPD experiment at JINR are presented. It is shown that the FTF (Fritiof)-model of the Geant4 toolkit qualitatively reproduces the observed regularities. For the first time estimates of the neutron energy flows are obtained at both RHIC and LHC energies.

  11. A Sealed-Accelerator-Tube Neutron Generator for Boron Neutron Capture Therapy Application

    SciTech Connect

    Leung, K.-N.; Leung, K.N.; Lee, Y.; Verbeke, J.M.; Vurjic, J.; Williams, M.D.; Wu, L.K.; Zahir, N.

    1998-06-01

    Radio-frequency (RF) driven ion sources are being developed in Lawrence Berkeley National Laboratory (LBNL) for sealed-accelerator-tube neutron generator applications. By using a 2.5-cm-diameter RF-driven multicusp source and a computer designed 100 keV accelerator column, peak extractable hydrogen current exceeding 1 A from a 3-mm-diameter aperture, together with H{sup +} yields over 94% have been achieved. These experimental findings together with recent moderator design will enable one to develop compact 14 MeV neutron generators based on the D-T fusion reaction. In this new neutron generator, the ion source, the accelerator and the target are all housed in a sealed metal container without pumping. With a 120 keV and 1 A deuteron beam, it is estimated that a treatment time of {approx} 45 minutes is needed for boron neutron capture therapy.

  12. Optimal Neutron Source & Beam Shaping Assembly for Boron Neutron Capture Therapy

    SciTech Connect

    J. Vujic; E. Greenspan; W.E. Kastenber; Y. Karni; D. Regev; J.M. Verbeke, K.N. Leung; D. Chivers; S. Guess; L. Kim; W. Waldron; Y. Zhu

    2003-04-30

    There were three objectives to this project: (1) The development of the 2-D Swan code for the optimization of the nuclear design of facilities for medical applications of radiation, radiation shields, blankets of accelerator-driven systems, fusion facilities, etc. (2) Identification of the maximum beam quality that can be obtained for Boron Neutron Capture Therapy (BNCT) from different reactor-, and accelerator-based neutron sources. The optimal beam-shaping assembly (BSA) design for each neutron source was also to e obtained. (3) Feasibility assessment of a new neutron source for NCT and other medical and industrial applications. This source consists of a state-of-the-art proton or deuteron accelerator driving and inherently safe, proliferation resistant, small subcritical fission assembly.

  13. Neutron Tube Design Study for Boron Neutron Capture TherapyApplication

    SciTech Connect

    Verbeke, J.M.; Lee, Y.; Leung, K.N.; Vujic, J.; Williams, M.D.; Wu, L.K.; Zahir, N.

    1998-01-04

    Radio-frequency (RF) driven ion sources are being developed in Lawrence Berkeley National Laboratory (LBNL) for sealed-accelerator-tube neutron generator application. By using a 5-cm-diameter RF-driven multicusp source H{sup +} yields over 95% have been achieved. These experimental findings will enable one to develop compact neutron generators based on the D-D or D-T fusion reactions. In this new neutron generator, the ion source, the accelerator and the target are all housed in a sealed metal container without external pumping. Recent moderator design simulation studies have shown that 14 MeV neutrons could be moderated to therapeutically useful energy ranges for boron neutron capture therapy (BNCT). The dose near the center of the brain with optimized moderators is about 65% higher than the dose obtained from a typical neutron spectrum produced by the Brookhaven Medical Research Reactor (BMRR), and is comparable to the dose obtained by other accelerator-based neutron sources. With a 120 keV and 1 A deuteron beam, a treatment time of {approx}35 minutes is estimated for BNCT.

  14. Gyrotron-driven high current ECR ion source for boron-neutron capture therapy neutron generator

    NASA Astrophysics Data System (ADS)

    Skalyga, V.; Izotov, I.; Golubev, S.; Razin, S.; Sidorov, A.; Maslennikova, A.; Volovecky, A.; Kalvas, T.; Koivisto, H.; Tarvainen, O.

    2014-12-01

    Boron-neutron capture therapy (BNCT) is a perspective treatment method for radiation resistant tumors. Unfortunately its development is strongly held back by a several physical and medical problems. Neutron sources for BNCT currently are limited to nuclear reactors and accelerators. For wide spread of BNCT investigations more compact and cheap neutron source would be much more preferable. In present paper an approach for compact D-D neutron generator creation based on a high current ECR ion source is suggested. Results on dense proton beams production are presented. A possibility of ion beams formation with current density up to 600 mA/cm2 is demonstrated. Estimations based on obtained experimental results show that neutron target bombarded by such deuteron beams would theoretically yield a neutron flux density up to 6·1010 cm-2/s. Thus, neutron generator based on a high-current deuteron ECR source with a powerful plasma heating by gyrotron radiation could fulfill the BNCT requirements significantly lower price, smaller size and ease of operation in comparison with existing reactors and accelerators.

  15. Epithermal neutron beams from the 7 Li(p,n) reaction near the threshold for neutron capture therapy

    NASA Astrophysics Data System (ADS)

    Porras, I.; Praena, J.; Arias de Saavedra, F.; Pedrosa, M.; Esquinas, P.; L. Jiménez-Bonilla, P.

    2016-11-01

    Two applications for neutron capture therapy of epithermal neutron beams calculated from the 7Li ( p , n reaction are discussed. In particular, i) for a proton beam of 1920 keV of a 30 mA, a neutron beam of adequate features for BNCT is found at an angle of 80° from the forward direction; and ii) for a proton beam of 1910 keV, a neutron beam is obtained at the forward direction suitable for performing radiobiology experiments for the determination of the biological weighting factors of the fast dose component in neutron capture therapy.

  16. Scintillating Fiber Array Characterization and Alignment for Neutron Imaging using the High Energy X-ray (HEX) Facility

    SciTech Connect

    Buckles, R. A., Ali, Z. A., Cradick, J. R., Traille, A. J., Warthan, W. A.

    2009-09-04

    The Neutron Imager diagnostic at the National Ignition Facility (NIF) located at Lawrence Livermore National Laboratory (LLNL) will produce high-resolution, gated images of neutron-generating implosions. A similar pinhole imaging experiment (PINEX) diagnostic was recently deployed at the Z facility at Sandia National Laboratories (SNL). Both the SNL and LLNL neutron imagers use similar fiber array scintillators (BCF-99-555). Despite diverse resolution and magnification requirements, both diagnostics put significant onus on the scintillator spatial quality and alignment precision to maintain optimal point spread. Characterization and alignment of the Z-PINEX scintillator and imaging system were done at NSTec/Livermore Operations in 2009, and is currently underway for the NIF Neutron Imager.

  17. Monte Carlo calculations of epithermal and fast neutron dose in a human head model for Boron Neutron Capture Therapy

    NASA Astrophysics Data System (ADS)

    Tyminska, Katarzyna

    2008-01-01

    Boron Neutron Capture Therapy is a very promising form of cancer therapy, consisting in irradiating a stable isotope of boron (10B) concentrated in tumor cells with a low energy neutron beam. This technique makes it possible to destroy tumor cells, leaving healthy tissues practically unaffected. In order to carry out the therapy in the proper way, the proper range of the neutron beam energy has to be chosen. In this paper we continue the earlier started calculations of the optimum energy range for BNCT, taking into account the absorbed dose from fast neutrons.

  18. Evaluation of absorbed dose in Gadolinium neutron capture therapy

    NASA Astrophysics Data System (ADS)

    Abdullaeva, Gayane; Djuraeva, Gulnara; Kim, Andrey; Koblik, Yuriy; Kulabdullaev, Gairatulla; Rakhmonov, Turdimukhammad; Saytjanov, Shavkat

    2015-02-01

    Gadolinium neutron capture therapy (GdNCT) is used for treatment of radioresistant malignant tumors. The absorbed dose in GdNCT can be divided into four primary dose components: thermal neutron, fast neutron, photon and natural gadolinium doses. The most significant is the dose created by natural gadolinium. The amount of gadolinium at the irradiated region is changeable and depends on the gadolinium delivery agent and on the structure of the location where the agent is injected. To de- fine the time dependence of the gadolinium concentration ρ(t) in the irradiated region the pharmacokinetics of gadolinium delivery agent (Magnevist) was studied at intratumoral injection in mice and intramuscular injection in rats. A polynomial approximation was applied to the experimental data and the influence of ρ(t) on the relative change of the absorbed dose of gadolinium was studied.

  19. A NEW SINGLE-CRYSTAL FILTERED THERMAL NEUTRON SOURCE FOR NEUTRON CAPTURE THERAPY RESEARCH AT THE UNIVERSITY OF MISSOURI

    SciTech Connect

    John D. Brockman; David W. Nigg; M. Frederick Hawthorne

    2008-09-01

    Parameter studies, design calculations and initial neutronic performance measurements have been completed for a new thermal neutron beamline to be used for neutron capture therapy cell and small-animal radiobiology studies at the University of Missouri Research Reactor. The beamline features the use of single-crystal silicon and bismuth sections for neutron filtering and for reduction of incident gamma radiation. The calculated and measured thermal neutron flux produced at the irradiation location is on the order of 9.5x108 neutrons/cm2-s, with a measured cadmium ratio (Au foils) of 105, indicating a well-thermalized spectrum.

  20. Application of an ultraminiature thermal neutron monitor for irradiation field study of accelerator-based neutron capture therapy

    PubMed Central

    Ishikawa, Masayori; Tanaka, Kenichi; Endo, Satrou; Hoshi, Masaharu

    2015-01-01

    Phantom experiments to evaluate thermal neutron flux distribution were performed using the Scintillator with Optical Fiber (SOF) detector, which was developed as a thermal neutron monitor during boron neutron capture therapy (BNCT) irradiation. Compared with the gold wire activation method and Monte Carlo N-particle (MCNP) calculations, it was confirmed that the SOF detector is capable of measuring thermal neutron flux as low as 105 n/cm2/s with sufficient accuracy. The SOF detector will be useful for phantom experiments with BNCT neutron fields from low-current accelerator-based neutron sources. PMID:25589504

  1. Epithermal neutron formation for boron neutron capture therapy by adiabatic resonance crossing concept

    NASA Astrophysics Data System (ADS)

    Khorshidi, A.; Ghafoori-Fard, H.; Sadeghi, M.

    2014-05-01

    Low-energy protons from the cyclotron in the range of 15-30 MeV and low current have been simulated on beryllium (Be) target with a lead moderator around the target. This research was accomplished to design an epithermal neutron beam for Boron Neutron Capture Therapy (BNCT) using the moderated neutron on the average produced from 9Be target via (p, xn) reaction in Adiabatic Resonance Crossing (ARC) concept. Generation of neutron to proton ratio, energy distribution, flux and dose components in head phantom have been simulated by MCNP5 code. The reflector and collimator were designed in prevention and collimation of derivation neutrons from proton bombarding. The scalp-skull-brain phantom consisting of bone and brain equivalent material has been simulated in order to evaluate the dosimetric effect on the brain. Results of this analysis demonstrated while the proton energy decreased, the dose factor altered according to filters thickness. The maximum epithermal flux revealed using fluental, Fe and bismuth (Bi) filters with thicknesses of 9.4, 3 and 2 cm, respectively and also the epithermal to thermal neutron flux ratio was 103.85. The potential of the ARC method to replace or complement the current reactor-based supply sources of BNCT purposes.

  2. Characteristics of a heavy water photoneutron source in boron neutron capture therapy

    NASA Astrophysics Data System (ADS)

    Danial, Salehi; Dariush, Sardari; M. Salehi, Jozani

    2013-07-01

    Bremsstrahlung photon beams produced by medical linear accelerators are currently the most commonly used method of radiation therapy for cancerous tumors. Photons with energies greater than 8-10 MeV potentially generate neutrons through photonuclear interactions in the accelerator's treatment head, patient's body, and treatment room ambient. Electrons impinging on a heavy target generate a cascade shower of bremsstrahlung photons, the energy spectrum of which shows an end point equal to the electron beam energy. By varying the target thickness, an optimum thickness exists for which, at the given electron energy, maximum photon flux is achievable. If a source of high-energy photons i.e. bremsstrahlung, is conveniently directed to a suitable D2O target, a novel approach for production of an acceptable flux of filterable photoneturons for boron neutron capture therapy (BNCT) application is possible. This study consists of two parts. 1. Comparison and assessment of deuterium photonuclear cross section data. 2. Evaluation of the heavy water photonuclear source.

  3. Alterations in dose and lineal energy spectra under different shieldings in the Los Alamos high-energy neutron field

    NASA Technical Reports Server (NTRS)

    Badhwar, G. D.; Huff, H.; Wilkins, R.

    2000-01-01

    Nuclear interactions of space radiation with shielding materials result in alterations in dose and lineal energy spectra that depend on the specific elemental composition, density and thickness of the material. The shielding characteristics of materials have been studied using charged-particle beams and radiation transport models by examining the risk reduction using the conventional dose-equivalent approach. Secondary neutrons contribute a significant fraction of the total radiation exposure in space. An experiment to study the changes in dose and lineal energy spectra by shielding materials was carried out at the Los Alamos Nuclear Science Center neutron facility. In the energy range of about 2 to 200 MeV, this neutron spectrum is similar in shape within a factor of about 2 to the spectrum expected in the International Space Station habitable modules. It is shown that with a shielding thickness of about 5 g cm(-2), the conventional radiation risk increases, in some cases by as much as a factor of 2, but decreases with thicknesses of about of 20 g cm(-2). This suggests that care must be taken in evaluating the shielding effectiveness of a given material by including both the charged-particle and neutron components of space radiation.

  4. Preliminary investigations of Monte Carlo Simulations of neutron energy and LET spectra for fast neutron therapy facilities

    SciTech Connect

    Kroc, T.K.; /Fermilab

    2009-10-01

    No fast neutron therapy facility has been built with optimized beam quality based on a thorough understanding of the neutron spectrum and its resulting biological effectiveness. A study has been initiated to provide the information necessary for such an optimization. Monte Carlo studies will be used to simulate neutron energy spectra and LET spectra. These studies will be bench-marked with data taken at existing fast neutron therapy facilities. Results will also be compared with radiobiological studies to further support beam quality ptimization. These simulations, anchored by this data, will then be used to determine what parameters might be optimized to take full advantage of the unique LET properties of fast neutron beams. This paper will present preliminary work in generating energy and LET spectra for the Fermilab fast neutron therapy facility.

  5. GE PETtrace cyclotron as a neutron source for boron neutron capture therapy.

    PubMed

    Bosko, A; Zhilchenkov, D; Reece, W D

    2004-11-01

    This paper discusses the use of a General Electric PETtrace cyclotron as a neutron source for boron neutron capture therapy. In particular, the standard PETtrace (18)O target is considered. The resulting dose from the neutrons emitted from the target is evaluated using the Monte Carlo radiation transport code MCNP at different depths in a brain phantom. MCNP-simulated results are presented at 1, 2, 3, 4, 5, 6, 7, and 8 cm depth inside this brain phantom. Results showed that using a PETtrace cyclotron in the current configuration allows treating tumors at a depth of up to 4 cm with reasonable treatment times. Further increase of a beam current should significantly improve the treatment time and allow treating tumors at greater depths. PMID:15308192

  6. Isodose Curves and Treatment Planning for Boron Neutron Capture Therapy.

    NASA Astrophysics Data System (ADS)

    Liu, Hungyuan B.

    The development of Boron Neutron Capture Therapy (BNCT) has been progressing in both ^{10 }B compound development and testing and neutron beam delivery. Animal tests are now in progress with several ^{10}B compounds and once the results of these animal tests are promising, patient trials can be initiated. The objective of this study is to create a treatment planning method based on the dose calculations by a Monte Carlo code of a mixed radiation field to provide linkage between phantom dosimetry and patient irradiation. The research started with an overall review of the development of BNCT. Three epithermal neutron facilities are described, including the operating Brookhaven Medical Research Reactor (BMRR) beam, the designed Missouri University Research Reactor (MURR) beam, and a designed accelerator based neutron source. The flux and dose distributions in a head model have been calculated for irradiation by these neutron beams. Different beam parameters were inter -compared for effectiveness. Dosimetric measurements in an elliptical lucite phantom and a cylindrical water phantom were made and compared to the MCNP calculations for irradiation by the BMRR beam. Repeated measurements were made and show consistent. To improve the statistical results calculated by MCNP, a neutron source plane was designed to start neutrons at the BMRR irradiation port. The source plane was used with the phantoms for dosimetric calculations. After being verified by different phantom dosimetry and in-air flux measurements at the irradiation port, the source plane was used to calculate the flux and dose distributions in the head model. A treatment planning program was created for use on a PC which uses the MCNP calculated results as input. This program calculates the thermal neutron flux and dose distributions of each component of radiation in the central coronal section of the head model for irradiation by a neutron beam. Different combinations of head orientations and irradiation

  7. The possible use of a spallation neutron source for neutron capture therapy with epithermal neutrons

    SciTech Connect

    Grusell, E.; Conde, H.; Larsson, B.; Roennqvist, T.; Sornsuntisook, O.; Crawford, J.; Reist, H.; Dahl, B.; Sjoestrand, N.G.; Russel, G. . Dept. of Radiation Sciences; Paul Scherrer Inst. , Villigen; Chalmers Univ. of Tech., Goeteborg . Dept. of Reactor Physics; Los Alamos National Lab., NM )

    1989-01-01

    Spallation is induced in a heavy material by 72 MeV protons. The hereby produced neutrons with essentially an evaporation spectrum with a peak energy of less than 2 MeV are moderated in two steps, first in iron, and then in carbon. Results from neutron fluence measurements in a perspex phantom placed close to the moderator are presented. Monte Carlo calculations of neutron fluence in a water phantom are also presented under some chosen configurations of spallation source and moderator. The calculations and measurements show a good agreement and also show that useful thermal neutron fluences are attainable in the depth of the brain, at proton currents of less than 0.5 mA. 3 refs., 5 figs., 4 tabs.

  8. Computational Dosimetry and Treatment Planning Considerations for Neutron Capture Therapy

    SciTech Connect

    Nigg, David Waler

    2003-03-01

    Specialized treatment planning software systems are generally required for neutron capture therapy (NCT) research and clinical applications. The standard simplifying approximations that work well for treatment planning computations in the case of many other modalities are usually not appropriate for application to neutron transport. One generally must obtain an explicit three-dimensional numerical solution of the governing transport equation, with energy-dependent neutron scattering completely taken into account. Treatment planning systems that have been successfully introduced for NCT applications over the past 15 years rely on the Monte Carlo stochastic simulation method for the necessary computations, primarily because of the geometric complexity of human anatomy. However, historically, there has also been interest in the application of deterministic methods, and there have been some practical developments in this area. Most recently, interest has turned toward the creation of treatment planning software that is not limited to any specific therapy modality, with NCT as only one of several applications. A key issue with NCT treatment planning has to do with boron quantification, and whether improved information concerning the spatial biodistribution of boron can be effectively used to improve the treatment planning process. Validation and benchmarking of computations for NCT are also of current developmental interest. Various institutions have their own procedures, but standard validation models are not yet in wide use.

  9. Boron Neutron Capture Therapy for Malignant Brain Tumors.

    PubMed

    Miyatake, Shin-Ichi; Kawabata, Shinji; Hiramatsu, Ryo; Kuroiwa, Toshihiko; Suzuki, Minoru; Kondo, Natsuko; Ono, Koji

    2016-07-15

    Boron neutron capture therapy (BNCT) is a biochemically targeted radiotherapy based on the nuclear capture and fission reactions that occur when non-radioactive boron-10, which is a constituent of natural elemental boron, is irradiated with low energy thermal neutrons to yield high linear energy transfer alpha particles and recoiling lithium-7 nuclei. Therefore, BNCT enables the application of a high dose of particle radiation selectively to tumor cells in which boron-10 compound has been accumulated. We applied BNCT using nuclear reactors for 167 cases of malignant brain tumors, including recurrent malignant gliomas, newly diagnosed malignant gliomas, and recurrent high-grade meningiomas from January 2002 to May 2014. Here, we review the principle and history of BNCT. In addition, we introduce fluoride-18-labeled boronophenylalanine positron emission tomography and the clinical results of BNCT for the above-mentioned malignant brain tumors. Finally, we discuss the recent development of accelerators producing epithermal neutron beams. This development could provide an alternative to the current use of specially modified nuclear reactors as a neutron source, and could allow BNCT to be performed in a hospital setting. PMID:27250576

  10. Boron Neutron Capture Therapy for Malignant Brain Tumors

    PubMed Central

    MIYATAKE, Shin-Ichi; KAWABATA, Shinji; HIRAMATSU, Ryo; KUROIWA, Toshihiko; SUZUKI, Minoru; KONDO, Natsuko; ONO, Koji

    2016-01-01

    Boron neutron capture therapy (BNCT) is a biochemically targeted radiotherapy based on the nuclear capture and fission reactions that occur when non-radioactive boron-10, which is a constituent of natural elemental boron, is irradiated with low energy thermal neutrons to yield high linear energy transfer alpha particles and recoiling lithium-7 nuclei. Therefore, BNCT enables the application of a high dose of particle radiation selectively to tumor cells in which boron-10 compound has been accumulated. We applied BNCT using nuclear reactors for 167 cases of malignant brain tumors, including recurrent malignant gliomas, newly diagnosed malignant gliomas, and recurrent high-grade meningiomas from January 2002 to May 2014. Here, we review the principle and history of BNCT. In addition, we introduce fluoride-18-labeled boronophenylalanine positron emission tomography and the clinical results of BNCT for the above-mentioned malignant brain tumors. Finally, we discuss the recent development of accelerators producing epithermal neutron beams. This development could provide an alternative to the current use of specially modified nuclear reactors as a neutron source, and could allow BNCT to be performed in a hospital setting. PMID:27250576

  11. Microdosimetric investigations at the Fast Neutron Therapy Facility at Fermilab

    SciTech Connect

    Langen, K.M.

    1997-12-31

    Microdosimetry was used to investigate three issues at the neutron therapy facility (NTF) at Fermilab. Firstly, the conversion factor from absorbed dose in A-150 tissue equivalent plastic to absorbed dose in ICRU tissue was determined. For this, the effective neutron kerma factor ratios, i.e. oxygen tissue equivalent plastic and carbon to A-150 tissue equivalent plastic, were measured in the neutron beam. An A-150 tissue equivalent plastic to ICRU tissue absorbed dose conversion factor of 0.92 {+-} 0.04 determined. Secondly, variations in the radiobiological effectiveness (RBE) in the beam were mapped by determining variations in two related quantities, e{sup *} and R, with field size and depth in tissue. Maximal variation in e{sup *} and R of 9% and 15% respectively were determined. Lastly, the feasibility of utilizing the boron neutron capture reaction on boron-10 to selectively enhance the tumor dose in the NTF beam was investigated. In the unmodified beam, a negligible enhancement for a 50 ppm boron loading was measured. To boost the boron dose enhancement to 3% it was necessary to change the primary proton energy from 66 MeV and to filter the beam by 90 mm of tungsten.

  12. Designing accelerator-based epithermal neutron beams for boron neutron capture therapy

    SciTech Connect

    Bleuel, D.L.; Donahue, R.J.; Ludewigt, B.A.; Vujic, J.

    1998-09-01

    The {sup 7}Li(p,n){sup 7}Be reaction has been investigated as an accelerator-driven neutron source for proton energies between 2.1 and 2.6 MeV. Epithermal neutron beams shaped by three moderator materials, Al/AlF{sub 3}, {sup 7}LiF, and D{sub 2}O, have been analyzed and their usefulness for boron neutron capture therapy (BNCT) treatments evaluated. Radiation transport through the moderator assembly has been simulated with the Monte Carlo {ital N}-particle code (MCNP). Fluence and dose distributions in a head phantom were calculated using BNCT treatment planning software. Depth-dose distributions and treatment times were studied as a function of proton beam energy and moderator thickness. It was found that an accelerator-based neutron source with Al/AlF{sub 3} or {sup 7}LiF as moderator material can produce depth-dose distributions superior to those calculated for a previously published neutron beam design for the Brookhaven Medical Research Reactor, achieving up to {approximately}50{percent} higher doses near the midline of the brain. For a single beam treatment, a proton beam current of 20 mA, and a {sup 7}LiF moderator, the treatment time was estimated to be about 40 min. The tumor dose deposited at a depth of 8 cm was calculated to be about 21 Gy-Eq. {copyright} {ital 1998 American Association of Physicists in Medicine.}

  13. High-energy particle production in solar flares (SEP, gamma-ray and neutron emissions). [solar energetic particles

    NASA Technical Reports Server (NTRS)

    Chupp, E. L.

    1987-01-01

    Electrons and ions, over a wide range of energies, are produced in association with solar flares. Solar energetic particles (SEPs), observed in space and near earth, consist of electrons and ions that range in energy from 10 keV to about 100 MeV and from 1 MeV to 20 GeV, respectively. SEPs are directly recorded by charged particle detectors, while X-ray, gamma-ray, and neutron detectors indicate the properties of the accelerated particles (electrons and ions) which have interacted in the solar atmosphere. A major problem of solar physics is to understand the relationship between these two groups of charged particles; in particular whether they are accelerated by the same mechanism. The paper reviews the physics of gamma-rays and neutron production in the solar atmosphere and the method by which properties of the primary charged particles produced in the solar flare can be deduced. Recent observations of energetic photons and neutrons in space and at the earth are used to present a current picture of the properties of impulsively flare accelerated electrons and ions. Some important properties discussed are time scale of production, composition, energy spectra, accelerator geometry. Particular attention is given to energetic particle production in the large flare on June 3, 1982.

  14. A high yield neutron target for cancer therapy

    NASA Technical Reports Server (NTRS)

    Alger, D. L.; Steinberg, R.

    1972-01-01

    A rotating target was developed that has the potential for providing an initial yield of 10 to the 13th power neutrons per second by the T(d,n)He-4 reaction, and a useable lifetime in excess of 600 hours. This yield and lifetime are indicated for a 300 Kv and 30 mA deuteron accelerator and a 30 microns thick titanium tritide film formed of the stoichiometric compound TiT2. The potential for extended lifetime is made possible by incorporating a sputtering electrode that permits use of titanium tritide thicknesses much greater than the deuteron range. The electrode is used to remove in situ depleted titanium layers to expose fresh tritide beneath. The utilization of the rotating target as a source of fast neutrons for cancer therapy is discussed.

  15. Real-time dosimetry for boron-neutron capture therapy

    SciTech Connect

    Bliss, M.; Craig, R.A.; Reeder, P.L.; Sunberg, D.S.

    1994-09-01

    Epithermal/thermal boron neutron-capture therapy (BNCT) is promising treatment method for malignant tumors. Because the doses and dose rates for medical therapeutic radiation are very close to the normal tissue tolerance, small errors in radiation delivery can result in harmful overdoses. A substantial need exists for a device that will monitor, in real time, the radiation dose being delivered to a patient. Pacific Northwest Laboratory (PNL) has developed a scintillating glass optical fiber that is sensitive to thermal neutrons. The small size of the fibers offers the possibility of in vivo dose monitoring at several points within the radiation field. The count rate of such detectors can approach 10 MHz because the lifetime of the cerium activator is fast. Fluxes typical of those in BNCT (i.e., 10{sup 9} n/cm{sup 2}/sec) may be measured because of this potentially high count rate and the small diameter of the fiber.

  16. Carborane derivative development for boron neutron capture therapy. Final report

    SciTech Connect

    Barnum, Beverly A.; Yan Hao; Moore, Roger; Hawthorne, M. Frederick; Baum, Kurt

    1999-04-01

    Boron Neutron Capture Therapy [BNCT] is a binary method of cancer therapy based on the capture of neutrons by a boron-10 atom [{sup 10}B]. Cytotoxic {sup 7}Li nuclei and {alpha}-particles are emitted, with a range in tissue of 9 and 5 {micro}m, respectively, about one cell diameter. The major obstacle to clinically viable BNCT is the selective localization of 5-30 ppm {sup 10}B in tumor cells required for effective therapy. A promising approach to BNCT is based on hydrophilic boron-rich oligomeric phosphate diesters, or ''trailers'' that have been shown to concentrate selectively in tumor tissue. Examples of these compounds were prepared previously at high cost using an automated DNA synthesizer. Direct synthesis methods are needed for the production of gram-scale quantities for further biological evaluation. The work accomplished as a result of the collaboration between Fluorochem, Inc. and UCLA demonstrates that short oligomers containing at least five carborane units with four phosphodiester linkages can be prepared in substantial quantities. This work was accomplished by the application of standard phosphoramidite coupling chemistry.

  17. First steps towards a fast-neutron therapy planning program

    PubMed Central

    2011-01-01

    Background The Monte Carlo code GEANT4 was used to implement first steps towards a treatment planning program for fast-neutron therapy at the FRM II research reactor in Garching, Germany. Depth dose curves were calculated inside a water phantom using measured primary neutron and simulated primary photon spectra and compared with depth dose curves measured earlier. The calculations were performed with GEANT4 in two different ways, simulating a simple box geometry and splitting this box into millions of small voxels (this was done to validate the voxelisation procedure that was also used to voxelise the human body). Results In both cases, the dose distributions were very similar to those measured in the water phantom, up to a depth of 30 cm. In order to model the situation of patients treated at the FRM II MEDAPP therapy beamline for salivary gland tumors, a human voxel phantom was implemented in GEANT4 and irradiated with the implemented MEDAPP neutron and photon spectra. The 3D dose distribution calculated inside the head of the phantom was similar to the depth dose curves in the water phantom, with some differences that are explained by differences in elementary composition. The lateral dose distribution was studied at various depths. The calculated cumulative dose volume histograms for the voxel phantom show the exposure of organs at risk surrounding the tumor. Conclusions In order to minimize the dose to healthy tissue, a conformal treatment is necessary. This can only be accomplished with the help of an advanced treatment planning system like the one developed here. Although all calculations were done for absorbed dose only, any biological dose weighting can be implemented easily, to take into account the increased radiobiological effectiveness of neutrons compared to photons. PMID:22118299

  18. Boronated monoclonal antibody conjugates for neutron capture therapy

    SciTech Connect

    Borg, D.C.; Elmore, J.J. Jr.; Ferrone, S.

    1986-01-01

    Monoclonal antibodies (MoAbs) to tumor-associated antigens are attractive for concentrating /sup 10/B in cancer tissue, in part because neutron capture therapy (NCT) is not disadvantaged by the hours to days required to optimize tumor:background concentration ratios of MoAbs or their F(ab')/sub 2/ or Fab fragments. Since direct coupling of /sup 10/B compounds in amounts sufficient for radiotherapy appears to inactivate MoAbs, the authors used dextran intermediate carriers to provide high levels of /sup 10/B per MoAb while modifying fewer amino acid residues.

  19. A New High Energy Resolution Neutron Transmission Detector at the Gaerttner LINAC Center and Isotopic Molybdenum Total Cross Section Measurements in the keV-Region

    NASA Astrophysics Data System (ADS)

    Bahran, Rian M.

    The Gaerttner LINAC Center at Rensselaer Polytechnic Institute is home to a 60 MeV electron linear accelerator (LINAC) that is used as a pulsed neutron source for TOF nuclear data experiments. High energy resolution total cross section measurements for the stable molybdenum isotopes of Mo-95, Mo-96, Mo-98, and Mo-100 were performed with a newly developed modular neutron transmission detector positioned at a 100 m experimental flight station. This work is part of an effort to both improve existing neutron total cross section libraries and measurement capabilities at the Gaerttner LINAC Center in and above the resolved resonance energy region (from 5-620 keV). The overall design optimization process and qualification of the new high resolution detector is presented. Additionally, a new method to quantify the energy-dependent neutron and gamma-ray experimental background of the detector was developed. High resolution isotopic molybdenum total cross section data are of particular importance because stable Mo isotopes can be found in significant concentrations in a nuclear fuel cycle either as a high yield fission product or in alloyed form with applications in reactor piping, fuel cladding, and as an advanced nuclear fuel in the form of U-Mo. The measured total cross section energy range encompasses the resolved resonance region and extends into the unresolved resonance region for each molybdenum isotope. New high accuracy resonance parameters for Mo-95 were generated from fitting experimental data using the multilevel R-matrix Bayesian code SAMMY in the resolved resonance region. In the unresolved resonance region, average resonance parameters and fits to the total cross section were obtained using the Hauser-Feshbach statistical model code FITACS which is embedded in SAMMY.

  20. High-energy magnetic excitations in overdoped La2 -xSrxCuO4 studied by neutron and resonant inelastic x-ray scattering

    NASA Astrophysics Data System (ADS)

    Wakimoto, S.; Ishii, K.; Kimura, H.; Fujita, M.; Dellea, G.; Kummer, K.; Braicovich, L.; Ghiringhelli, G.; Debeer-Schmitt, L. M.; Granroth, G. E.

    2015-05-01

    We have performed neutron inelastic scattering and resonant inelastic x-ray scattering (RIXS) at the Cu-L3 edge to study high-energy magnetic excitations at energy transfers of more than 100 meV for overdoped La2 -xSrxCuO4 with x =0.25 (Tc=15 K) and x =0.30 (nonsuperconducting) using identical single-crystal samples for the two techniques. From constant-energy slices of neutron-scattering cross sections, we have identified magnetic excitations up to ˜250 meV for x =0.25 . Although the width in the momentum direction is large, the peak positions along the (π ,π ) direction agree with the dispersion relation of the spin wave in the nondoped La2CuO4 (LCO), which is consistent with the previous RIXS results of cuprate superconductors. Using RIXS at the Cu-L3 edge, we have measured the dispersion relations of the so-called paramagnon mode along both (π ,π ) and (π ,0 ) directions. Although in both directions the neutron and RIXS data connect with each other and the paramagnon along (π ,0 ) agrees well with the LCO spin-wave dispersion, the paramagnon in the (π ,π ) direction probed by RIXS appears to be less dispersive and the excitation energy is lower than the spin wave of LCO near (π /2 ,π /2 ) . Thus, our results indicate consistency between neutron inelastic scattering and RIXS, and elucidate the entire magnetic excitation in the (π ,π ) direction by the complementary use of two probes. The polarization dependence of the RIXS profiles indicates that appreciable charge excitations exist in the same energy range of magnetic excitations, reflecting the itinerant character of the overdoped sample. A possible anisotropy in the charge excitation intensity might explain the apparent differences in the paramagnon dispersion in the (π ,π ) direction as detected by the x-ray scattering.

  1. Measurement of activation cross-sections for high-energy neutron-induced reactions of Bi and Pb

    NASA Astrophysics Data System (ADS)

    Zaman, Muhammad; Kim, Guinyun; Kim, Kwangsoo; Naik, Haladhara; Shahid, Muhammad; Lee, Manwoo

    2015-08-01

    The cross-sections for 209Bi(n, 4n)206Bi, 209Bi(n, 5n)205Bi, natPb(n, xn)204mPb, natPb(n, xn)203Pb, natPb(n, xn)202mPb,natPb(n, xn)201Pb, natPb(n, xn)200Pb, natPb(n, αxn)203Hg and natPb(n, p xn)202Tl reactions were determined at the Korean Institute of Radiological and Medical Sciences (KIRAMS), Korea in the neutron energy range of 15.2 to 37.2 MeV. The above cross-sections were obtained by using the activation and off-line γ-ray spectrometric technique. The quasi-monoenergetic neutron used for the above reactions are based on the 9Be(p, n) reaction. Simulations of the spectral flux from the Be target were done using the MCNPX program. The cross-sections were estimated with the TALYS 1.6 code using the default parameter. The data from the present work and literature were compared with the data from the EAF-2010 and the TENDL-2013 libraries, and calculated values of TALYS 1.6 code. It shows that appropriate level density model, the γ-ray strength function, and the spin cut-off parameter are needed to obtain a good agreement between experimental data and theoretical values from TALYS 1.6 code.

  2. General Electric PETtrace cyclotron as a neutron source for boron neutron capture therapy

    NASA Astrophysics Data System (ADS)

    Bosko, Andrey

    This research investigates the use of a PETtrace cyclotron produced by General Electric (GE) as a neutron source for boron neutron capture therapy (BNCT). The GE PETtrace was chosen for this investigation because this type of cyclotron is popular among nuclear pharmacies and clinics in many countries; it is compact and reliable; it produces protons with energies high enough to produce neutrons with appropriate energy and fluence rate for BNCT and it does not require significant changes in design to provide neutrons. In particular, the standard PETtrace 18O target is considered. The cyclotron efficiency may be significantly increased if unused neutrons produced during radioisotopes production could be utilized for other medical modalities such as BNCT at the same time. The resulting dose from the radiation emitted from the target is evaluated using the Monte Carlo radiation transport code MCNP at several depths in a brain phantom for different scattering geometries. Four different moderating materials of various thicknesses were considered: light water, carbon, heavy water, arid Fluental(TM). The fluence rate tally was used to calculate photon and neutron dose, by applying fluence rate-to-dose conversion factors. Fifteen different geometries were considered and a 30-cm thick heavy water moderator was chosen as the most suitable for BNCT with the GE PETtrace cyclotron. According to the Brookhaven Medical Research Reactor (BMRR) protocol, the maximum dose to the normal brain is set to 12.5 RBEGy, which for the conditions of using a heavy water moderator, assuming a 60 muA beam current, would be reached with a treatment time of 258 min. Results showed that using a PETtrace cyclotron in this configuration provides a therapeutic ratio of about 2.4 for depths up to 4 cm inside a brain phantom. Further increase of beam current proposed by GE should significantly improve the beam quality or the treatment time and allow treating tumors at greater depths.

  3. A Project of Boron Neutron Capture Therapy System based on a Proton Linac Neutron Source

    NASA Astrophysics Data System (ADS)

    Kiyanagi, Yoshikai; Asano, Kenji; Arakawa, Akihiro; Fukuchi, Shin; Hiraga, Fujio; Kimura, Kenju; Kobayashi, Hitoshi; Kubota, Michio; Kumada, Hiroaki; Matsumoto, Hiroshi; Matsumoto, Akira; Sakae, Takeji; Saitoh, Kimiaki; Shibata, Tokushi; Yoshioka, Masakazu

    At present, the clinical trials of Boron Neutron Capture Therapy (BNCT) are being performed at research reactor facilities. However, an accelerator based BNCT has a merit that it can be built in a hospital. So, we just launched a development project for the BNCT based on an accelerator in order to establish and to spread the BNCT as an effective therapy in the near future. In the project, a compact proton linac installed in a hospital will be applied as a neutron source, and energy of the proton beam is planned to be less than about 10 MeV to reduce the radioactivity. The BNCT requires epithermal neutron beam with an intensity of around 1x109 (n/cm2/sec) to deliver the therapeutic dose to a deeper region in a body and to complete the irradiation within an hour. From this condition, the current of the proton beam required is estimated to be a few mA on average. Enormous heat deposition in the target is a big issue. We are aiming at total optimization of the accelerator based BNCT from the linac to the irradiation position. Here, the outline of the project is introduced and the moderator design is presented.

  4. Thiourea derivatives, methods of their preparation and their use in neutron capture therapy of malignant melanoma

    DOEpatents

    Gabel, D.

    1991-06-04

    The present invention pertains to boron containing thiouracil derivatives, their method of preparations, and their use in the therapy of malignant melanoma using boron neutron capture therapy. No Drawings

  5. Boron containing compounds and their preparation and use in neutron capture therapy

    DOEpatents

    Gabel, D.

    1992-09-01

    The present invention pertains to boron containing thiouracil derivatives, their method of preparations, and their use in the therapy of malignant melanoma using boron neutron capture therapy. No Drawings

  6. Analysis of lateritic material from Cerro Impacto by instrumental neutron activation employing a low-energy photon semiconductor and a high-energy Ge(Li) detector

    SciTech Connect

    LaBrecque, J.J.; Beusen, J.M.; Van Grieken, R.E.

    1986-01-01

    Nineteen elements were determined in four different grain size fractions of a bulk geological material from Cerro Impacto for a study of the physical (mechanical) concentration process of different elements based upon the hardness of the different minerals. The analysis was performed by excitation of the sample with a high, slow neutron flux followed by gamma-ray spectroscopy with both a conventional Ge(Li) high-energy detector and a low-energy photon detector (LEPD). The accuracy of this method was studied with the use of two standard reference materials, SY-2 and SY-3, which are similar to the real samples. The values determined were also compared with a secondary target x-ray fluorescence method for all the elements that were suitable to both methods. Actually, the x-ray fluorescence method was found to be more complementary than competitive. 10 refs., 2 figs., 4 tabs.

  7. Thermal neutron irradiation field design for boron neutron capture therapy of human explanted liver

    SciTech Connect

    Bortolussi, S.; Altieri, S.

    2007-12-15

    The selective uptake of boron by tumors compared to that by healthy tissue makes boron neutron capture therapy (BNCT) an extremely advantageous technique for the treatment of tumors that affect a whole vital organ. An example is represented by colon adenocarcinoma metastases invading the liver, often resulting in a fatal outcome, even if surgical resection of the primary tumor is successful. BNCT can be performed by irradiating the explanted organ in a suitable neutron field. In the thermal column of the Triga Mark II reactor at Pavia University, a facility was created for this purpose and used for the irradiation of explanted human livers. The neutron field distribution inside the organ was studied both experimentally and by means of the Monte Carlo N-particle transport code (MCNP). The liver was modeled as a spherical segment in MCNP and a hepatic-equivalent solution was used as an experimental phantom. In the as-built facility, the ratio between maximum and minimum flux values inside the phantom ({phi}{sub max}/{phi}{sub min}) was 3.8; this value can be lowered to 2.3 by rotating the liver during the irradiation. In this study, the authors proposed a new facility configuration to achieve a uniform thermal neutron flux distribution in the liver. They showed that a {phi}{sub max}/{phi}{sub min} ratio of 1.4 could be obtained without the need for organ rotation. Flux distributions and dose volume histograms were reported for different graphite configurations.

  8. Thermal neutron irradiation field design for boron neutron capture therapy of human explanted liver.

    PubMed

    Bortolussi, S; Altieri, S

    2007-12-01

    The selective uptake of boron by tumors compared to that by healthy tissue makes boron neutron capture therapy (BNCT) an extremely advantageous technique for the treatment of tumors that affect a whole vital organ. An example is represented by colon adenocarcinoma metastases invading the liver, often resulting in a fatal outcome, even if surgical resection of the primary tumor is successful. BNCT can be performed by irradiating the explanted organ in a suitable neutron field. In the thermal column of the Triga Mark II reactor at Pavia University, a facility was created for this purpose and used for the irradiation of explanted human livers. The neutron field distribution inside the organ was studied both experimentally and by means of the Monte Carlo N-particle transport code (MCNP). The liver was modeled as a spherical segment in MCNP and a hepatic-equivalent solution was used as an experimental phantom. In the as-built facility, the ratio between maximum and minimum flux values inside the phantom ((phi(max)/phi(min)) was 3.8; this value can be lowered to 2.3 by rotating the liver during the irradiation. In this study, the authors proposed a new facility configuration to achieve a uniform thermal neutron flux distribution in the liver. They showed that a phi(max)/phi(min) ratio of 1.4 could be obtained without the need for organ rotation. Flux distributions and dose volume histograms were reported for different graphite configurations. PMID:18196797

  9. Ground-based observations of thunderstorm-correlated fluxes of high-energy electrons, gamma rays, and neutrons

    SciTech Connect

    Chilingarian, A.; Daryan, A.; Arakelyan, K.; Hovhannisyan, A.; Mailyan, B.; Melkumyan, L.; Hovsepyan, G.; Chilingaryan, S.; Reymers, A.; Vanyan, L.

    2010-08-15

    The Aragats Space Environmental Center facilities continuously measure fluxes of neutral and charged secondary cosmic ray incidents on the Earth's surface. Since 2003 in the 1-minute time series we have detected more than 100 enhancements in the electron, gamma ray, and neutron fluxes correlated with thunderstorm activities. During the periods of the count rate enhancements, lasting tens of minutes, millions of additional particles were detected. Based on the largest particle event of September 19, 2009, we show that our measurements support the existence of long-lasting particle multiplication and acceleration mechanisms in the thunderstorm atmosphere. For the first time we present the energy spectra of electrons and gamma rays from the particle avalanches produced in the thunderstorm atmosphere, reaching the Earth's surface.

  10. Comparison of graphite, aluminum, and TransHab shielding material characteristics in a high-energy neutron field

    NASA Technical Reports Server (NTRS)

    Badhwar, G. D.; Huff, H.; Wilkins, R.; Thibeault, Sheila

    2002-01-01

    Space radiation transport models clearly show that low atomic weight materials provide a better shielding protection for interplanetary human missions than high atomic weight materials. These model studies have concentrated on shielding properties against charged particles. A light-weight, inflatable habitat module called TransHab was built and shown to provide adequate protection against micrometeoroid impacts and good shielding properties against charged particle radiation in the International Space Station orbits. An experiment using a tissue equivalent proportional counter, to study the changes in dose and lineal energy spectra with graphite, aluminum, and a TransHab build-up as shielding, was carried out at the Los Alamos Nuclear Science Center neutron facility. It is a continuation of a previous study using regolith and doped polyethylene materials. This paper describes the results and their comparison with the previous study. Published by Elsevier Science Ltd.

  11. Comparison of graphite, aluminum, and TransHab shielding material characteristics in a high-energy neutron field.

    PubMed

    Badhwar, G D; Huff, H; Wilkins, R; Thibeault, Sheila

    2002-12-01

    Space radiation transport models clearly show that low atomic weight materials provide a better shielding protection for interplanetary human missions than high atomic weight materials. These model studies have concentrated on shielding properties against charged particles. A light-weight, inflatable habitat module called TransHab was built and shown to provide adequate protection against micrometeoroid impacts and good shielding properties against charged particle radiation in the International Space Station orbits. An experiment using a tissue equivalent proportional counter, to study the changes in dose and lineal energy spectra with graphite, aluminum, and a TransHab build-up as shielding, was carried out at the Los Alamos Nuclear Science Center neutron facility. It is a continuation of a previous study using regolith and doped polyethylene materials. This paper describes the results and their comparison with the previous study. PMID:12455499

  12. Treatment Planning for Accelerator-Based Boron Neutron Capture Therapy

    NASA Astrophysics Data System (ADS)

    Herrera, María S.; González, Sara J.; Minsky, Daniel M.; Kreiner, Andrés J.

    2010-08-01

    Glioblastoma multiforme and metastatic melanoma are frequent brain tumors in adults and presently still incurable diseases. Boron Neutron Capture Therapy (BNCT) is a promising alternative for this kind of pathologies. Accelerators have been proposed for BNCT as a way to circumvent the problem of siting reactors in hospitals and for their relative simplicity and lower cost among other advantages. Considerable effort is going into the development of accelerator-based BNCT neutron sources in Argentina. Epithermal neutron beams will be produced through appropriate proton-induced nuclear reactions and optimized beam shaping assemblies. Using these sources, computational dose distributions were evaluated in a real patient with diagnosed glioblastoma treated with BNCT. The simulated irradiation was delivered in order to optimize dose to the tumors within the normal tissue constraints. Using Monte Carlo radiation transport calculations, dose distributions were generated for brain, skin and tumor. Also, the dosimetry was studied by computing cumulative dose-volume histograms for volumes of interest. The results suggest acceptable skin average dose and a significant dose delivered to tumor with low average whole brain dose for irradiation times less than 60 minutes, indicating a good performance of an accelerator-based BNCT treatment.

  13. Osteogenic Sarcoma of the Maxilla: Neutron Therapy for Unresectable Disease

    DOE PAGESBeta

    Smoron, Geoffrey L.; Lennox, Arlene J.; Mcgee, James L.

    1999-01-01

    Purpose. To present a case study involving the use of fast neutron therapy to treat an extensive unresectable osteogenic sarcoma arising from the left maxilla. Patient. A 14-year-old male presented with a massive tumor producing severe distortion of his facial structures. He had already received six courses of chemotherapy, which had reduced his pain, but had not measurably reduced the tumor. Methods. The patient was treated with 66 MeV fast neutrons to a dose of 20.4 Gy in 13 fractions over 35 days. Results. CT assessments indicate gradually increasing calcification and noticeable reduction of soft-tissue disease in the frontalmore » sinus, orbit and maxillary antrum.There has been some recontouring of the facial structures.The boy conducts an active life, has no pain, and feels well. He was 17 years old at the last follow-up. Discussion. Fast neutrons have a greater biological effectiveness than conventional photon beams. Their use has been associated with improved chance for local control of unresectable disease.This case illustrates their effectiveness in controlling an unusual and aggressive osteogenic sarcoma of the facial bone and sinuses.« less

  14. Treatment Planning for Accelerator-Based Boron Neutron Capture Therapy

    SciTech Connect

    Herrera, Maria S.; Gonzalez, Sara J.; Minsky, Daniel M.; Kreiner, Andres J.

    2010-08-04

    Glioblastoma multiforme and metastatic melanoma are frequent brain tumors in adults and presently still incurable diseases. Boron Neutron Capture Therapy (BNCT) is a promising alternative for this kind of pathologies. Accelerators have been proposed for BNCT as a way to circumvent the problem of siting reactors in hospitals and for their relative simplicity and lower cost among other advantages. Considerable effort is going into the development of accelerator-based BNCT neutron sources in Argentina. Epithermal neutron beams will be produced through appropriate proton-induced nuclear reactions and optimized beam shaping assemblies. Using these sources, computational dose distributions were evaluated in a real patient with diagnosed glioblastoma treated with BNCT. The simulated irradiation was delivered in order to optimize dose to the tumors within the normal tissue constraints. Using Monte Carlo radiation transport calculations, dose distributions were generated for brain, skin and tumor. Also, the dosimetry was studied by computing cumulative dose-volume histograms for volumes of interest. The results suggest acceptable skin average dose and a significant dose delivered to tumor with low average whole brain dose for irradiation times less than 60 minutes, indicating a good performance of an accelerator-based BNCT treatment.

  15. Imaging of boron in tissue at the cellular level for boron neutron capture therapy.

    PubMed

    Arlinghaus, H F; Spaar, M T; Switzer, R C; Kabalka, G W

    1997-08-15

    Glioblastoma multiforme, and other tumors involving the brain, are undergoing experimental treatment with a promising new technique: boron neutron capture therapy (BNCT). BNCT relies on the capture of thermal neutrons by boron deposited biochemically in the tumor and the subsequent fission of the boron into energetic lithium ions and alpha particles. An important requirement for improved BNCT is the development of more selective boron delivery mechanisms. The ability to image the boron concentration in tissue sections and even inside individual cells would be an important aid in the development of these delivery mechanisms. We have compared both sputter-initiated resonance ionization microprobe (SIRIMP), which combines resonance ionization with a high-energy pulsed focused sputter ion beam and mass spectrometric detection of ions, with laser atomization resonance ionization microprobe (LARIMP), which uses a laser pulse instead of an ion pulse for the atomization process, to determine their characteristics in locating and quantifying boron concentrations as a function of position in tissues obtained from a rat which had been infused with a BNCT drug. The data show that the SIRIMP/LARIMP techniques are well suited for quantitative and ultrasensitive imaging of boron trace element concentrations in biological tissue sections. The LARIMP mode could be used to quickly determine the spatial boron concentration with intercellular resolution over large areas down to the low nanograms-per-gram level, while the SIRIMP mode could be used to determine the spatial boron concentration and its variability in intracellular areas. PMID:9271061

  16. Neutron beam studies for a medical therapy reactor.

    PubMed

    Neuman, W A

    1990-01-01

    A conceptual design of a Medical Therapy Reactor (MTR) for neutron capture therapy (NCT) has been performed at the Idaho National Engineering Laboratory (INEL). The initial emphasis of the conceptual design was toward the treatment of glioblastoma multiforme and other presently incurable cancers. The design goal of the facility is to provide routine patient treatments both in brief time intervals (approximately 10 minutes) and inexpensively. The conceptual study has shown this goal to be achievable by locating an MTR at a major medical facility. This paper addresses the next step in the conceptual design process: a guide to the optimization of the epithermal-neutron filter and collimator assembly for the treatment of brain tumors. The current scope includes the sensitivity of the treatment beam to variations in filter length, gamma shield length, and collimator lengths as well as exit beam aperture size. The study shows the areas which can provide the greatest latitude in improving beam intensity and quality. Suggestions are given for future areas of optimization of beam filtering and collimation. PMID:2268234

  17. Boron neutron capture therapy for malignant melanoma: An experimental approach

    SciTech Connect

    Larsson, B.S.; Larsson, B.; Roberto, A. )

    1989-07-01

    Previous studies have shown that some thioamides, e.g., thiouracil, are incorporated as false precursors into melanin during its synthesis. If boronated analogs of the thioamides share this property, the melanin of melanotic melanomas offers a possibility for specific tumoural uptake and retention of boron as a basis for neutron capture therapy. We report on the synthesis of boronated 1H-1,2,4-triazole-3-thiol (B-TZT), boronated 5-carboxy-2-thiouracil (B-CTU), and boronated 5-diethylaminomethyl-2-thiouracil (B-DEAMTU) and the localization of these substances in melanotic melanomas transplanted to mice. The distribution in the mice was studied by boron neutron capture radiography. B-TZT and B-CTU showed the highest tumour:normal tissue concentration ratios, with tumour:liver ratios of about 4 and tumour:muscle ratios of about 14; B-DEAMTU showed corresponding ratios of 1.4 and 5, respectively. The absolute concentration of boron in the tumours, however, was more than three times higher in the mice injected with B-TZT, compared with B-CTU. The results suggest that B-TZT may be the most promising compound of the three tested with regard to possible therapy of melanotic melanomas.

  18. Study on High Speed Lithium Jet For Neutron Source of Boron Neutron Capture Therapy (BNCT)

    NASA Astrophysics Data System (ADS)

    Takahashi, Minoru; Kobayashi, Tooru; Zhang, Mingguang; Mák, Michael; Štefanica, Jirí; Dostál, Václav; Zhao, Wei

    The feasibility study of a liquid lithium type proton beam target was performed for the neutron source of the boron neutron capture therapy (BNCT). As the candidates of the liquid lithium target, a thin sheet jet and a thin film flow on a concave wall were chosen, and a lithium flow experiment was conducted to investigate the hydrodynamic stability of the targets. The surfaces of the jets and film flows with a thickness of 0.5 mm and a width of 50 mm were observed by means of photography. It has been found that a stable sheet jet and a stable film flow on a concave wall can be formed up to certain velocities by using a straight nozzle and a curved nozzle with the concave wall, respectively.

  19. The clinical potential of high energy, intensity and energy modulated electron beams optimized by simulated annealing for conformal radiation therapy

    NASA Astrophysics Data System (ADS)

    Salter, Bill Jean, Jr.

    Purpose. The advent of new, so called IVth Generation, external beam radiation therapy treatment machines (e.g. Scanditronix' MM50 Racetrack Microtron) has raised the question of how the capabilities of these new machines might be exploited to produce extremely conformal dose distributions. Such machines possess the ability to produce electron energies as high as 50 MeV and, due to their scanned beam delivery of electron treatments, to modulate intensity and even energy, within a broad field. Materials and methods. Two patients with 'challenging' tumor geometries were selected from the patient archives of the Cancer Therapy and Research Center (CTRC), in San Antonio Texas. The treatment scheme that was tested allowed for twelve, energy and intensity modulated beams, equi-spaced about the patient-only intensity was modulated for the photon treatment. The elementary beams, incident from any of the twelve allowed directions, were assumed parallel, and the elementary electron beams were modeled by elementary beam data. The optimal arrangement of elementary beam energies and/or intensities was optimized by Szu-Hartley Fast Simulated Annealing Optimization. Optimized treatment plans were determined for each patient using both the high energy, intensity and energy modulated electron (HIEME) modality, and the 6 MV photon modality. The 'quality' of rival plans were scored using three different, popular objective functions which included Root Mean Square (RMS), Maximize Dose Subject to Dose and Volume Limitations (MDVL - Morrill et. al.), and Probability of Uncomplicated Tumor Control (PUTC) methods. The scores of the two optimized treatments (i.e. HIEME and intensity modulated photons) were compared to the score of the conventional plan with which the patient was actually treated. Results. The first patient evaluated presented a deeply located target volume, partially surrounding the spinal cord. A healthy right kidney was immediately adjacent to the tumor volume, separated

  20. Monte Carlo Calculations of Selected Dose Components in a Head Model for Boron Neutron Capture Therapy

    NASA Astrophysics Data System (ADS)

    Tymińska, Katarzyna

    2007-01-01

    Boron Neutron Capture Therapy is a very promising form of cancer therapy, consisting in irradiating a stable isotope of boron (10B) concentrated in tumor cells with a low energy neutron beam. This technique makes it possible to destroy tumor cells, leaving healthy tissues practically unaffected. In order to carry out the therapy in the proper way, the proper range of the neutron beam energy has to be chosen. In this paper we present the results of the calculations, using the MCNP code, aiming at studying the energetic dependence of the absorbed dose from the neutron capture reaction on boron (the therapeutic dose), and hydrogen and nitrogen (the injuring dose).

  1. Correlation of radiation-induced changes in mechanical properties and microstructural development of Alloy 718 irradiated with mixed spectra of high-energy protons and spallation neutrons

    NASA Astrophysics Data System (ADS)

    Sencer, B. H.; Bond, G. M.; Garner, F. A.; Hamilton, M. L.; Maloy, S. A.; Sommer, W. F.

    2001-07-01

    Alloy 718 is a γ '(Ni 3(Al,Ti))-γ″(Ni 3Nb) hardenable superalloy with attractive strength, and corrosion resistance. This alloy is a candidate material for use in accelerator production of tritium (APT) target and blanket applications, where it would have to withstand low-temperature irradiation by high-energy protons and spallation neutrons. The existing data base, relevant to such irradiation conditions, is very limited. Alloy 718 has therefore been exposed to a particle flux and spectrum at the Los Alamos Neutron Science Center (LANSCE), closely matching those expected in the APT target and blanket applications. The yield stress of Alloy 718 increases with increasing dose up to ˜0.5 dpa, and then decreases with further increase in dose. The uniform elongation, however, drastically decreases with increasing dose at very low doses (<0.5 dpa), and does not recover when the alloy later softens somewhat. Transmission electron microscopy (TEM) investigation of Alloy 718 shows that superlattice spots corresponding to the age-hardening precipitate phases γ ' and γ″ are lost from the diffraction patterns for Alloy 718 by only 0.6 dpa, the lowest proton-induced dose level achieved in this experiment. Examination of samples that were neutron irradiated to doses of only ˜0.1 dpa showed that precipitates are faintly visible in diffraction patterns but are rapidly becoming invisible. It is proposed that the γ ' and γ″ first become disordered (by <0.6 dpa), but remain as solute-rich aggregates that still contribute to the hardness at relatively low dpa levels, and then are gradually dispersed at higher doses.

  2. Initial Performance Characterization for a Thermalized Neutron Beam for Neutron Capture Therapy Research at Washington State University

    SciTech Connect

    David W. Nigg; P.E> Sloan; J.R. Venhuizen; C.A. Wemple

    2005-11-01

    The Idaho National Engineering and Environmental Laboratory (INEEL) and Washington State University (WSU) have constructed a new epithermal-neutron beam for collaborative Boron Neutron Capture Therapy (BNCT) preclinical research at the WSU TRIGATM research reactor facility1. More recently, additional beamline components were developed to permit the optional thermalization of the beam for certain types of studies where it is advantageous to use a thermal neutron source rather than an epithermal source. This article summarizes the results of some initial neutronic performance measurements for the thermalized system, with a comparison to the expected performance from the design computations.

  3. Experimental Transport Benchmarks for Physical Dosimetry to Support Development of Fast-Neutron Therapy with Neutron Capture Augmentation

    SciTech Connect

    D. W. Nigg; J. K. Hartwell; J. R. Venhuizen; C. A. Wemple; R. Risler; G. E. Laramore; W. Sauerwein; G. Hudepohl; A. Lennox

    2006-06-01

    The Idaho National Laboratory (INL), the University of Washington (UW) Neutron Therapy Center, the University of Essen (Germany) Neutron Therapy Clinic, and the Northern Illinois University(NIU) Institute for Neutron Therapy at Fermilab have been collaborating in the development of fast-neutron therapy (FNT) with concurrent neutron capture (NCT) augmentation [1,2]. As part of this effort, we have conducted measurements to produce suitable benchmark data as an aid in validation of advanced three-dimensional treatment planning methodologies required for successful administration of FNT/NCT. Free-beam spectral measurements as well as phantom measurements with Lucite{trademark} cylinders using thermal, resonance, and threshold activation foil techniques have now been completed at all three clinical accelerator facilities. The same protocol was used for all measurements to facilitate intercomparison of data. The results will be useful for further detailed characterization of the neutron beams of interest as well as for validation of various charged particle and neutron transport codes and methodologies for FNT/NCT computational dosimetry, such as MCNP [3], LAHET [4], and MINERVA [5].

  4. Biological activity of N(4)-boronated derivatives of 2'-deoxycytidine, potential agents for boron-neutron capture therapy.

    PubMed

    Nizioł, Joanna; Uram, Łukasz; Szuster, Magdalena; Sekuła, Justyna; Ruman, Tomasz

    2015-10-01

    Boron-neutron capture therapy (BNCT) is a binary anticancer therapy that requires boron compound for nuclear reaction during which high energy alpha particles and lithium nuclei are formed. Unnatural, boron-containing nucleoside with hydrophobic pinacol moiety was investigated as a potential BNCT boron delivery agent. Biological properties of this compound are presented for the first time and prove that boron nucleoside has low cytotoxicity and that observed apoptotic effects suggest alteration of important functions of cancer cells. Mass spectrometry analysis of DNA from cancer cells proved that boron nucleoside is inserted into nucleic acids as a functional nucleotide derivative. NMR studies present very high degree of similarity of natural dG-dC base pair with dG-boron nucleoside system. PMID:26344594

  5. High-energy magnetic excitations in overdoped La2-xSrxCuO4 studied by neutron and resonant inelastic X-ray scattering

    DOE PAGESBeta

    Wakimoto, S.; Ishii, K.; Kimura, H.; Fujita, M.; Dellea, G.; Kummer, K.; Braicovich, L.; Ghiringhelli, G.; Debeer-Schmitt, Lisa M.; Granroth, Garrett E.

    2015-05-21

    We have performed neutron inelastic scattering and resonant inelastic x-ray scattering (RIXS) at the Cu-L3 edge to study high-energy magnetic excitations at energy transfers of more than 100 meV for overdoped La2₋xSrxCuO4 with x=0.25 (Tc=15 K) and x=0.30 (nonsuperconducting) using identical single-crystal samples for the two techniques. From constant-energy slices of neutron-scattering cross sections, we have identified magnetic excitations up to ~250 meV for x=0.25. Although the width in the momentum direction is large, the peak positions along the (π,π) direction agree with the dispersion relation of the spin wave in the nondoped La2CuO4 (LCO), which is consistent with themore » previous RIXS results of cuprate superconductors. Using RIXS at the Cu-L3 edge, we have measured the dispersion relations of the so-called paramagnon mode along both (π,π) and (π,0) directions. Although in both directions the neutron and RIXS data connect with each other and the paramagnon along (π,0) agrees well with the LCO spin-wave dispersion, the paramagnon in the (π,π) direction probed by RIXS appears to be less dispersive and the excitation energy is lower than the spin wave of LCO near (π/2,π/2). Thus, our results indicate consistency between neutron inelastic scattering and RIXS, and elucidate the entire magnetic excitation in the (π,π) direction by the complementary use of two probes. The polarization dependence of the RIXS profiles indicates that appreciable charge excitations exist in the same energy range of magnetic excitations, reflecting the itinerant character of the overdoped sample. Lastly, we find a possible anisotropy in the charge excitation intensity might explain the apparent differences in the paramagnon dispersion in the (π,π) direction as detected by the x-ray scattering.« less

  6. SERA - An Advanced Treatment Planning System for Neutron Therapy

    SciTech Connect

    C. A. Wemple; C. L. Albright; D. W. Nigg; D. W. Wessol; F. J. Wheeler; G. J. Harkin; M. B. Rossmeirer; M. T. Cohen; M. W. Frandsen

    1999-06-01

    The technology for computational dosimetry and treatment planning for Boron Neutron Capture Therapy (BNCT) has advanced significantly over the past few years. Because of the more complex nature of the problem, the computational methods that work well for treatment planning in photon radiotherapy are not applicable to BNCT. The necessary methods have, however, been developed and have been successfully employed both for research applications as well as human trials. Computational geometry for BNCT applications can be constructed directly from tomographic medical imagery and computed radiation dose distributions can be readily displayed in formats that are familiar to the radiotherapy community. The SERA system represents a significant advance in several areas for treatment planning. However further improvements in speed and results presentation are still needed for routine clinical applications, particularly when optimizations of dose pattern is required.

  7. Boron neutron capture therapy for the prevention of restenosis

    SciTech Connect

    Yanch, J.C.; Delfaus, M.L.

    1997-12-01

    The potential application of boron neutron capture therapy (BNCT) for the prevention of restenosis following angioplasty is under investigation at Massachusetts Institute of Technology`s Laboratory for Accelerator Beam Applications. The process of Percutaneous transluminal coronary angioplasty involves the insertion of a balloon dilation catheter into the occluded artery. The balloon is then inflated for several minutes to dilate the artery. The blockage is decreased, and blood flow through the artery is improved. This procedure is, initially, very successful. However, 30 to 60% of patients treated also show restenosis within 6 months. Although many physiological processes may contribute to restenosis, the primary mechanism is thought to be abnormal proliferation of the smooth muscle cells in the treated artery.

  8. Dose homogeneity in boron neutron capture therapy using an epithermal neutron beam

    SciTech Connect

    Konijnenberg, M.W.; Dewit, L.G.H.; Mijnheer, B.J.

    1995-06-01

    Simulation models based on the neutron and photon Monte Carlo code MCNP were used to study the therapeutic possibilities of the HB11 epithermal neutron beam at the High Flux Reactor in Petten. Irradiations were simulated in two types of phantoms filled with water or tissue-equivalent material for benchmark treatment planning calculations. In a cuboid phantom the influence of different field sizes on the thermal-neutron-induced dose distribution was investigated. Various shapes of collimators were studied to test their efficacy in optimizing the thermal-neutron distribution over a planning target volume and healthy tissues. Using circular collimators of 8, 12 and 15 cm diameter it was shown that with the 15-cm field a relatively larger volume within 85% of the maximum neutron-induced dose was obtained than with the 8- or 12-cm-diameter field. However, even for this large field the maximum diameter of this volume was 7.5 cm. In an ellipsoid head phantom the neutron-induced dose was calculated assuming the skull to contain 10 ppm {sup 10}B, the brain 5 ppm {sup 10}B and the tumor 30 ppm {sup 10}B. It was found that with a single 15-cm-diameter circular beam a very inhomogeneous dose distribution in a typical target volume was obtained. Applying two equally weighted opposing 15-cm-diameter fields, however, a dose homogeneity within {+-} 10% in this planning target volume was obtained. The dose in the surrounding healthy brain tissue is 30% at maximum of the dose in the center of the target volume. Contrary to the situation for the 8-cm field, combining four fields of 15 cm diameter gave no large improvement of the dose homogeneity over the target volume or a lower maximum dose in the healthy brain. Therapy with BNCT on brain tumors must be performed either with an 8-cm four-field irradiation or with two opposing 15- or 12-cm fields to obtain an optimal dose distribution. 27 refs., 10 figs., 3 tabs.

  9. Monte Carlo simulation of secondary radiation exposure from high-energy photon therapy using an anthropomorphic phantom.

    PubMed

    Frankl, Matthias; Macián-Juan, Rafael

    2016-03-01

    The development of intensity-modulated radiotherapy treatments delivering large amounts of monitor units (MUs) recently raised concern about higher risks for secondary malignancies. In this study, optimised combinations of several variance reduction techniques (VRTs) have been implemented in order to achieve a high precision in Monte Carlo (MC) radiation transport simulations and the calculation of in- and out-of-field photon and neutron dose-equivalent distributions in an anthropomorphic phantom using MCNPX, v.2.7. The computer model included a Varian Clinac 2100C treatment head and a high-resolution head phantom. By means of the applied VRTs, a relative uncertainty for the photon dose-equivalent distribution of <1 % in-field and 15 % in average over the rest of the phantom could be obtained. Neutron dose equivalent, caused by photonuclear reactions in the linear accelerator components at photon energies of approximately >8 MeV, has been calculated. Relative uncertainty, calculated for each voxel, could be kept below 5 % in average over all voxels of the phantom. Thus, a very detailed neutron dose distribution could be obtained. The achieved precision now allows a far better estimation of both photon and especially neutron doses out-of-field, where neutrons can become the predominant component of secondary radiation. PMID:26311702

  10. New compounds for neutron capture therapy (NCT) and their significance

    SciTech Connect

    Fairchild, R.G.; Bond, V.P.

    1982-01-01

    Clearly the most effective tumor therapy would be obtained by the selective targeting of cytotoxic agents to tumor cells. Although many biomolecules are known to be taken up in tumors, the targeting of cytotoxic agents to tumors is limited by the fact that other essential cell pools compete with equal or even greater effectiveness. The approach of delivering stable non-toxic isotopes to tumor, with activation by means of an external radiation beam, is advantageous for two reasons: (1) it obviates problems associated with high uptake of isotopes in normal tissues, as these cell pools can be excluded from the radiation field, and (2) the general tumor area can be included in the activating beam field; thus, the possibility exists that all microscopic tumor extensions can be irradiated. As long as range of reaction products is short, dose will be restricted to the tumor, with a resultant high therapeutic ratio. This method can be accomplished with either photon activation therapy (PAT) or Neutron Capture Therapy (NCT), the latter will be emphasized here. The range of the high LET, low OER particles from the /sup 10/B(n,..cap alpha..)/sup 7/Li reaction is approx. 10 ..mu..m, or one cell diameter; hence this reaction is optimal for cell killing. A number of biomolecules have been investigated as possible vehicles for transport of boron to tumors, including phenothiazines, thiouracils, porphyrins, nucleosides, and amino acids. Biodistributions of these compounds show selective concentration in tumor adequate for therapy. The biological halflives are in the order of days, allowing the possibility of fractionated or protracted irradiations. The radiobiological and physical implication of these parameters on NCT are discussed. The possibility of using an approximately-monoenergetic, scandium-filtered beam of about 2 keV, to reduce the dose from background radiations by about 85%, is also discussed. (ERB)